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Abbreviations 
 
For amino acids the suggestions of the IUPAC-IUB-commission for biological 
nomenclature [Eur. J. Biochem. 1984, 138, 9-37] were applied. 
 
 
Ac   Acetyl 
ACN   acetonitrile 
AcOH   acetic acid 
Ac2O   acetic acid anhydride 
Ado   8-amino-3,6-dioxaoctanoic acid 
Ahx   6-aminohexanoic acid 
Antp  Antennapedia (here referring to the 16 amino acid Penetratin 
peptide) 
AntpHD  Antennapedia homeodomain 
bFGF   basic fibroplast growth factor 
Boc   tert.-butyloxycarbonyl 
CPP   cell-penetrating peptide 
DCM   dichloromethane 
Dde   1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl 
DHAP   2,5 dihydroxyacetophenone 
DIC   N,N’-diisopropyl carbodiimide 
DIPEA  N,N’-diisopropylethylamine 
DMF   N,N’-dimethylformamide 
DMSO  dimethylsulfoxide  
DMEM  Dulbecco´s Modified Eagle’s Medium 
EDT   ethanedithiole 
EDTA   ethylenediaminetetraacetic acid 
eq   equivalent 
ER   Endoplasmic reticulum 
ES   Electrospray 
EtOH   ethanol 
FCM   fluorescence correlation microscopy  
FCS   fluorescence correlation spectroscopy 
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FITC   fluorescein isothiocyanate 
Fluo   5(6)-carboxyfluorescein 
Fmoc   N-(9-fluorenyl)methoxycarbonyl 
FRET   fluorescence resonance energy transfer 
FT-ATR-IR  fourier transform attenuated total reflection-infra red 
HBS   HEPES buffered saline 
HBSS   Hank’s buffered salt solution 
HEPES  N-(2-hydroxyethyl) piperazine-N´-(2-ethanesulfonic acid) 
HFIP   hexafluoro-2-isopropanol 
HIV   human immunodeficiency virus 
HOBt   1-hydroxybenzotriazol 
HPLC   high-performance liquid chromatography 
λ   wave length 
M   molar 
MALDI  matrix-assisted laser desorption ionisation 
MeOH  methanol 
MHC   major histocompatibility complex 
MS   mass spectrometry 
Mtt    4-methyltrityl 
MTS    membrane translocating sequence 
m/z   mass/charge ration 
NDGA  nordihydroguaiaretic acid 
NMR    nuclear magnetic resonance 
Pamb   4-aminomethyl benzoic acid 
Pam3Cys  tripalmitoyl-S-glycerylcysteinyl 
Pbf   2,2,5,7,8-pentamethyl-dihydrobenzofuran-5-sulfonyl 
PBS   phosphate-buffered saline 
POPC   1-palmitoyl-2-2-oleoyl-phosphocholine 
POPG  1-palmitoyl-2-2-oleoyl-phosphoglycerol 
RP   reversed phase 
RT   room temperature 
S0387 2-(4-acetanilino-1,3-butadienyl)-3,3-dimethyl-1-(4-sulfobutyl)-
indolium inner salt 
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SPPS   solid-phase peptide synthesis 
t   time 
Tamra    5(6)-carboxytetramethylrhodamine 
tR   retention time 
tBu   tert.-butyl 
tBuOH  tert.-butyl alcohol 
TBTU 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
tetrafluoroborate 
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TFA   trifluoroacetic acid 
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Tris   tris(hydroxymethyl)aminomethane 
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Preface 
Contents of this PhD thesis 
The content of this PhD thesis has been adapted from a total of four 
manuscripts. Three out of these four manuscripts deal with cell-penetrating 
peptides (CPPs) and one manuscript describes the preparation of fluorescently 
labeled peptides in solid-phase synthesis (Fischer et al., 2003). Three of the four 
manuscripts have already been published, whereas the one in preparation will be 
submitted in 2005. In addition, the methods and reagents presented have 
contributed to other manuscripts, which are summarized in Chapter 2. 
This PhD thesis can be considered as witness of the dramatic change of view 
within the CPP research field. When the first manuscripts were prepared 
(Waizenegger et al., 2002;Fischer et al., 2002) most cationic CPPs were still 
supposed to enter cells via a non-endocytic mechanism. Nevertheless some of the 
findings obtained in our laboratory which were partially shown in these initial 
contributions, disagreed with some of the findings obtained by others. Afterwards 
these discrepancies could be attributed to the fact that our investigations were all 
performed with living, non-fixed cells. In 2003 fixation was identified as the major 
source of artefacts in the analysis of the cellular trafficking of CPPs. 
Chapter 3 deals with the application of carboxyfluorescein in solid-phase 
synthesis and the establishment of the synthesis of doubly-labeled peptides 
(Fischer et al., 2003). These protocols were the prerequisites for chapters 4 to 6. 
Chapter 4 investigates the fluorophore and cargo-dependence of cell-penetrating 
peptides (Fischer et al., 2002). The manuscript “A stepwise dissection of the 
intracellular fate of cationic cell-penetrating peptides” elucidated the endosomal 
fate of cationic CPPs (Fischer et al., 2004). The fourth manuscript represents the 
merger of the two converging fields of this PhD thesis, i.e. the synthesis and cell-
biological testing of doubly-labeled CPPs (Fischer et al., 2005b). The introduction 
was partially adapted from a review (Fischer et al., 2005a).  
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1. Introduction 
Viruses provide expressive examples for the potential of perturbing molecular 
mechanisms inside the cell via introduction of foreign molecules, especially DNA 
(Smith and Helenius, 2004). For this reason, it is no surprise that today’s 
molecular and cellular biology exploit very similar strategies. Introduction of DNA 
into cells for the expression of proteins that either modulate or interfere with 
cellular function is a commonplace for the analysis of intracellular molecular 
processes. In addition, the function of gene products has been analyzed by the 
introduction of oligonucleotides, either antisense DNA or siRNA, that inhibit the 
translation of messenger RNA into a protein (Scherer and Rossi, 2003). A further 
class of molecules that has proven useful in the analysis of molecular events 
inside cells are peptides that specifically disrupt molecular interactions, e. g. in 
cellular signal transduction (Prochiantz, 1996). 
For viruses and molecular biologists alike, crossing of the plasma membrane is a 
common challenge. The lipid bilayer of the plasma protects the cellular content 
from entry of pathogens and molecules that interfere with cellular function and 
replication. Import and export of non-permeable molecules into and out of the 
cytoplasm is a tightly regulated process. Only molecules within a narrow range of 
molecular size, net charge and polarity are able to directly cross the plasma 
membrane by passive diffusion along a concentration gradient (Lipinski et al., 
2001). In mammalian cells a large number of transporters are expressed that 
maintain the balance of entry and exit. In contrast, for large hydrophilic 
macromolecules it is generally assumed that endocytosis is the mode of 
internalization (Rejman et al., 2004). Endocytosis, however, guides external 
molecules through compartments with high hydrolytic activity, thereby exerting an 
important protective role (Pillay et al., 2002). 
Pathogens have therefore evolved sophisticated means for bypassing or 
stunning the hydrolytic guards for obtaining access to the cytoplasm. For viruses 
the docking of molecules to cell surface receptors followed by internalization and 
release of genetic information into the cytoplasm provides a highly specific mode 
of entry into only those cells that express the respective receptor. For biologists 
working with a homogeneous population of cells in tissue culture experiments, 
such specificity is usually not required. For this reason, most strategies to cross 
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the plasma membrane for laboratory purposes are poised to efficiency and 
robustness rather than specificity and lack the sophistication of viral entry.  
 
1.1 Crossing the plasma membrane – a crucial prerequisite for 
cell-biological investigations  
Give the demand for introducing macromolecules into living cells, cell-biologists 
have developed a variety of techniques in order to get molecules in. Many cell-
biological experiments aim at the understanding of intracellular biochemical 
events, such as chemical modifications of proteins or intermolecular interactions. 
Many of these experiments require the introduction of molecules into the 
cytoplasm of living cells.  
The strategies developed can roughly be subdivided into those based either on a 
transient disruption of the integrity of the plasma membrane or based on carrier-
mediated approaches (Stephens and Pepperkok, 2001). Examples for the former 
are the generation of pores by application of short high-power electric pulses in 
electroporation or the incubation with pore forming molecules such as 
streptolysine O. Techniques that are based on the transient permeabilization suffer 
from harsh experimental conditions, which clearly limit the survival rate of the cells. 
 
 
Figure 1.1 Different techniques for the introduction of macromolecules into cells (adapted from 
Stephens and Pepperkok, 2001). 
 
Capillary injection on the other hand is another widely used method. Thin glass 
micropipettes are used to inject the sample of interest directly into the cytoplasm.  
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The so-called “carrier-mediated transfer” methods require the linkage of the 
cargo molecule to a moiety that possesses the ability to mediate the transfer of 
other molecules into cells.  
Transfection reagents 
Especially for the introduction of foreign DNA into mammalian cells, carrier-
mediated approaches are well established. Transfection reagents (Surovoy et al., 
1998;Flechsler et al., 1998) improve the import efficiency of cargo molecules by (i) 
neutralization of negative charge and (ii) conferring hydrophobicity, characteristics 
that facilitate the interaction of the resulting complexes with the plasma 
membrane. However despite the fact that these so-called lipoplexes are rather 
hydrophobic, a mechanism that involves internalization via endocytosis has 
received considerable support (Zuhorn et al., 2002). Similarly, loading of 
molecules into liposomes incorporates the cargo into a high molecular weight 
complex with physicochemical characteristics that more closely match those of the 
plasma membrane. Evidently, these carriers exert their activity to a major part by 
disguising the physicochemical characteristics of the cargo. 
Lipopeptides 
Another very compelling strategy for the carrier-mediated uptake, especially in 
the case of biologically active peptides, is the covalent conjugation of a lipid moiety 
to the cargo. This approach has attracted considerable attention for the import of 
peptides (Gras-Masse, 2003). A straight-forward synthetic access to lipopeptides 
based on standard solid-phase synthesis protocols makes these lipoconjugates 
very attractive agents for various biological applications. 
The first works on synthetic lipopeptides were based on the immunologically 
active N-terminal moiety of the principal lipoprotein of Escherichia coli, also known 
as Braun’s lipoprotein (Braun, 1975). The tripalmitoyl-S-glycerylcysteinyl- 
(Pam3Cys) scaffold mediates attachment to the cell membrane, internalization into 
the cytoplasm, and activates macrophages to secrete cytokines (Hoffmann et al., 
1988;Wolf et al., 1989;Metzger et al., 1993). Synthetic viral peptides covalently 
linked to Pam3Cys were demonstrated to efficiently prime influenza virus-specific 
CTLs in vivo (Deres et al., 1989), making these conjugates attractive agents for 
the generation of fully synthetic vaccines. Due to its immune system modulating 
activity and the identification of the Toll like receptor 2 as its physiological receptor 
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(Lien et al., 1999;Aliprantis et al., 1999), Pam3Cys-conjugates have seen a 
tremendous growth in interest within the last 5 years. 
Peptides conjugated to one single lipid chain have also been applied for a large 
variety of purposes. Myristoylated pseudosubstrate domains of protein kinase C 
were demonstrated to be delivered into the cytoplasm of mammalian cells and 
exert an inhibitory activity (Verhoeven et al., 1993;Eichholtz et al., 1993). 
Monolipidated peptides were also shown to be applicable for targeting of MHC I 
(Loing et al., 2000) and MHC II molecules (Papini et al., 2001). The internalization 
of lipopeptides is suggested to be endocytosis-dependent (Schörner, 
1999;Andrieu et al., 2000). 
1.2 Cell-penetrating peptides as a carrier-mediated delivery 
strategy 
CPPs are small molecules of mostly 9 to 30 amino acids in length. Efficient 
cellular import has been achieved for cargos as diverse as peptides (Prochiantz, 
1996;Hawiger, 1999), proteins as large as 120 kDa (Rojas et al., 1998;Schwarze 
et al., 1999), oligonucleotides (Astriab-Fisher et al., 2002), plasmids (Singh et al., 
1999), peptide nucleic acids (Pooga et al., 1998b), siRNA (Muratovska and 
Eccles, 2004;Chiu et al., 2004) and even nanoparticles (Lewin et al., 2000).  
In most of these applications conjugation of only one carrier peptide to a cargo 
renders the molecule import competent. However, a nine amino acid peptide will 
have little impact on the physicochemical characteristics of a 120 kDa protein 
(Schwarze et al., 1999) or a duplex 21 nt siRNA (Chiu et al., 2004). As a 
consequence, in contrast to the transfection reagents described above, rather than 
disguising the physicochemical characteristics, CPPs are well defined 
pharmacokinetic modifiers that add a new functionality to a specific site of an 
otherwise unperturbed molecule. Rapid cellular uptake (Richard et al., 2003) in 
combination with a highly defined molecular structure and ease of handling 
renders the CPPs highly attractive mediators of import. Moreover, the advantages 
of CPPs as peptide-based transport vehicles are the accessibility of large 
collections of different peptides by well-established automated procedures (Jung 
and Beck-Sickinger, 1992) allowing detailed structure-activity relationships and a 
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rational and straight-forward approach to the generation of new and optimized 
CPPs.  
Applications of CPPs exceed well beyond mere tissue culture experiments. 
CPP/peptide conjugates and CPP-fusion proteins that interfere with protein-protein 
interactions have been successfully applied as therapeutic agents in animal 
models (Fujihara et al., 2000;Myou et al., 2003). In contrast to liposomes, CPP-
peptide conjugates possess many beneficial drug-like characteristics. In the case 
of peptide cargos, covalent CPP-conjugates are analytically well defined, storable, 
and no leakage of the active moiety occurs.  
1.3 The origin of cell-penetrating peptides 
In 1965, Ryser and Hancock demonstrated that the addition of homopolymers of 
cationic amino acids (~ 100 kDa) to tissue culture media containing radio labeled 
albumin enhanced the uptake of the radiolabel into the cell (Ryser and Hancock, 
1965). In the 1970ies again Ryser et al. demonstrated that covalent coupling of 
poly (L-lysine) to proteins or small molecules enhances their cellular uptake and, in 
the case of methotrexate, the biological activity of this drug (Ryser and Shen, 
1978;Shen and Ryser, 1978).  
About 10 years later Frankel et al. observed that the HIV-1 Tat protein is taken 
up by tissue culture cells. The internalized Tat protein is then capable of 
transactivating the viral promoter in the nucleus of the targeted eukaryotic cell 
(Frankel and Pabo, 1988). Only some years later, the 60-amino acid polypeptide 
corresponding to the sequence of the homeodomain of the Drosophila 
Antennapedia transcription factor was shown to penetrate neurons and augment 
their morphological differentiation (Joliot et al., 1991). These findings suggested 
that the efficient internalization of proteins into cells, first observed for a synthetic 
oligopeptide by Ryser and Hancock, has a correspondence in nature.  
In the case of the HIV-1 Tat protein the internalization was attributed to a basic 
domain comprising amino acids 48 to 60 (Vives et al., 1997). The peptide 
corresponding to this region of the protein is termed “Tat peptide”. In the case of 
the Antennapedia protein a peptide of 16 amino acids in length corresponding to 
the third helix of the homeodomain was still capable of “translocating through the 
plasma membrane” (Derossi et al., 1994). As a CPP, this domain is also referred 
to as Penetratin. During the following years, the compelling properties of these 
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peptides promoted the identification of further CPPs. These peptides were either 
based on small domains of naturally existing proteins (Lin et al., 1995;Pooga et al., 
1998a;Oess and Hildt, 2000) or designed de novo (Sheldon et al., 1995;Morris et 
al., 2001). An overview of the current diversity of cell-penetrating peptides is given 
in Figure 1.2. 
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Figure 1.2 An overview of the current peptide motifs considered to be cell-penetrating. 
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1.4 Cell-penetrating peptides versus antimicrobial and 
membrane-active peptides 
Membrane-active peptides 
Many membrane-active peptides, including antimicrobials and toxins, are known 
to induce transmembrane pores. The first peptide discovered to do so is 
alamethicin (Mueller and Rudin, 1968). Alamethicin was first supposed to induce 
pores only in the presence of a transmembrane potential. However, it was shown 
that alamethicin could insert into bilayers also in the absence of an external field 
(Fringeli and Fringeli, 1979). At micromolar concentrations alamethicin has also 
been shown to cause hemolysis in human erythrocytes. In black lipid membranes 
at nanomolar concentrations the peptide induces the formation of voltage-
dependent pores with multi-state properties (Irmscher and Jung, 1977).  
Two other extensively studied peptides, the bee venom toxin melittin 
(Habermann, 1972) and the frog peptide magainin (Zasloff, 1987) exhibit similar 
behaviours. Both melittin (Hanke et al., 1983;Matsuzaki et al., 1997) and magainin 
cause the leakage of fluorescent dyes from lipid vesicles indicating formation of 
pores. In the last 15 years, a great variety of antimicrobial peptides have been 
shown to similarly  induce transmembrane pores in bacterial cells as well as in 
lipid vesicles (Jack and Jung, 1998;Zasloff, 2002).  
Cell-penetrating peptides versus antimicrobial peptides 
The Penetratin peptide was initially demonstrated to traverse a pure lipid bilayer 
(Thoren et al., 2000) without forming pores (Thoren et al., 2000;Persson et al., 
2003), a finding that clearly distinguishes this CPP from antimicrobial peptides. 
Moreover CPPs such as Tat and Penetratin are considerably less toxic and 
haemolytic than most antimicrobial peptides (Vives et al., 1997;Trehin et al., 
2004). 
Antimicrobial peptides as CPPs 
Recent findings indicate that CPPs and antimicrobial peptides share common 
functional characteristics. Both groups of peptides bind to lipid membranes. 
Magainin was demonstrated to be internalized rapidly into mammalian cells 
exhibiting a cooperative concentration dependence of uptake. This finding 
suggests that the peptide forms a pore as an intermediate similar to the 
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observations in membranes. Furthermore, translocation was accompanied by 
cytotoxicity (Takeshima et al., 2003). In contrast, buforin another cationic 
antimicrobial peptide, translocated by a less concentration-dependent, passive 
mechanism, without showing any significant toxicity (Takeshima et al., 2003).  
CPPs as antimicrobial peptides 
Given that CPPs are cationic and often amphipathic, similar to membrane active 
antimicrobial peptides, a recent work investigated whether CPPs may also act as 
antimicrobial peptides (Nekhotiaeva et al., 2004). TP10, a 21-amino acid deletion 
analogue of the chimeric CPP transportan (Pooga et al., 2001), inhibited Candida 
albicans and Staphylococcus aureus growth. pVEC, another cationic CPP 
(Elmquist et al., 2001), inhibited Mycobacterium smegmatis growth at low 
micromolar doses, below the levels that harmed human HeLa cells. Therefore, 
TP10 and pVEC can enter both mammalian and microbial cells and preferentially 
permeabilize and kill microbes (Nekhotiaeva et al., 2004). 
 
 
INTRODUCTION 
 
 - 11 -  
1.5 Mode of action 
Up until recently, flow cytometric and microscopic experiments addressing the 
uptake of CPPs were conducted by incubation of cells with fluorescently labeled 
peptides and subsequent fixation. Alternatively, biotinylated CPPs were visualized 
post fixation and permeabilization via staining with fluorescently labeled 
streptavidin. The results of these experiments suggested that the uptake of 
Penetratin, the HIV-1 Tat peptide and oligo-arginine was insensitive to low 
temperature (Derossi et al., 1994;Vives et al., 1997;Futaki et al., 2001) and to 
inhibitors of endocytosis (Vives et al., 1997;Suzuki et al., 2002). For this reason, a 
mechanism of import by direct crossing of the plasma membrane was postulated 
(Derossi et al., 1994;Vives et al., 1997). The data was fully supported by 
biophysical experiments according to which Penetratin was able to traverse a pure 
lipid bilayer  without forming pores (Thoren et al., 2000;Persson et al., 2003).  
Although having difficulties to explain how hydrophilic macromolecules cross a 
lipid bilayer and given the reports on the endocytic uptake of the Tat protein (Mann 
and Frankel, 1991) this model remained more or less unchallenged until 2003. At 
the beginning of 2003 Olsnes et al. stated that “experiments to exclude that the 
entry of endocytosed (Tat) peptide into the nucleus occurred after fixation and 
permeabilization are highly desirable” (Olsnes et al., 2003). The same group had 
reported earlier that neither the Tat basic domain nor the viral protein VP22 had 
been able to mediate membrane translocation of Diphteria toxin A-fragment 
(Falnes et al., 2001). Import of the Diphteria A toxin into the cytoplasm provided a 
highly sensitive functional assay for detecting the cytoplasmic delivery of a cargo. 
The authors therefore concluded that the CPP-mediated import was inefficient.  
State-of-the-art findings: Post-fixation era 
In 2003 it was shown by Richard et al. (Richard et al., 2003) that the earlier cell-
biological experiments had suffered from an artifactual uptake of CPPs caused by 
fixation of cells. These researchers used live cell fluorescence microscopy to 
monitor the uptake of fluorescein-labeled peptides. Moreover, it was demonstrated 
that cationic CPPs associated with the outer leaflet of the plasma membrane. 
Removal of these peptides was achieved by incubation of cells with trypsin. Very 
likely, this population of peptides accounted for the intracellular fluorescence 
observed previously for fixed cells which had been incubated at 4°C. The data 
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presented in this work demonstrated the involvement of endocytosis in the cellular 
internalization of the Tat peptide and the (Arg)9 peptide. In a second, rather 
unnoticed work, cationic CPPs were demonstrated to bind to plastic and glass, 
materials which are commonly used in cellular assays applied in the CPP field 
(Chico et al., 2003). It was stated that “under certain conditions, such non-specific 
to plastic or glass surfaces binding could be mistaken for cellular 
penetration”(Chico et al., 2003).  
Within the past two years the role of endocytosis for the uptake of CPP-protein 
conjugates was substantiated by several publications. Inhibitors of metabolism or 
endocytosis, such as cytochalasin D were demonstrated to impair the uptake of 
Penetratin (Drin et al., 2003). Moreover Penetratin and the Tat peptide were 
shown to promote endocytosis of high molecular weight cargo upon binding to cell 
surface glycosaminoglycans (Console et al., 2003). Another comparison of CPPs 
revealed that endocytosis depends only on the number of positives charges within 
the peptide whereas oligopeptide transduction requires the guanidine structure of 
arginine (Zaro and Shen, 2003).  
The contribution of the individual endocytic pathways is still under dispute. For Tat 
fusion proteins caveolar endocytosis (Fittipaldi et al., 2003) as well as 
macropinocytosis (Wadia et al., 2004) were proposed. It should be emphasized 
that both contributions included reliable functional cellular assays for detecting the 
delivery of functional proteins into the cytoplasm. These assays were based either 
on the transactivating activity of the Tat-protein (Fittipaldi et al., 2003) or on the 
enzymatic activity of the Cre-recombinase (Wadia et al., 2004). For short CPPs 
alone, to our knowledge no functional assay has been established so far, to 
reliably compare the arrival of intact and biologically active CPPs in the cytosolic 
compartment under different experimental conditions. This deficit may still lead to 
wrong conclusions on the cellular uptake and intracellular fate of CPPs. Even 
though, our understanding of the cellular trafficking of CPPs has benefited 
enormously from the use of fluorescently tagged CPPs in live cell microscopy, we 
should be aware that the subcellular distribution of the fluorescent dye may not 
represent the one of the CPP but rather the one of a proteolytic product. 
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In spite of the accumulating evidence for endocytosis, the refined experimental 
approaches, as well, provide new evidence for at least a contribution of membrane 
permeation to the cellular uptake of these peptides (Thoren et al., 2003). In two 
different cells lines an endocytic uptake was observed for Penetratin. However, a 
hepta-arginine peptide, with a tryptophane residue added to the C-terminus, was 
found to be internalized via an energy-independent, non-endocytic pathway. For 
the Antennapedia protein and the HIV Tat protein, minute amounts that directly 
enter the cytoplasm and transfer into the nucleus may already be sufficient for 
these proteins to exert their physiological functions.  
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1.6 Applications of CPPs 
Despite the fact that the mode of action of CPPs is still not understood in detail 
and currently a matter of great debate, the applications of CPPs are undoubtedly a 
story of great success. The applications range from mere cell-culture experiments 
to animal studies and show promise for potential therapeutics. 
 
Applications 
of CPPs
Delivery of signal transduction 
inhibitors into the cytosol
- pseudosubstrates
- competitive inhibitors of an 
  enzyme active site
- compartment specific 
  localization signals
- structural mimetics of 
  interaction domains
Immunological applications
- 
- Delivery of whole proteins 
   into the MHC I pathway
- 
Delivery of MHC I epitopes
Delivery of epitopes into the 
   MHC II pathway
Protein transduction
- Cell-biological applications
- Vaccination purposes
- Therapeutic applications
Delivery of nucleic acids and PNAs
- Plasmids
- siRNA
Delivery of nanoparticles
PROTACS
- Targeted degradation 
  of proteins
Protein semi-synthesis 
in living cells
 
 
Figure 1.3 An overview of the applications of cell-penetrating peptides. 
 
Delivery of peptides into the cytoplasm for the interference with cellular 
signal transduction 
Most applications of CPPs include the introduction of peptides into the cytoplasm 
in order to interfere with signal transduction (Prochiantz, 1996;Hawiger, 1999). 
Peptide cargos delivered by conjugation to CPPs included pseudo-substrates 
(Theodore et al., 1995), competitive inhibitors of an enzyme active site (Nishikawa 
et al., 2000), compartment-specific localization sequences (Lin et al., 1995), and 
structural mimetics of interaction domains (Horng et al., 2001). The advantages of 
peptide-based functional analyses in cell biology are the accessibility of large 
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collections of different compounds by well-established automated procedures 
(Jung et al., 1992) as well as a rational approach to the generation of biologically 
active compounds based on available structural information of interaction 
domains.  
Within the last two years several successful animal studies using CPP-peptide 
conjugates have been published. One of the most astonishing studies showed that 
a cell-penetrating inhibitor of NFAT (nuclear factor of activated T-cells) based on 
the polyarginine delivery system was able to provide immunosuppression for fully 
mismatched islet allografts in mice. In addition, this compound did not affect insulin 
secretion, whereas FK506, as established calcineurin inhibitor, caused a dose-
dependent decrease in insulin secretion (Noguchi et al., 2004). This surprising 
study implies that CPP-based drugs may represent more than just a laboratory 
approach but an alternative to traditional low molecular weight drugs. Nevertheless 
the antigenicity of those peptides may limit their broad applicability. 
CPPs for immunological applications 
The delivery of exogenous antigens into the MHC class I processing pathway 
using CPPs has been presented in vitro and in whole animals (Schutze-
Redelmeier et al., 1996;Pietersz et al., 2001). On dendritic cells CPP-epitope 
conjugates were shown to enable prolonged antigen presentation on MHC I 
molecules (Wang and Wang, 2002). CPPs therefore have the promise to 
represent a widely applicable means to enhance immune responses against 
cancer and infectious diseases. A more recent work showed that the detailed 
knowledge of the intracellular fate of CPPs allows a rational design of CPP-epitope 
constructs for the optimization of peptide-based vaccines (Lu et al., 2004). In this 
work it was also demonstrated that CPPs bearing a CTL and a T helper cell 
epitope can generate both the corresponding MHC class I – and II-binding 
peptides and elicit a strong CTL and T helper cell response.  
Proteins as cargos 
The application of CPPs for the delivery of proteins renders them an attractive 
alternative to genetic intervention (Ford et al., 2001). Cargo proteins have been as 
large as 120 kDa (Rojas et al., 1998;Schwarze et al., 1999). Their principal 
applicability to animal studies has been demonstrated using the 120 kDa-β-
galactosidase protein (Schwarze et al., 1999). The therapeutic potential of protein 
transduction has been proven in a recent work reporting on the blockade of 
INTRODUCTION 
 
 
 - 16 - 
inflammation and airway hyper responsiveness in immune–sensitized mice using a 
cell-penetrating dominant-negative phosphoinositide 3-kinase (Myou et al., 2003). 
Protein transduction has also been applied to the introduction of proteins into the 
MHC class I processing pathway (Kim et al., 1997). 
Nucleic acids 
CPPs have moreover been used for the transfer of plasmid DNA (Rudolph et al., 
2003) and siRNA (Simeoni et al., 2003;Muratovska et al., 2004;Chiu et al., 2004) 
into mammalian cells and for the successful application of peptide nucleic acids in 
an animal model (Pooga et al., 1998b).  
Nanoparticles 
CPP-derivatized super magnetic nanoparticles have been demonstrated to be 
suitable for cell labeling (Lewin et al., 2000).  
Generation of chemical knockouts 
A compelling strategy for the generation of a transient protein knock-out has 
been described by Crews et al. (Schneekloth, Jr. et al., 2004). A ligand for an 
intracellular target protein was chemically linked to a peptide sequence that binds 
to the E3 ubiquitin ligase. This chimeric molecule was introduced into mammalian 
cells using a CPP leading to the recruitment of the target protein to the 
proteasome and subsequently to its degradation. 
Protein semi-synthesis in living cells 
Muir et al. have developed an approach to obtain semi-synthetic proteins in 
living cells (Giriat and Muir, 2003). The protein of interest was expressed in living 
cells with the first half of the naturally occurring Ssp Dna split intein fused to its C-
terminus. Then, a semi-synthetic polypeptide, consisting of the second half of the 
intein covalently linked to a synthetic probe (which may be a fluorescent dye) and 
a CPP, was added to the culture media. The CPP delivered the probe into the cell, 
whereupon the probe associated with its complementary half triggering protein 
splicing. This splicing event resulted in the removal of the intein and ligation of the 
probe to the selected protein through a normal peptide bond. 
 
INTRODUCTION 
 
 - 17 -  
CPP
 
 
Figure 1.4 Principle of semi-synthetic protein trans-splicing in living cells. IN is the first half of the 
naturally occurring Ssp DnaE intein, IC is its second half (adapted from (Giriat et al., 2003). 
 
 
 
 
CONTRIBUTIONS TO OTHER PROJECTS 
 
 
 - 18 - 
2. Contributions to other projects 
 
Listed below are the contributions to other projects that led to already published 
scientific articles and manuscripts which have either been submitted or which are 
preparation. 
 
2.1 Intracellular concentration measurements in adherent cells: 
A comparison of import efficiencies of cell-permeable peptides 
(Waizenegger et al., 2002) 
The author of this thesis synthesized all peptides used in this study. Moreover he 
established the analysis of cell-penetrating peptides using Fluorescence 
Correlation Microscopy (FCM) during his diploma thesis. 
 
2.2 Structure property analysis of pentamethine indocyanine 
dyes: Identification of a new dye for life science applications 
(Mader et al., 2004) 
The author of this thesis tested several pentamethine indocyanine dyes with 
respect to their applicability in solid-phase synthesis. Moreover several peptides 
labeled with S0387 were prepared, e.g. an MHC I binding peptide, that was used 
in this study. 
 
2.3 Chemolabile cellular microarrays for screening of small 
compounds and peptides (Hoff et al., 2004) 
The author of this thesis synthesized several peptides used in the experiments. He 
performed experiments to validate the proof of principle for the non-covalent 
attachment of peptides on glass substrates for their use in cellular microarrays. 
Moreover he assisted the diploma student M. Hulko in the design and synthesis of 
the chemolabile compounds presented in the manuscript. 
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2.4 Reversible cross-linking of hyperbranched polymers: A 
strategy for the combinatorial decoration of multivalent scaffolds 
(Barth et al., 2005) 
The author of this thesis tested peptide-decorated hyperbranched polymers, 
synthesized by Dr. M. Barth, with respect to their biological applicability, i.e. 
evaluation of toxicity and investigation of internalization using confocal 
fluorescence microscopy and flow cytometry.  
 
2.5 Peptide microarrays for the detection of molecular 
interactions in cellular signal transduction (Stoevesandt et al., 
2005) 
The author of this thesis synthesized the bis-phosphorylated ZAP-70 binding 
peptide used in this study. 
 
2.6 Autophagy promotes presentation of MHC-II peptides from 
intracellular source proteins (Dengjel et al., 2005) 
The author of this thesis performed fluorescence microscopy und fluorescence 
spectroscopy measurements in order to identify conditions under which autophagy 
was induced in the investigated cell line.  
 
2.7 A ratiometric fluorescence-based LPS-sensor (Voss et al., 
2005) 
The author of this thesis conceived the concept of a doubly-labeled peptide as 
biosensor for LPS based on an LPS-binding peptide and intramolecular 
Fluorescence Resonance Energy Transfer (FRET). He moreover synthesized a 
doubly-labeled LPS-binding peptide and performed initial experiments to establish 
the proof of principle. S. Voss successfully continued these initial experiments and 
substantially extended the scope of this application.   
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3   Extending the applicability of carboxyfluorescein in solid-phase 
synthesis 
 
This chapter was published in Bioconjugate Chemistry in 2003. The author of 
this thesis contributed Figures 1, 2, 3, 4, and 6. Figure 5 was contributed by Dr. O. 
Mader.  
3.1 Summary 
Optimized coupling protocols are presented for the efficient and automated 
generation of carboxyfluorescein-labeled peptides. Side products, generated when 
applying earlier protocols for the in situ activation of carboxyfluorescein, were 
eliminated by a simple procedure, yielding highly pure fluorescent peptides and 
minimizing post-synthesis work-up. For the cost-efficient labeling of large 
compound collections, coupling protocols were developed reducing the amount of 
coupling reagent and fluorophore. In order to enable further chemical 
derivatization of carboxyfluorescein-labeled peptides in solid-phase synthesis, the 
on-resin introduction of the trityl group was devised as a protecting group strategy 
for carboxyfluorescein. This protecting group strategy was exploited for the 
synthesis of peptides labeled with two different fluorescent dyes; essential tools for 
bioanalytical applications based on fluorescence resonance energy transfer 
(FRET). Tritylation and optimized labeling conditions led to the development of a 
fluorescein-preloaded resin for the automated synthesis of fluorescein-labeled 
compound collections with uniform labeling yields.  
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3.2 Introduction 
A growing number of applications in bioanalytical chemistry depend on 
fluorescently labeled molecules with biological activity (Brand and Johnson, 1997). 
Carboxyfluorescein has remained a reagent of choice for the preparation of 
hydrolytically stable fluorescent peptides and protein conjugates (Brinkley, 
1992;Weber et al., 1998). Fluorescein owes this popularity to its biocompatibility, 
low price and availability of instrumentation for the detection of its fluorescence. 
Fluorescein-labeled peptide derivatives have been employed as fluorescent 
markers in bioanalytical applications, such as confocal laser scanning microscopy 
(Schmidt et al., 1998), flow cytometry (Owens and Loken, 1995), and more 
recently fluorescence polarization measurements (Dedier et al., 2001) and 
intracellular fluorescence correlation spectroscopy (Waizenegger et al., 2002). 
Moreover, carboxyfluorescein has been shown to be a useful educt for the 
synthesis of further fluorescent reagents (Mattingly, 1992;Theisen et al., 
1992;Adamczyk et al., 1997).  
Labeling of peptides with fluorescein can either be performed in solution or using 
side chain-protected polymer bound peptides in solid-phase peptide synthesis 
(SPPS). In most cases reported so far, labeling has been accomplished using 
activated reagents, namely fluorescein isothiocyanate (Dettin et al., 1998) or 
carboxyfluorescein-N-succinimidylester (Hoogerhout et al., 1999). However, these 
activated fluorescein derivatives are rather expensive in comparison to 5(6)-
carboxyfluorescein (Weber et al., 1998). 
In solid-phase synthesis, coupling of carboxyfluorescein has been accomplished 
using in situ activation with different coupling reagents (Weber et al., 1998;Fulop et 
al., 2001). However, when applying the published protocols, we detected the 
formation of various side products. Here we present the elucidation of these side 
products and their removal by a very simple procedure yielding highly pure 
carboxyfluorescein-labeled peptides. 
When dealing with the synthesis of large peptide collections (Jung et al., 1992) 
and combinatorial compound libraries (Jung, 1996;Jung, 1999) the use of a large 
excess of fluorophore is not economical. This is especially the case when 
isomerically pure carboxyfluorescein is desired (Rossi and Kao, 1997). Thus we 
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have established a protocol employing far less equivalents of carboxyfluorescein, 
which still results in complete turnover of the solid-phase bound peptides. 
Peptides bearing two different fluorescent dyes extend the use of fluorescently 
labeled reporter molecules to fluorescence resonance energy transfer (FRET) 
experiments (Clegg, 1995). These peptides can be used for various in vitro 
applications, e.g. the detection of metal ions (Pearce et al., 1998), the investigation 
of protein-ligand interactions (Wei et al., 1994) and monitoring of transpeptidation 
reactions (Kruger et al., 2002) or proteolytic activity (Cummings et al., 2002). In 
combination with large genetically encoded libraries of protein variants, such 
compounds have been used as substrates in order to identify proteolytic enzymes 
with novel substrate specificities (Olsen et al., 2000). For in vivo studies, such 
peptides have been employed for the analysis of cellular uptake and proteolytic 
processing of peptides (Hoogerhout et al., 1999;Bark and Hahn, 2000). 
During solid-phase synthesis of such doubly-labeled peptides, two complications 
are encountered. (i) The first fluorophore introduced must be chemically inert to 
the reaction conditions required for the selective deprotection of the second 
attachment site. (ii) Moreover, the first fluorophore may itself possess functional 
groups that may react with the activated second fluorophore.  
Here a generally applicable strategy is presented in which carboxyfluorescein is 
introduced as the first fluorophore. By introducing an O-trityl-protecting group to 
polymer bound carboxyfluorescein, the reaction of an activated second 
fluorophore with the phenolic hydroxy groups of the fluorescein moiety could be 
prevented. In addition, carboxyfluorescein was rendered chemically inert to the 
removal of the Dde-protecting group by hydrazine treatment enabling the 
orthogonal exposure of a second functional group. Trityl deprotection is achieved 
during the final TFA-cleavage of the peptide from the resin. 
The ability to render carboxyfluorescein chemically inert to a broad range of 
conditions in SPPS led to the development of a carboxyfluorescein-preloaded 
resin. This resin is ideally suited for the automated synthesis of large collections of 
fluorescein-labeled peptides with uniform labeling efficiency, and for the 
generation of large numbers of doubly-labeled peptides, bearing a fluorescein 
moiety at the C-terminus and a second dye of choice at the N-terminus. 
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3.3 Results 
3.3.1 Optimization of reaction conditions for fluorescein labeling 
The in situ generation of active esters in solid-phase peptide synthesis 
circumvents the need for the synthesis, work-up and storage of water-labile amino 
acid active esters. Nevertheless the introduction of amine-reactive fluorescent 
reporter groups has mostly relied on the use of cost-intensive preformed active 
ester derivatives (Hoogerhout et al., 1999). We applied a protocol describing the 
introduction of 5(6)-carboxyfluorescein by in situ activation using 10 equivalents of 
dye, DIC and HOBt (1:1:1) and a reaction time of 1 h for the labeling of several 
peptides (Weber et al., 1998).  Using this protocol, we detected several additional 
products by analytical HPLC and MALDI-MS. The molecular weights of the 
additional products differed from the masses of the carboxyfluorescein-labeled 
peptides by additional masses of n times 358.3 Da. These mass differences 
correspond to the masses of one, and several additional 5(6)-carboxyfluorescein 
groups.  
In order to analyze the identity of the side-products in more detail, Wang resin 
bound L-phenylalanine was chosen as a model compound. The phenyl moiety 
enables the detection of unlabeled material by UV-spectroscopy. HPLC-MS 
analysis of the product (1a) formed by reacting Phe-Wang resin with excess 5(6)-
carboxyfluorescein, as described (Weber et al., 1998), confirmed the formation of 
side products (29% according to HPLC-analysis [214 nm], Fig. 3.1 B). The two 
positional isomers of Fluo-Phe-OH showed retention times of 21.5 and 22 min 
([M+H]+ = 524.2 Da]. Three further products eluted at about 25.5 min ([M+H]+ = 
882.3 Da] followed by further additional products eluting at about 27.7 min ([M+H]+ 
= 1241.1 Da]. The masses of these side products corresponded to 
carboxyfluorescein-labeled phenylalanine, carrying two and three additional 
carboxyfluorescein molecules. These side products could also be detected by 
MALDI-MS (Fig. 3.1 A). Treatment of resin 1 with piperidine/DMF (1:4, v/v) prior to 
TFA cleavage removed these side products, yielding highly pure Fluo-Phe-OH 
(Fig. 3.1 B, 1a).  
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Figure 3.1 (A) MALDI mass spectrum of Fluo-Phe-OH (compound 1b, theor. [M+H]+ = 524.5 Da) 
without piperidine treatment. The side products ([M+H]+ = 882.7 Da, [M+H]+ = 1242.5 Da) differ by 
mass differences corresponding to one and two additional carboxyfluorescein moieties. (B) HPLC 
elution profiles of Fluo-Phe-OH synthesized with (compound 1a) and without (compound 1b) 
subsequent piperidine treatment. LC-MS analysis revealed the following masses: products eluting 
at 21.5 and 22 min, [M+H]+ = 524.2 Da; three products at 25.5 min, [M+H]+ = 882.3 Da; several 
additional products at 27.7 min [M+H]+ = 1241.1 Da. The larger number of peaks for side products 
with higher molecular masses and eluting at later times may be explained by side products carrying 
different combinations of 5- and 6-carboxyfluorescein. 
 
Even though complete turnover of the starting material was achieved in only 1 h, 
the use of 10 equivalents of dye and coupling reagent is uneconomical. For this 
reason, fewer equivalents but longer reaction times were tested as an alternative 
coupling condition. Labeling of Phe-Wang resin with only 2.5 equivalents of 5(6)-
carboxyfluorescein, DIC and HOBt (1:1:1) for 16 h resulted in complete acylation 
as monitored by Kaiser-Test. However, side products bearing additional 
carboxyfluorescein moieties were still formed. Again, the removal of these side 
products was achieved by piperidine treatment (data not shown).  
Next, we validated this labeling procedure for the octapeptide DYGIPADH, 
which has been shown to exhibit selective protein kinase C ε isozyme agonist 
activity (Chen et al., 2001). Acylation with 2.5 eq of 5(6)-
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carboxyfluorescein/DIC/HOBt (1:1:1) for 16 h again resulted in complete formation 
of the desired product Fluo-DYGIPADH (Fig. 3.2). Without piperidine/DMF 
treatment of the resin bound carboxyfluorescein-labeled peptide, more than 40% 
(HPLC, [214 nm]) of the peptide was labeled with more than one molecule of 5(6)-
carboxyfluorescein. These analytical data for an N-terminally labeled octapeptide 
again outline the importance of the piperidine treatment for the generation of 
carboxyfluorescein-labeled pure products.  
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Figure 3.2 (A) MALDI mass spectrum of Fluo-DYGIPADH-OH synthesized with piperidine 
treatment following the coupling of carboxyfluorescein (compound 2a) (theor. [M+H]+ = 1246.2 Da). 
(B) HPLC elution profiles of Fluo-DYGIPADH-OH with (compound 2a) and without (compound 2b) 
piperidine treatment. The unlabeled peptide H-DYGIPADH-OH eluted at 13.5 min, the positional 
isomers of Fluo-DYGIPADH-OH at 17.8 and 18.0 min. In 2b the side products eluting at 22.5 min, 
24.7 min and 26.6 min correspond to peptides carrying several molecules of carboxyfluorescein 
([M+H]+ = 1604.4 Da, [M+H]+ = 1963.0 Da, [M+H]+ = 2322.3 Da, respectively).  
 
The MHC class I-binding peptide ligand SIINFEK(Fluo)L (Wiesmüller et al., 
1955;Rötzschke et al., 1991) was synthesized in order to confirm that our strategy 
is also applicable to the labeling of peptides via a lysine side chain. Fmoc-
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Lys(Dde)-OH was incorporated by automated SPPS, yielding resin bound 
SIINFEK(Dde)L. After introducing the Boc protecting group at the N-terminus, the 
Dde protecting group was removed and the free ε-amino group was labeled with 
5(6)-carboxyfluorescein according to our protocol, yielding highly pure peptide. 
3.3.2 On-resin O-tritylation of carboxyfluorescein 
Peptides labeled with two different fluorescent dyes can either be generated in 
solution or using side chain-protected polymer bound peptides in SPPS in 
combination with orthogonal protecting group strategies. The scope of solution phase 
labeling is severely limited to sequences with special side-chain characteristics (Wei 
et al., 1994;Geoghegan et al., 2000). Moreover, several laborious purification steps 
are often required for this approach. In order to explore and optimize the generation of 
doubly-labeled peptides by an SPPS-based approach, Fmoc-Lys(Dde)-OH (Bycroft et 
al., 1993;Augustyns et al., 1998) was selected as a building block for the introduction 
of a second fluorescent dye via a selectively deprotectable lysine side chain 
(Hoogerhout et al., 1999). The Dde-protecting group can be removed by treatment of 
the resin bound peptide with 2% hydrazine hydrate/DMF. We chose this strategy 
instead of the incorporation of Fmoc-Lys(Mtt)-OH (Aletras et al., 1995). When working 
with Fmoc-Lys(Mtt)-OH in the presence of other trityl-based protecting groups, 
selective Mtt removal had been difficult to achieve (Bourel et al., 2000). Our strategy, 
described here, is based on the introduction of carboxyfluorescein at the N-terminus of 
a solid-phase bound peptide and of a second fluorophore via the selectively 
deprotectable lysine side chain. 
However, exposure of carboxyfluorescein-labeled peptides to 2% hydrazine 
hydrate/DMF twice for 3 min resulted in the formation of side products eluting several 
minutes earlier in analytical HPLC and possessing a mass 14 Da higher than that of 
the desired product.  
In order to assess whether this side product was due to the fluorescein moiety, the 
Fluo-Phe-Wang resin was also treated with 2% hydrazine hydrate/DMF. Again the 
formation of a side product with a mass surplus of 14 Da decreased the purity of the 
Fluo-Phe-OH compound by 24% (Fig. 3.3 B). This mass difference is indicative of the 
formation of a hydrazone or a hydrazide with peptide bound carboxyfluorescein.  
At this point we realized that the phenolic hydroxy groups of carboxyfluorescein 
could be protected by treatment with anhydrides, such as acetic anhydride or 
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trimethylacetic anhydride. These reactions lead to the conversion of 
carboxyfluorescein into the corresponding phenolic diesters of the lactone form 
(Mattingly, 1992;Theisen et al., 1992;Rossi et al., 1997). The conversion of the 
fluorescein moiety into its lactonic form can be monitored visually by the color change 
from orange to yellow and the loss of fluorescence. However, due to the lability of 
these phenolic esters to basic conditions, this protecting group strategy is 
incompatible with the conditions of hydrazine treatment. Instead, phenols can also be 
efficiently protected by base-stabile trityl-based protecting groups (Barlos et al., 1991) 
using trityl chloride for the introduction (Jung, 1996). Removal can be accomplished 
during TFA cleavage of the peptide from the resin.  
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Figure 3.3 (A) Relevant regions of the on-bead FT-ATR-IR spectra of the Fluo(Trt)-Phe-Wang 
resin (3a) and of the Fluo-Phe-Wang resin (3b). The broad peak at 3300 cm-1 indicates the 
presence of unprotected hydroxy groups of resin bound carboxyfluorescein (3b). For the Fluo(Trt)-
Phe-Wang resin no such peak is detectable. The intensities of the two spectra were adjusted 
according to the intensity of the amide band at 1670 cm-1. (B) Analytical HPLC profile of Fluo-Phe-
OH after treatment with 2% hydrazine/DMF, with (compound 3a) and without (compound 3b) prior 
tritylation. Apart from the two positional isomers of Fluo-Phe-OH ([M+H]+ = 524.1 Da) two side 
products of compound 3b eluted at 19.5 min and 20.2 min ([M+H]+ = 538.1 Da). In the upper HPLC 
trace (3a) triphenylmethane, originating from the trityl-protecting group, eluted at 32.1 min. 
Fluo-Phe-Wang resin was treated with trityl chloride/DIPEA in DCM. Completeness 
of the tritylation was confirmed by the disappearance of the infrared band due to free 
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hydroxy groups (3600-3200 cm-1) by on-bead FT-ATR-IR spectroscopy (Fig. 3.3 A). 
Moreover, consistent with a conversion of carboxyfluorescein from its acid into its 
lactone form, the color of the resin changed from orange to yellow. Subsequently, the 
Fluo(Trt)-Phe-Wang resin was treated with 2% hydrazine hydrate/DMF twice for 3 
min. In this case, almost no side product with a mass difference of 14 Da was formed 
(Fig. 3.3 B). This result clearly demonstrates that the trityl-protecting group renders 
resin bound carboxyfluorescein stable to the modification by hydrazine.  
3.3.3 Synthesis of a doubly-labeled peptide 
In order to evaluate the trityl-protecting group strategy for the generation of doubly-
labeled peptides, the peptide amide Fluo-APPPEPPP-Pamb-Lys(Tamra) was 
synthesized using SPPS on Rink amide resin (Fig. 3.4).  
 
Rink amide resin
Ala-Pro-Pro-Pro-Glu(tBu)-Pro-Pro-Pro-Pamb-Lys(Dde)-
Fluo-Ala-Pro-Pro-Pro-Glu(tBu)-Pro-Pro-Pro-Pamb-Lys(Dde)-
Fluo(Trt)-Ala-Pro-Pro-Pro-Glu(tBu)-Pro-Pro-Pro-Pamb-Lys(Dde)-
2.5 eq  5(6)-carboxyfluorescein
2.5 eq DIC
2.5 eq HOBt,  DMF
16 h
12 eq  tritylchloride
12 eq DIPEA, DCM
2 x 16 h
Fluo(Trt)-Ala-Pro-Pro-Pro-Glu(tBu)-Pro-Pro-Pro-Pamb-Lys-
2 % hydrazine hydrate,  DMF
2 x 3 min
Fluo(Trt)-Ala-Pro-Pro-Pro-Glu(tBu)-Pro-Pro-Pro-Pamb-Lys(Tamra)-
2 eq  5(6)-carboxytetramethyl-
rhodamin-N-succinimidyl ester
5 eq DIPEA,  DMF
 16 h
95 % TFA, 2.5 % water, 2.5 % TIS
4 h
Fluo-Ala-Pro-Pro-Pro-Glu-Pro-Pro-Pro-Pamb-Lys(Tamra)-NH2
a
b
c
d
e
f
 
 
Figure 3.4 Synthesis of the doubly-labeled peptide amide Fluo-APPPEPPP-Pamb-Lys(Tamra)-
NH2 (compound 4). Optimized procedures include the introduction of 5(6)-carboxyfluorescein as the 
first fluorophore (a), cleavage of the phenolic ester (b), protection of the phenol (c), cleavage of the 
Dde-group (d), introduction of the second fluorophore (e), cleavage of the peptide (f). 
Such L-proline oligomers had been presented as peptide-bridged fluorescence 
resonance energy transfer cassettes (Li and Glazer, 1999) in order to study FRET 
characteristics of different dye-pairs. After introducing carboxyfluorescein at the N-
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terminus of the resin bound peptide amide APPPEPPP-Pamb-Lys(Dde), piperidine 
treatment and subsequent tritylation, the Dde-protecting group was removed by 
hydrazinolysis. The ε-amino group of the C-terminal lysine was dye labeled using 
activated 5(6)-carboxytetramethylrhodamine-N-succinimidylester. According to 
analytical HPLC, the purity of the crude Fluo-APPPEPPP-Pamb-Lys(Tamra) 
peptide amide after cleavage was 85%, (calc. [M+H]+ = 1833.0 Da, exp. [M+H]+ = 
1833.2 Da, determined by MALDI-MS). Figure 3.5 shows the fluorescence 
emission spectra of the doubly-labeled peptide, of 5(6)-
carboxytetramethylrhodamine and of 5(6)-carboxyfluorescein. When compared 
with the free fluorophores the fluorescence of both labels in this peptide was 
quenched significantly as reported previously for other peptides carrying this 
combination of fluorophores (Wei et al., 1994;Hoogerhout et al., 1999;Geoghegan 
et al., 2000).  
 
a
c
A
b
B
 
Figure 3.5 (A) Fluorescence emission spectra of 5(6)-carboxyfluorescein (500 nM, curve a), 
5(6)-carboxytetramethylrhodamine (1 µM, curve b) and the peptide amide Fluo-APPPEPPP-Pamb-
Lys(Tamra)-NH2 (1 µM, curve c). Fluorescence was excited at 492 nm. (B) Absorption spectrum of 
the peptide Fluo-APPPEPPP-Pamb-Lys(Tamra)-NH2.  
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3.3.4 Generation of a fluorescein-preloaded resin for the 
automated synthesis of C-terminally labeled peptides 
The procedures described so far require the fluorescent derivatization of 
peptides after automated SPPS. In order to accelerate the generation of 
carboxyfluorescein-labeled peptides and guarantee uniform labeling yields for all 
peptides, we decided to establish a resin already carrying a fluorescein moiety. 
Such a preloaded resin should be compatible with automated parallel peptide 
synthesis. 
Rink amide resin was loaded with Fmoc-Lys(Dde)-OH, followed by deprotection 
of the Nα-amino group and coupling of 5(6)-carboxyfluorescein, as described. 
Following tritylation of the fluorescein moiety and removal of the Dde protecting 
group, the Nα-group was available for further peptide synthesis (Fig. 3.6).  
 
Rink amide resin
Fmoc-Lys(Dde)-
SPPS
5 eq Fmoc-Lys(Dde)-OH
5 eq DIC
5 eq HOBt, DMF
16 h
Fmoc-deprotection
2% hydrazine hydrate, DMF
2 x 3 min
2.5 eq  5(6)-carboxyfluorescein
2.5 eq DIC
2.5 eq HOBt, DMF 
16 h
Fluo-Lys(Dde)-
12 eq DIPEA, DCM
2 x 16 h
12 eq tritylchloride
Fluo(Trt)-Lys(Dde)-
2% hydrazine 
hydrate, DMF
2 x 3 min
Fluo(Trt)-Lys- Fluo-Lys-
SPPS
Fluo-Lys(Dde)-
Fluo-Lys(Dde)-
Resin 5a Resin 5b
Fmoc-Deprotection
20 % piperidine/DMF
40 min
 
 
Figure 3.6 Preparation of the Nα-carboxyfluorescein-labeled lysyl-Rink amide resins 5a and 5b 
with a free ε-amino group for peptide assembly.  
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A set of four peptides was synthesized by automated parallel peptide synthesis 
on this resin (resin 5a, Fluo(Trt)-Lys-Rink amide resin) and compared with the 
peptides synthesized on a resin carrying a non-tritylated carboxyfluorescein moiety 
(resin 5b, Fluo-Lys-Rink amide resin). Tritylation of the fluorescein moiety 
increased the purity of all peptides significantly (Tab. 3.1).  
 
Table 3.1 Analytical data for the peptides synthesized on resins 5a and 5b. 
 
Peptide Sequence, 
calc. [M+H]+ 
Resin 5a 
purity,  
[M+H]+ 
Resin 5b, 
purity 
 
Resin 5b, 
major side product,  
[M+H]+ 
Ahx-KGFKGVDAQGTLS-Ahx-εLys(Fluo) 
2020.3 Da 
 90 %, 
2019.8 Da 
49 % 28 %, 
2087.2 Da 
DYGIPADH-εLys(Fluo) 
1373.4 Da 
> 95 %, 
1373.2 Da 
76% 12 %, 
1441.0 Da 
APPPEPPP-Pamb-εLys(Fluo) 
1420.6 Da 
> 95 %, 
1420.4 Da 
75 % 13 %, 
1488.1 Da 
Ahx-EQKLISEEDL-Ahx-εLys(Fluo) 
1916.2 Da 
 87 %, 
1917.1 Da 
48 % 
 
29 %, 
1983.6 Da  
 
The purity was increased by about 20% for the two 9mer peptides and by about 
40% for the 16 and 13mer peptides. For the non-tritylated resin 5b the ∆M = +14 
Da side product (compound 3b) was present, as well as an unidentified side 
product with a mass surplus of 68 Da (Tab. 3.1). The latter reduced the purity of 
the peptides most significantly. All peptides synthesized on resin 5b did not exhibit 
the typical yellow color of fluorescein in aqueous solutions, but a slightly brown 
color. 
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3.4 Discussion 
This contribution presents optimized coupling procedures and protocols for the 
generation of fluorescently labeled peptides and particularly doubly-labeled 
peptides by SPPS. So far no investigator has addressed the chemistry of the 
introduction of 5(6)-carboxyfluorescein by in situ activation in detail. A large excess 
of fluorophore and coupling reagents for N-terminal labeling of solid-phase bound 
peptides led to the generation of side products with higher molecular masses 
which matched multiples of the carboxyfluorescein moiety. Alternative in situ 
activation reagents, such as TBTU, did not affect the formation of these side 
products (data not shown). Considering the absence of any reactive functional 
group in the chosen L-phenylalanine model compound, apart from the free α-
amino group, the phenolic hydroxy groups of fluorescein are the only available 
reactive functional groups. In organic solvents, like DMF, fluorescein exists 
predominantly in its lactonic form (Fompeydie and Levillain, 1980). Evidently, the 
phenolic hydroxy group of carboxyfluorescein can be acylated by in situ activated 
carboxyfluorescein resulting in the formation of phenolic esters. Moreover, 
phenolic esters, in particular activated phenyl esters with electron withdrawing 
groups, are well known to be cleavable by nucleophiles, such as free amino 
groups of peptides or in basic media. Consistent with this hypothesis, treatment 
with piperidine readily removed these side products yielding highly pure 
carboxyfluorescein-labeled peptides.  
Completion of removal of the ester bound carboxyfluorescein could be 
confirmed by the absence of the red color of carboxyfluorescein in piperidine/DMF. 
It should be noted that using continuous flow-through, the removal of ester bound 
carboxyfluorescein with 20% piperidine/DMF lasted between 10 and 45 min, 
depending on the peptide sequence. The use of piperidine for this crucial ester 
cleavage makes it possible to work with automated parallel SPPS, because 
piperidine is routinely used for Fmoc-removal during Fmoc/tBu-based SPPS. 
Moreover, peptide synthesizers are frequently equipped with UV-detection devices 
in order to monitor Fmoc-removal, which makes it possible to monitor the removal 
of the carboxyfluorescein molecules.  
A considerable reduction of the equivalents of fluorophore and coupling 
reagents and the extension of the reaction times still ensured a quantitative 
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turnover. This procedure is especially useful for applications in which the use of 
isomerically pure carboxyfluorescein is desired, which is far more expensive than 
the mixture of the two positional isomers (Rossi et al., 1997). Fulop et al. 
presented the labeling of individual peptides with 1.5 and 3 fold excess and 
variable coupling times from 4 to 24 h. Here, we validated a 2.5 fold excess and a 
16 h coupling time as a general approach yielding complete turn over and high 
purities of the crude products for a large number of different peptides. 
Labeling of resin bound L-phenylalanine with 5-carboxyfluorescein resulted in 
only one single product peak after piperidine treatment, consistent with a lack of 
reactivity of the carboxy group in the 2’ position. Fluorescein derivatives are known 
to exist as lactones or free acid tautomers (Anthoni et al., 1995). The lack of 
reactivity of the 2’ carboxy group is indicative of the fact, that fluorescein exists 
predominantly in its lactonic form in organic solvents, like DMF (Fompeydie et al., 
1980).  
For further derivatization of fluorescein-labeled peptides, the phenolic hydroxy 
groups were protected by tritylation. O-tritylation could be monitored by the change 
of color of the resin from orange to yellow, consistent with a conversion of 
carboxyfluorescein from the acid into its lactonic form. Completeness of the O-
tritylation of the carboxyfluorescein moiety was deduced from on-bead FT-ATR-IR 
spectroscopy and the resulting chemical inertness. A direct structural confirmation 
by NMR was not possible due to the failure to release the protected compound 
from the resin without partial loss of the highly acid labile trityl protecting group.  
The availability of a protecting group strategy for carboxyfluorescein compatible 
with Fmoc/tBu-SPPS and orthogonal side chain protecting groups, such as Dde or 
allyloxycarbonyl (Alloc) (Loffet and Zhang, 1993), offers highly attractive options 
for the generation of biological probe molecules carrying a second dye or 
modification (e.g. a biotin or a lipid moiety) apart from N-terminal 
carboxyfluorescein. In the absence of tritylation, removal of Dde with hydrazine led 
to the formation of a side product with a 14 Da mass surplus. While the prevalence 
of the lactonic form of fluorescein favors the hydrazide as the side product, the 
formation of the hydrazone with the quinoid carbonyl C-atom of carboxyfluorescein 
in a residual fraction of the acid form may also be possible.  
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In spite of the O-tritylation of the Fluo-Phe model compound, minor amounts of 
the side product were still formed, as shown in Fig. 3.3 B (trace 3a). This residual 
formation of side product is probably caused by incomplete tritylation and not by 
the lability of the trityl group. In our hands O-tritylation of carboxyfluorescein has 
proven to be stable to various conditions of SPPS employing the Fluo(Trt)-Lys-
Rink amide resin, i.e. repetitive steps of coupling, piperidine treatment and 
washing. Methanol was omitted from the washing steps, however, because 
prolonged exposure to protic solvents led to partial removal of the trityl-protecting 
group.      
 O-tritylation enables the efficient synthesis of doubly-labeled peptides because 
it renders resin bound fluorescein inert towards an activated second dye, which 
may by itself react with the fluorescein moiety. In contrast to protocols published 
previously our procedure leads to a major improvement in the purity of the crude 
peptides and reduces the number of steps required for the generation of a doubly-
labeled peptide after automated peptide synthesis from four to only one  
(Hoogerhout et al., 1999;Kruger et al., 2002).  
Finally, the O-trityl-protecting group enabled the development of a Fluo(Trt)-Lys-
OH preloaded resin for the generation of C-terminally labeled peptides. This resin 
eliminates the problem of sequence dependent reaction times necessary for the 
cleavage of the phenolic esters. Using this resin, carboxyfluorescein-labeled 
peptides with uniform labeling yields could be obtained by automated procedures. 
Interestingly, when using non-tritylated carboxyfluorescein for this purpose the 
major side product was not derived from hydrazine treatment. The major side 
product accumulated with increasing length of the assembled peptide and showed 
a mass surplus of 68 Da. This mass difference might be explained by the addition 
of piperidine under conditions of water condensation. The exact identity of this side 
product is under investigation. 
The Fluo(Trt)-Lys-Rink amide resin is currently used in our laboratory for the 
parallel-automated synthesis of doubly-labeled peptides, carrying 
carboxyfluorescein as the C-terminal fluorescent dye and a second fluorophore of 
choice at the N-terminus. Moreover, we expect that such a resin is of general use 
in solid-phase synthesis with applications in the generation of fluorescein-labeled 
combinatorial compound collections. 
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3.5 Materials and methods 
3.5.1 Peptide synthesis 
Automated peptide synthesis was performed by solid-phase Fmoc/tBu-chemistry 
using an automated peptide synthesizer for multiple peptide synthesis (RSP5032, 
Tecan, Hombrechtlikon, Switzerland) in 2 ml syringes. Fmoc-protected amino 
acids (twelve fold excess) were activated in situ using DIC/HOBt. After 90 min, the 
Fmoc group was removed by treatment with piperidine/DMF (1:4, v/v) twice for 8 
min. The resin was washed with DMF (6x) after each coupling and deprotection 
step. Side chains of Asp, Glu, Ser, Thr and Tyr were tBu protected, side chains of 
His and Gln were Trt protected and the side chain of Lys was Boc protected. 
Fmoc-(4-aminomethyl) benzoic acid (Fmoc-Pamb) was purchased from 
Neosystem (Strasbourg, France) and Fmoc-Lys(Dde)-OH from Novabiochem 
(Läufelfingen, Schweiz). 5(6)-carboxyfluorescein (Fluo) and 5(6)-
carboxytetramethylrhodamine (Tamra)-N-succinimidylester were from Fluka 
(Deisenhofen, Germany).  
Derivatizations of peptides were performed manually in 2 ml syringes on a 
shaker at RT. Reactions were stopped by washing the resins 3 times each with 
DMF, MeOH, DCM and diethyl ether. Completeness of amine acylation was 
confirmed using the Kaiser-Test (Sarin et al., 1981). Manual Fmoc-deprotection 
was achieved by treating the resin with piperidine/DMF (1:4, v/v) twice for 10 min. 
Deprotection of the Dde protecting group was performed using 2% hydrazine 
monohydrate in DMF (v/v) twice for 3 min.  
Unless otherwise stated, peptides were cleaved off the resin using TFA/TIS/H2O 
(95:2.5:2.5, v/v/v) for the indicated period of time. Crude peptides were 
precipitated by adding cold diethyl ether (-20°C). The precipitated peptide was 
collected by centrifugation and resuspended in cold diethyl ether. This procedure 
was repeated twice. Finally peptides were dissolved in tBuOH/H2O (4:1, v/v) and 
lyophilized.  
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3.5.2 FT-ATR-IR spectroscopy 
On-bead FT-ATR-IR spectroscopy was performed on a Bruker IFS48 
Spectrometer (Bremen, Germany). The intensities of the spectra were adjusted 
according to the intensity of the amide band at 1670 cm-1. 
3.5.3 HPLC 
Peptides and conjugates were analyzed using analytical RP-HPLC using a 
water (0.1% TFA) (solvent A)/ACN (0.1% TFA) (solvent B) gradient on a Waters 
600 System (Eschborn, Germany) with detection at 214 nm. The samples were 
analyzed on an analytical column (Nucleosil 100, 250 x 2 mm, C18 column, 5 µm 
particle diameter; Grom, Herrenberg, Germany), using a linear gradient from 10% 
B to 100% B within 30 min (flow rate: 0.3 ml/min).  
Peptides were purified by preparative RP-HPLC (Nucleosil 300, 250 x 20 mm, 
C18 column, 10 µm particle diameter; Grom, Herrenberg, Germany) on a Waters 
600 Multisolvent Delivery System (flow rate: 10 ml/min). Gradient Systems were 
adjusted according to the elution profiles and peak profiles obtained from the 
analytical HPLC chromatograms.  
3.5.4 MALDI-MS 
One micro liter of DHAP matrix (20 mg of DHAP, 5 mg of ammonium citrate in 1 
ml of 80% isopropyl alcohol) was mixed with 1 µl of each sample (dissolved in 
ACN/water (1:1) at a concentration of 1 mg/ml) on a gold target. Measurements 
were made using a laser-desorption time of flight system (G2025A, Hewlett-
Packard, USA). For signal generation 20-50 laser shots were added up in the 
single shot mode. 
3.5.5 Labeling of peptides with carboxyfluorescein 
In all experiments, the isomeric mixture of 5-and 6-carboxyfluorescein (61:39 
isomer ratio, purchased from Fluka) was used for labeling, unless otherwise 
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stated. 5(6)-carboxyfluorescein is also known as 4(5)-carboxyfluorescein 
(Adamczyk et al., 1997;Rossi et al., 1997). 
3.5.6 Fluorescence emission and absorption spectra 
Fluorescence emission spectra were recorded from 450 to 750 nm (excitation at 
492 nm) at RT in 100 mM Tris/HCl (pH 8.8) using an LS50B spectrofluorometer 
(Perkin-Elmer, Norwalk, CT, USA). The spectra were corrected for the sensitivity 
of the detection system. The excitation and emission bandwidths were set to 5 nm. 
Absorption spectra were acquired using an Ultrospec 2000 (Pharmacia Biotech, 
Cambridge, England) using 100 mM Tris/HCl (pH 8.8).  
3.5.7 Procedures for the synthesis of the different fluorescently 
labeled compounds 
Synthesis of Fluo-Phe-OH (1a and 1b) with high excess of 
carboxyfluorescein. Fmoc-Phe-Wang resin (14 mg, 10 µmol) was Fmoc-
deprotected and treated as described (Weber et al., 1998) for 1 h with 5(6)-
carboxyfluorescein (37.6 mg, 100 µmol), DIC (15.5 µl, 100 µmol), HOBt (15.3 mg, 
100 µmol) in DMF (130 µl). The resin was divided into two portions of 5 µmol each 
(1a and 1b). 1a was treated with 20% piperidine/DMF (v/v) in a syringe until the 
solution was free of excess carboxyfluorescein (15 min). The products (1a and 1b) 
were cleaved off using TFA/H2O (97.5:2.5, v/v) over 4 h. After evaporation of the 
cleavage mixture to dryness, the products were dissolved in ACN/water (1:1), 
lyophilized and analyzed by HPLC and MALDI-MS.    
 
Synthesis of Fluo-DYGIPADH (2a and 2b) with low excess of 
carboxyfluorescein. The peptide H-DYGIPADH-OH was synthesized 
automatically on 2-chlorotrityl resin, which was preloaded with Fmoc-His(Trt)-OH. 
Resin bound H-DYGIPADH-OH (6 µmol) was allowed to react with 5(6)-
carboxyfluorescein (5.6 mg, 15 µmol), DIC (2.3 µl, 15 µmol), HOBt (2.3 mg, 15 
µmol) in DMF (150 µl) for 16 h. After washing the resin as described, the resin was 
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divided into two portions of 3 µmol each (2a and 2b). 2a was treated with 20% 
piperidine/DMF as described for 1a (45 min).  
The carboxyfluorescein-labeled peptides 2a and 2b were cleaved from the resin 
with TFA/TIS/H2O (95:2.5:2.5, v/v/v) for 4 h. After precipitation with diethyl ether, 
both peptides were dissolved in ACN/water, lyophilized and analyzed by HPLC 
and MALDI-MS. 
 
On-resin introduction of the O-trityl-protecting group to 
carboxyfluorescein (3). Fluo-Phe-Wang resin (10 µmol) was prepared as 
described for 1. The resin was then divided into two portions of 5 µmol each (3a 
and 3b). 3a was treated twice with trityl chloride (16.7 mg, 60 µmol) and DIPEA 
(10.3 µl, 60 µmol) in DCM for 16 h. Small amounts of resins 3a and 3b were 
vacuum dried and analyzed by on-bead FT-ATR-IR spectroscopy.  
 
Treatment of 3a and 3b with hydrazine. Resins 3a and 3b were treated twice 
using 2% hydrazine hydrate in DMF for 3 min and washed thoroughly. Products 
were cleaved off using TFA/TIS/H2O (95:2.5:2.5, v/v/v) for 2 h. After evaporation of 
the cleavage mixture to dryness the products were dissolved in ACN/water, 
lyophilized and analyzed by HPLC and MALDI-MS.  
 
Synthesis of Fluo-APPPEPPP-Pamb-Lys(Tamra) (4). The peptide amide H-
APPPEPPP-Pamb-Lys(Dde)-NH2 was synthesized by automated solid-phase 
peptide synthesis on Rink amide resin. H-APPPEPPP-Pamb-Lys(Dde)-NH2 Rink 
amide resin (14 µmol) was labeled with 5(6)-carboxyfluorescein as described for 
2a and then treated twice with trityl chloride (168 µmol, 46.8 mg) and DIPEA (168 
µmol, 28.8 µl) in DCM for 16 h. Subsequently, Dde-deprotection of resin bound 
Fluo(Trt)-APPPEPPP-Pamb-Lys(Dde)-NH2 was performed as described. 5(6)-
carboxytetramethylrhodamine-N-succinimidyl ester (8 µmol, 4.2 mg) was dissolved 
in DMF (150 µl) containing DIPEA (20 µmol, 3.4 µl) and the solution was then 
added to resin loaded with 4 µmol of peptide. After 16 h, the resin was thoroughly 
washed. Deprotection of the doubly-labeled peptide amide was performed using 
TFA/TIS/H2O (95:2.5:2.5, v/v/v) for 4 h. Following ether precipitation, peptide 4 
was dissolved in ACN/water, lyophilized and analyzed by HPLC and MALDI-MS. 
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The peptide was purified as described by preparative HPLC for spectroscopic 
characterization. 
 
Preparation of Fluo(Trt)-Lys-Rink amide resin (5a, 5b). Fmoc-Rink amide 
resin (200 µmol, 270 mg) was deprotected and reacted with Fmoc-Lys(Dde)-OH (1 
mmol, 533 mg), DIC (155 µl, 1 mmol) and HOBt (153 mg, 1 mmol) in DMF for 16 
h. After Nα-Fmoc-deprotection, the Nα-amino group was labeled with 5(6)-
carboxyfluorescein as described for 2a, yielding Fluo-Lys(Dde)-Rink amide resin. 
Immediately afterwards, 50 µmol of the Fluo-Lys(Dde)-Rink amide resin were Dde-
deprotected (5a). In a parallel reaction 100 µmol of the Fluo-Lys(Dde)-Rink amide 
resin was tritylated first as described for 3a and then Dde deprotected (5b). A set 
of four peptides (as listed in Tab. 3.1) were synthesized by automated peptide 
synthesis on the ε-lysine side chain of resins 5a and 5b for a comparative study. 
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4 A quantitative validation of fluorophore-labeled cell-
penetrating peptide conjugates: Fluorophore and cargo 
dependence of import 
This chapter was published in Biochimica Biophysica Acta-Biomembranes in 
2002. The author of this thesis performed all experiments shown in Figures 1, 2, 5 
and 6. Figure 3 was contributed by T. Waizenegger as part of his diploma thesis. 
Figure 4 gives a comparison between the data obtained by flow cytometry 
(contributed by R.F.) and FCM (contributed by T. Waizenegger). The author of this 
work has established FCM for the validation of the cellular import of CPPs during 
his own diploma thesis. T. Waizenegger has optimized and published these 
protocols during his diploma thesis (Waizenegger et al. 2002).  
4.1 Summary 
Cell-penetrating peptides (CPPs) were evaluated for a quantitatively controlled 
import of small molecules. The dependence of the import efficiency on the 
fluorophore, on the position of the fluorophore as well as on the nature of the 
cargo was addressed. Cellular uptake was quantified by flow cytometry and 
fluorescence correlation microscopy (FCM). Fluorophores with different spectral 
characteristics, covering the whole visible spectral range were selected in order to 
enable the simultaneous detection of several cell-penetrating peptide constructs. 
The transcytosis sequences were based either on the sequence of the 
Antennapedia homeodomain-derived Penetratin peptide (Antp) or the Kaposi 
bFGF-derived MTS-peptide. In general, the Antp-derived peptides had a three to 
four fold higher import efficiency than the MTS-derived peptides. In spite of the 
very different physicochemical characteristics of the fluorophores, the import 
efficiencies for analogues labeled at different positions within the sequence of the 
import peptides showed a strong positive correlation. However, even for peptide 
cargos of very similar size, pronounced differences in import efficiency were 
observed. The use of CPP/cargo constructs for intracellular analyses of structure-
function relationships therefore requires the determination of the intracellular 
concentrations for each construct, individually.  
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4.2 Introduction 
Many CPPs were originally considered to cross the plasma membrane in a 
receptor and energy-independent manner (Derossi et al., 1994;Derossi et al., 
1996). More recent data demonstrated, that earlier interpretations of cell-biological 
experiments, may have suffered from artifactual uptake of CPPs caused by 
fixation of cells. Endocytosis is currently implicated in the internalization of the 
HIV-1 Tat peptide (Richard et al., 2003). CPPs represent a structural diverse class 
of substances. Some CPPs are derived from hydrophobic sequences of signal 
peptides, such as the Kaposi basic fibroblast growth factor-derived membrane 
translocating sequence (MTS) (Lin et al., 1995), or from insect proteins, such as 
the third helix of the DNA-binding domain of the Antennapedia homeodomain 
protein (Antp) (Derossi et al., 1994). While the former is a highly hydrophobic 
sequence with 8 out of 16 amino acids being valine and leucine residues and the 
remainder either alanine or proline, the latter is basic with 7 out of 16 residues 
being arginine or lysine.  
Covalent or non-covalent (Dokka et al., 1997) linkage of CPPs to other 
molecules mediates the non-invasive import of these cargo molecules into cells ex 
vivo, as well as in whole animals (Schutze-Redelmeier et al., 1996;Schwarze et 
al., 1999). Such cargo have been peptides (Prochiantz, 1996;Hawiger, 1999), 
oligonucleotides (Dokka et al., 1997), as well as proteins as large as 120 kDa 
(Rojas et al., 1998;Schwarze et al., 1999). The capacity to mediate entry of 
impermeable molecules into cells renders CPPs a valuable tool in the early stages 
of the drug development process. Import of inhibitors may serve to identify and 
validate intracellular molecules as targets for achieving a desired therapeutic 
outcome (Wallace, 1997). Substances exhibiting biological activity for isolated 
molecules in vitro, but unfavourable pharmacokinetic properties for in vivo tests 
may be rendered cell-permeable. Fusion of CPPs to antisense-oligonucleotides 
has been employed for suppressing the expression of certain proteins (Pooga et 
al., 1998b). Peptide conjugates have served as pseudo-substrates, competitive 
inhibitors of the enzyme active site (Rojas et al., 1996) or structural mimics of the 
interaction domain. The advantages of peptide-based approaches are the 
accessibility of large collections of different compounds by well-established 
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automated procedures, as well as the generation of active compounds based on 
available structural information of interaction domains. Structure-function 
relationships of intracellular interaction domains have been analysed by testing a 
series of different peptides fused to a CPP moiety (Liu et al., 1996).  
If the import efficiency of CPP-constructs is cargo-dependent, the determination 
of the intracellular concentrations for each of the CPP/cargo constructs is 
mandatory, particularly in the analysis of structure-function relationships. 
Otherwise differences in a biological response may simply reflect differences in 
uptake efficiency. Fluorescent derivatization of CPPs provides a sensitive and 
specific quantitative read-out on intracellular peptide concentration using 
established techniques such as flow cytometry. In addition, the analysis of the 
subcellular distribution of CPP/cargo constructs by fluorescence microscopy 
enables the identification of cellular compartments targeted by a cell-penetrating 
construct. Attaching the fluorescent reporter group to the CPP moiety minimizes 
the risk of interference of the fluorescent label with the activity of the cargo. By 
means of  chemical ligation (Zhang et al., 1998) or disulfide linkage (Schulz et al., 
2000), CPPs or fluorescent analogues of these peptides may be used as building 
blocks for rendering molecules cell permeable. 
To date, however, fluorescent labeling of CPPs has been limited to N-terminal 
derivatization of peptides either with fluorescein (Scheller et al., 2000;Fischer et 
al., 2000) or NBD (7-nitrobenz-2-oxo-1,3-diazol-4-yl) (Drin et al., 2001). The import 
of CPP constructs into cells expressing GFP fusion proteins, as well as the 
simultaneous detection of several different CPP constructs requires the 
identification of spectrally distinct fluorophores compatible with import. For this 
purpose, it needs to be determined to which degree reporter groups with different 
physicochemical characteristics influence the import characteristics of the CPP 
constructs. A fluorescein reporter group, for example, carries negative charge, 
while a tetramethylrhodamine (Tamra) reporter group is zwitterionic. Positive 
charge as well as hydrophobicity were identified as important physicochemical 
determinants for import efficiency for the AntpHD peptide (Derossi et al., 
1994;Futaki et al., 2001). It was therefore to be expected that the import efficiency 
of the transcytosis sequences should be affected by the physicochemical 
characteristics of the fluorophore. Furthermore, fluorescent analogues carrying the 
fluorophore at a residue within the peptide sequence rather than at the N-terminus 
A QUANTITATIVE VALIDATION OF CELL-PENETRATING PEPTIDES 
 
 
 - 44 - 
are still missing. Such analogues would enable the N-terminal modification of 
CPPs with cargo molecules by solid-phase synthesis. In addition, the introduction 
of one fluorophore within the transcytosis peptide and a second reporter group 
within the cargo would enable the tuning of the spectral characteristics of double 
labeled constructs for fluorescence resonance energy transfer (FRET) (Clegg, 
1995). Such molecules are valuable tools for the intracellular monitoring of e. g. 
kinase (Nagai et al., 2000) or protease activity (Jones et al., 2000). 
In order to establish fluorescently labeled CPPs as pharmacokinetic modifiers 
for small molecules, the impact of a fluorescent tag on the ability of the CPPs to 
enter cells was addressed. For this purpose, sets of analogues labeled with 
different fluorophores were generated by solid-phase peptide synthesis. 
Fluorophores were attached to the side chains of lysine residues introduced at 
different positions within the peptide sequence, and the effect of different 
fluorophores on import was compared.  
For both, the Antp and the MTS peptides, internally labeled analogues were 
identified with import efficiencies equivalent to the N-terminally labeled peptides. 
Surprisingly, the relative import efficiencies of peptides labeled either with 
fluorescein or Tamra at the N-terminus or within the peptide showed a strong 
positive correlation. This correlation of import efficiencies for fluorescein and 
Tamra-labeled CPP analogues demonstrates that the capacity for import resides 
within the structure of the peptide, and is little affected by the physicochemical 
characteristics of the fluorophore. This finding was confirmed by fluorescence 
correlation microscopy (FCM) (Brock et al., 1999) of fluorescein and Tamra-
labeled peptides at lower nanomolar concentrations. The spectral range was 
extended to the near infrared by conjugation of an indocyanine dye with Cy5-like 
(Southwick et al., 1990;Mader et al., 2004) spectral characteristics. Import of three 
different CPP analogues was simultaneously detected by confocal laser scanning 
microscopy of living cells.  
Finally, the dependence of import on the cargo was addressed for small peptide 
cargos. Perez et al. have presented one example, in which for one out of three 
structurally related constructs, import was completely abrogated (Perez et al., 
1994). A thorough quantitative analysis of import efficiencies for small peptide 
cargos has been missing, however. For this purpose a panel of different cargo 
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peptides of eight to ten amino acids in length, as well as peptides with free or 
amidated C-termini were synthesized. The intracellular concentrations of these 
molecules differed by factors of up to eight. These findings underscore the need 
for an individual determination of intracellular concentrations in applications, such 
as the intracellular analysis of structure-function relationships and target validation. 
The results presented in this paper validate fluorescence as the analytical method 
of choice for these measurements. 
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4.3 Results 
Fluorescently labeled CPPs were established as pharmacokinetic modifiers in 
intracellular target validation. For this purpose, the import capacity was compared 
for CPP analogues labeled with fluorophores at different positions along the 
peptide. Moreover, the dependence of import on the peptide cargo was 
determined.  All peptides were generated by solid-phase peptide synthesis and 
purified by preparative HPLC. Import of peptides into the human melanoma cell 
line SKMel37 was quantified in living cells after trypsinization by flow cytometry. 
Fluorescence correlation microscopy (FCM), as well as confocal laser scanning 
microscopy was employed to fully interpret the results obtained by flow cytometry. 
4.3.1 Internally labeled fluorescent analogues 
To this end, import of CPPs had only been observed for peptides labeled with 
fluorophores at their N-terminus. In order to extend the range of fluorescently 
labeled CPPs, analogues derivatized with a fluorophore within the peptide 
sequence were generated.  
 
Table 4.1 Name and sequence of carboxyfluorescein-labeled Antp and MTS analogues. 
Those peptides marked with an asterisk were also synthesized as carboxytetramethylrhodamine-
labeled analogues. “Ac” denotes an N-terminal acetylation, “Ado” represents a hydrophilic 8-amino-
3,6-dioxaoctanoic acid building block. All peptides were synthesized as peptide carboxylic acids. 
 
Abbreviation  Amino acid sequence 
Antp WT(Fluo)* Fluo-RQIKIWFQNRRMKWKK-COOH 
Antp W6K(Fluo) Ac-RQIKIK(Fluo)FQNRRMKWKK-COOH 
Antp F7K(Fluo)* Ac-RQIKIWK(Fluo)QNRRMKWKK-COOH 
Antp Q8K(Fluo) Ac-RQIKIWFK(Fluo)QNRRMKWKK-COOH 
Antp N9K(Fluo)* Ac-RQIKIWFQK(Fluo)NRRMKWKK-COOH 
MTS WT(Fluo)* Fluo-AAVALLPAVLLALLAP-Ado-A-COOH 
MTS V9K(Fluo) Ac-Ado-AAVALLPAK(Fluo)LLALLAP-Ado-A-COOH 
MTS L10K(Fluo)* Ac-Ado-AAVALLPAVK(Fluo)LALLAP-Ado-A-COOH 
MTS L11K(Fluo) Ac-Ado-AAVALLPAVLK(Fluo)ALLAP-Ado-A-COOH 
MTS A12K(Fluo)* Ac-Ado-AAVALLPAVLLK(Fluo)LLAP-Ado-A-COOH 
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The availability of such compounds would (i) significantly increase the options 
for the generation of doubly-labeled CPP constructs and (ii) enable the N-terminal 
extension of fluorescently labeled CPPs with cargo. Analogues were generated for 
both, the Antp and the MTS peptide. The uptake efficiencies were compared and 
the effect of different fluorophores on uptake properties addressed. 
For both transcytosis peptides, series of analogues were synthesized in which 
one of four consecutive residues in the central portion of the peptide was replaced 
by a lysine residue derivatized with carboxyfluorescein via its ε-amino group (Tab. 
4.1). Relative import efficiencies into adherently growing SKMel37 cells were 
determined by flow cytometry. As reported earlier for measurements by 
fluorescence correlation microscopy (Waizenegger et al., 2002), import of the N-
terminally labeled Antp analogue was about 2.5 times that of the corresponding 
MTS analogue (Fig. 4.1).  
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Figure 4.1 Relative import efficiencies of carboxyfluorescein-labeled CPPs. Given are the 
means for two independent experiments. The experiments were normalized based on the total 
fluorescence of both experiments. As a control for unspecific peptide binding, the amidated peptide 
Fluo-Ahx-SFHTMSAAKLI was used. Adherently growing SKMel37 cells were incubated with 
peptides at a concentration of 4 µM at 37°C for 2 h followed by trypsinization and flow cytometry. 
 
The relative import efficiencies were highly reproducible. Except for the 
fluorescein-labeled A12K(Fluo) MTS analogue, fluorescent derivatization within 
the MTS peptide reduced the import efficiency to the levels of unspecific binding 
and uptake of a fluorescein-labeled control peptide. The import efficiency of the 
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A12K(Fluo) analogue was about 85% that of the N-terminal analogue. For the 
Antp peptide, as well, one analogue (N9K(Fluo)) was imported as efficiently as the 
N-terminal analogue, while the other three fluorescein derivatives showed greatly 
reduced import efficiencies. For the Q8K(Fluo) analogue, import was reduced by 
50% and nearly completely abolished for the other two analogues.   
4.3.2 Effect of the fluorophore on import efficiency 
So far, fluorescent labeling of CPPs has been limited to the introduction of 
fluorophores emitting in the short-wavelength visible part of the spectrum. 
Fluorophores emitting in the orange to far red spectral range are highly desirable 
for the elimination of autofluorescence (Aubin, 1979) and for the detection of CPPs 
in the presence of GFP-fusion proteins. The fluorophore tetramethylrhodamine 
(Tamra) was selected based on its compatibility with solid-phase peptide 
synthesis, price, high photostability and spectral compatibility with fluorescein and 
Cy5-like dyes for simultaneous detection. A subset of Tamra-labeled analogues 
was synthesized and import quantified by flow cytometry (Fig. 4.2 A).  
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Figure 4.2 Comparison of import efficiencies of carboxyfluorescein and Tamra-labeled 
CPP analogues. (A) Relative import efficiencies of Tamra-labeled peptide analogues. Adherent 
SKMel37 tissue culture cells were incubated with peptide at a concentration of 4 µM for 2 h, 
trypsinized and fluorescence measured by flow cytometry. (B) Correlation of import efficiencies of 
Tamra and carboxyfluorescein-labeled peptide analogues. 
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In contrast to fluorescein carrying one negative charge at neutral pH, Tamra is a 
zwitterionic compound with a neutral net charge. Earlier analyses of structure-
function relationships of CPPs had stressed the significance of the 
physicochemical characteristics of the transcytosis sequence (Fischer et al., 
2000). Negative charge, in particular, was shown to be incompatible with import 
(Scheller et al., 1999). In comparison to fluorescein, it was therefore suspected 
that Tamra would significantly promote import.  
As for the fluorescein analogue, full import capacity was observed for the MTS 
A12K(Tamra) and Antp N9K(Tamra) variants, while import was abolished for the 
MTS L10K(Tamra) analogue. In contrast to the fluorescein derivatives, import of 
the Antp F7K(Tamra) was reduced by only 50%. The relative import efficiencies for 
the fluorescein-labeled constructs showed a strong positive correlation with those 
of the Tamra-labeled constructs (Fig. 4.2. B). In spite of the differences in the 
physicochemical characteristics of the dyes, derivatization of individual residues 
affected import in a similar way, independent of the dye. Measurements of 
intracellular concentrations by fluorescence correlation microscopy (see below), 
revealed that import of the N-terminally labeled Tamra-labeled peptides was more 
efficient by a factor of 1.5 than that of the respective fluorescein-labeled peptides. 
Considering the positive correlation of import efficiencies, the Tamra reporter 
group affected import of all analogues in a similar fashion. 
4.3.3 Concentration independence of peptide import 
The concentration independence of import is a vital prerequisite for the analysis 
of intracellular dose-response characteristics using CPP/cargo constructs. To 
date, however, the analysis of import has been limited to the micromolar range. 
Recently, we presented intracellular concentration measurements of fluorescein-
labeled CPPs in the nanomolar range by fluorescence correlation microscopy 
(Waizenegger et al., 2002). In contrast to other techniques, FCM allows for a direct 
determination of molecule numbers. Due to the minuteness of the confocal 
detection volume (sub-femtoliter), intracellular measurements can be conducted 
with peptide present in the incubation buffer outside the cell.  
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Figure 4.3 Intracellular concentration measurements of CPPs labeled at the N-terminus 
with either fluorescein or Tamra by fluorescence correlation microscopy. (A) Intranuclear 
autocorrelation measurement of Fluo-Antp at a concentration of peptide in the buffer of 75 nM. The 
amplitude of the autocorrelation function at τ=0 s is inversely related to the number of molecules in 
the confocal detection volume. (B, C) FCM measurements of MTS and Antp peptides labeled at the 
N-terminus with either carboxyfluorescein (B) or Tamra (C). The number of molecules were derived 
from two-component fits to the autocorrelation functions and corrected for fluorescence originating 
from molecules adsorbed to the bottom of the measurement chambers. For MTS peptides as well 
as for Tamra-labeled Antp peptides the molecule numbers in the buffer were lower than those of 
the fluorescein-labeled Antp peptide due to stronger absorption of the peptides to the walls and the 
bottom of the measurement chamber. 
 
Cellular import of analogues labeled at the N-terminus was measured by FCM at 
lower nanomolar concentrations. Import of peptides was compared by calculating 
the partition coefficients as the ratio of the number of molecules in the nucleus and 
in the incubation buffer (Fig. 4.3).  
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Figure 4.4 Concentration-independence of import. (A) FCM-derived partition coefficients of 
cellular uptake calculated by dividing the number of molecules in the nucleus by the number of 
molecules in the incubation buffer (see Fig. 4.3). (B, C) Import efficiencies for Antp and MTS 
peptides N-terminally labeled with either carboxyfluorescein or Tamra. (D) Comparison of relative 
import efficiencies of carboxyfluorescein and Tamra-labeled peptides determined by FCM and flow 
cytometry. For FCM measurements, peptide concentrations were 75 nM for carboxyfluorescein and 
25 nM for Tamra-labeled peptides, and 2 µM and 4 µM for flow cytometry. In spite of these very 
different concentrations, the relative import efficiencies for Antp and MTS labeled peptides agreed 
with each other.  
 
The Tamra-labeled peptides were internalized more efficiently than the 
fluorescein-labeled peptides by a factor of 1.5 (Fig. 4.4 A). The application of FCM 
is limited to the subnanomolar to lower nanomolar concentration range. For this 
reason, it was impossible to compare the import efficiencies at nanomolar 
concentrations directly with those at micromolar concentrations. Instead, the 
relative import efficiencies of fluorescein and Tamra-labeled MTS and AntpHD 
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peptides determined by flow cytometry (Fig. 4.4 B and C) were compared with 
those determined by FCM (Fig. 4.4 D).  
The larger standard deviations of the FCM data result from the fact that this 
number is the ratio of the number of molecules outside and inside the cell. A total 
of at least 30 measurements in eight different cells were included for each 
condition. The higher standard deviations of the MTS peptides are explained by 
the stronger absorption to the bottom of the measurement chamber which had to 
be compensated for in order to determine the intracellular molecule number. A 
detailed presentation of these intracellular concentration measurements can be 
found in the publication by Waizenegger et al. (Waizenegger et al., 2002). The 
relative import efficiencies determined by both methods closely matched one 
another. If import for either one peptide was concentration dependent, this 
correspondence of import efficiencies would be very unlikely. This result, 
therefore, strongly supports a concentration independence of import covering the 
lower nanomolar to the lower micromolar range. Except for the Tamra-labeled 
Antp analogue, all partition coefficients were significantly smaller than one (Fig. 
4.4 A), i. e. the concentration of the peptide inside the cells was lower than the 
concentration outside. The peptide concentration in the buffer therefore does not 
reflect the intracellular concentration; the latter depends on the peptide in each 
individual case.  
4.3.4 Cargo-dependence of import 
In order to address the cargo-dependence of import for small peptide cargos in 
detail, N-terminally labeled Antp analogues with C-terminal peptide cargos of 
similar size were synthesized. Cargos were representative for primary applications 
of CPP constructs. These were the Myc-tag peptide EQKLISEEDL, a recently 
reported peptide inhibitor of the tyrosine kinase ZAP-70 KLILFLLL (Nishikawa et 
al., 2000), as well as the MHC class I-binding T-lymphocyte epitope SIINFEKL 
(Rötzschke et al., 1991). The latter two have already been employed in 
combination with CPPs (Nishikawa et al., 2000;Pietersz et al., 2001). 
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Figure 4.5 Cargo-dependence of import. (A) Import of Antp-based constructs labeled with 
carboxyfluorescein at the N-terminus. All peptides were synthesized as C-terminal peptide acids (-
COOH). The N-terminal glycine residue for the ZAP-70 inhibitor peptide KLILFLLL was introduced 
as a spacer amino acid. (B) Dependence of import on C-terminal amidation. Constructs were 
based on a truncated form of the Antp-sequence (tAntp) (Fischer et al., 2000) and the import of 
these peptides was compared with the import efficiency of the full length Antp peptide. For the 
inhibitor constructs, the C-terminal lysine residue of the tAntp peptide served as the first residue of 
the inhibitor. Cells were incubated with 2 µM peptide for 2 h. 
 
Intracellular fluorescence of cells incubated with the Antp-ZAP-70 inhibitor 
peptide for 2 h was five times that of cells incubated with the Antp peptide alone 
(Fig. 4.5 A). In contrast to this, the C-terminal extension of the Antp peptide with 
the Myc-tag peptide decreased the intracellular signal in comparison with the Antp 
peptide by more than 50%. For the MHC epitope, the intracellular signal was 3.5 
times that of the Antp peptide. 
The impact of minimal structural differences on import was addressed by 
quantifying intracellular fluorescence for pairs of peptides with either a free or 
amidated C-terminus. The constructs were based on a recently described 
truncated form of the Antp peptide comprising the C-terminal eight amino acids 
NRRMKWKK only (Fischer et al., 2000). C-terminal amidation had a great impact 
on import efficiency. Import of the amidated inhibitor construct was seven-times 
that of the construct with the free carboxy terminus, import of the amidated 
truncated peptide alone was 1.5 times that of the free acid. In contrast to the initial 
report on the truncated peptide, in our hands this molecule only translocated 
weakly. The truncated Penetratin peptides conjugated to the inhibitor peptide, 
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however, exhibited an internalization efficiency similar to the efficiency of the full 
length Penetratin. 
4.3.5 Triple labeling 
The availability of CPPs labeled with spectrally distinct fluorophores affords the use 
of combinations of different CPP/cargo constructs. In this way, several molecular 
interactions may be addressed simultaneously. To this end, only one CPP/cargo 
construct carrying one specific fluorophore has been used at a time. To explore the 
possibility of simultaneously detecting three CPP constructs in one cell, a further 
fluorescent analogue emitting fluorescence in the near infra-red part of the spectrum 
was generated. Cells were incubated with fluorescein-labeled, Tamra-labeled and 
S0387-labeled Antp (Mader et al., 2004) peptides and fluorescence detected by triple-
channel confocal laser scanning microscopy (Fig. 4.6). The cellular localization was 
very similar for all peptides, with a homogeneously distributed fluorescence present in 
the cytoplasm and in the nucleus and a vesicular pattern of fluorescence in the extra-
nuclear region of the cell. In comparison to the fluorescein- and S0387-labeled 
peptides, the Tamra-labeled peptide exhibited a stronger tendency to accumulate in 
vesicular structures.  
A B C
 
Figure 4.6 Simultaneous internalization of three different CPPs. Carboxyfluorescein- (A), 
carboxytetramethylrhodamine- (B), and S0387-labeled (C) Antp peptides were detected by 
multichannel confocal laser scanning microscopy of living cells. Cells were incubated with peptide 
at concentrations of 4 µM, 1 µM, and 2 µM for the fluorescein-, Tamra-, and S0387-labeled 
peptides, respectively, for 2 h at 37°C. The rhodamine and S0387 channel were virtually free of 
cross-talk as determined from control samples loaded with either fluorescein- or Tamra-labeled 
peptides, alone. The bar denotes 10 µm.  
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4.4 Discussion 
4.4.1 Import efficiencies of fluorescent derivatives 
For both the Antp and the MTS peptide, an internally labeled analogue was 
identified with an import efficiency comparable to the efficiency of the respective 
N-terminally labeled peptide. All peptides were generated by solid-phase peptide 
synthesis. The internal label was coupled to a lysine ε-amino-group with the fully 
side-chain protected peptide still attached to the polymeric support. For this 
reason, once the peptide moiety is synthesized, the N-terminus of a fully side-
chain protected peptide is available for extension with a peptide cargo or non-
peptide cargo molecule. Based on this labeling strategy, we anticipate that 
fluorescently labeled CPPs will gain significance as pharmacokinetic modifiers for 
small molecules that otherwise do not penetrate the plasma membrane. The 
fluorophore serves as the reporter group to quantify import of the small molecule.  
Import of Antp analogues was more efficient than import of MTS analogues by a 
factor of about three. So far only few reports exist in which the import competence 
of different sequence motifs were compared relative to each other. To our 
knowledge, no direct comparison of a purely aliphatic motif, such as the MTS 
peptide, and a cationic motif such as the Antp peptide, has been presented so far. 
One should note, however, that in our case a hydrophilic building block (Ado) was 
introduced at the C-terminus of the MTS peptide in order to increase the solubility 
in aqueous buffers. In our hands, Antp is the preferred CPP moiety because of the 
higher import efficiency, higher solubility in aqueous buffers and comparatively 
less adsorption to the walls of the measurement chambers (Waizenegger et al., 
2002). 
By introduction of fluorophores within the central part of the peptide sequence, 
constructs carrying a second fluorophore either within the cargo or at the N-
terminus of the cargo may be generated. Such constructs may serve as cell-
permeable probes for intracellular protease activity by detection of fluorescence 
resonance energy transfer (FRET, (Clegg, 1995)) with optimized FRET 
characteristics.  
The abrogation of import of the Antp W6K(Fluo) construct further substantiates 
the role of this specific amino acid side chain for import (Derossi et al., 1994). 
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Interestingly, replacement with the large aromatic fluorophore moiety had the 
same effect as replacement with alanine (Drin et al., 2001). While import 
competence may be conveyed by the general physicochemical characteristics of 
the whole peptide (Scheller et al., 2000), efficient uptake is strongly dependent on 
the presence of structural determinants at specific positions of the CPP. The 
finding that only one out of four analogues derivatized with bulky fluorophores at 
consecutive positions entered cells efficiently supports the view that these 
peptides associate to a biological membrane in a well-defined orientation (Du et 
al., 1998;Drin et al., 2001). 
The import efficiencies for Antp as well as MTS peptides labeled with the 
negatively charged carboxyfluorescein strongly correlated with those labeled with 
the zwitterionic Tamra fluorophore. This finding supports the notion that for these 
two CPP motifs, efficient uptake is a function of the peptide structure rather than 
the overall physicochemical characteristic. Surprisingly, the introduction of the 
negatively charged fluorescein moiety in the central part of the strongly basic Antp 
peptide was compatible with efficient import. Recently, we introduced fluorescence 
correlation microscopy for a direct determination of intracellular peptide 
concentrations (Waizenegger et al., 2002). The determination of partition 
coefficients for cellular uptake by FCM revealed that import of the Tamra-labeled 
analogues was slightly more efficient than that of the fluorescein-labeled 
analogues. From the correlation of import efficiencies we conclude, however, that 
this effect must be very similar for all Tamra derivatives. Comparison of the cellular 
distribution of fluorescein and Tamra-labeled peptides having no intrinsic 
transcytosis capacity has shown that the Tamra label may promote accumulation 
of these peptides in vesicular structures by itself (own unpublished data). This dye-
dependent contribution may provide an explanation for the generally higher import 
efficiency of Tamra over fluorescein-labeled peptides. One should note that 
fluorescence correlation microscopy is the only technique capable of comparing 
import efficiencies for cell-permeable substances labeled with different 
fluorophores that does not depend on cumbersome calibration procedures to 
normalize on the detection efficiencies for different spectral ranges. 
Comparison of import efficiencies determined by FCM and flow cytometry 
demonstrated a concentration independence of import from the lower micromolar 
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to the lower nanomolar range. So far, the analysis of the concentration 
dependence of import has been limited from the higher nanomolar to the mean 
micromolar range (Derossi et al., 1996;Mitchell et al., 2000;Fischer et al., 2000). 
That large of a concentration range could only be covered by combination of these 
two analytical techniques. Flow cytometry is too insensitive to quantify import in 
the lower nanomolar range, while FCM can only be used at lower nanomolar 
concentrations.  
To further expand the spectral range of fluorescent CPP derivatives, an N-
terminal analogue of Antp labeled with the indocyanine dye S0387 (Mader et al., 
2004) was generated and the intracellular distribution investigated with confocal 
laser scanning microscopy. In this way we were able to demonstrate the 
simultaneous detection of three different CPP constructs. In all cases, a vesicular 
staining was present that was most pronounced for the Tamra-labeled derivative. 
So far the nature of the vesicles has not been addressed. The vesicular 
accumulation of the CPPs will present some limitation in the analysis of a cargo 
driven subcellular targeting of CPP constructs, e. g. to target molecules present in 
specific cellular compartments. Our data indicate that Tamra will be the least 
suited fluorophore for this kind of application. 
4.4.2 Cargo-dependence of import 
The independence of import on the nature of the fluorophore was contrasted by 
a marked dependence on the peptide cargo. Even though all peptides investigated 
were very similar in size, ranging from eight to ten amino acids, import efficiencies 
varied by as much as a factor of eight for the Myc-tag peptide and for the ZAP-70 
inhibitor peptide. While the Myc-tag peptide is characterized by a negative charge 
surplus, the Antp-conjugated SIINFEKL-epitope carries one negative net charge, 
and the ZAP-70 inhibitor peptide is strongly hydrophobic with a neutral net charge. 
Apparently, a strong negative correlation exists between the negative charge of 
the cargo and the import efficiency. So far, this observation has only been reported 
for the transcytosis sequence, alone (Scheller et al., 1999). The effect that subtle 
structural changes may have on uptake was addressed using a truncated 
analogue of the Penetratin peptide. For the import peptide alone, as much as for a 
conjugate with the ZAP-70 inhibitor peptide, C-terminal amidation greatly affected 
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the import efficiency. Interestingly, the truncated peptide alone was very inefficient 
in cellular import when compared with the full-length Penetratin peptide. 
Previously, this peptide was shown to possess about 60% of the translocation 
efficiency of the full length Antennapedia peptide (Fischer et al., 2000). This 
discrepancy may result from the differences in assay conditions. In the initial 
report, a biotinylated analogue was employed and cells were labeled with 
fluorescently labeled streptavidin after fixation. Fixation, however, may lead to a 
loss of small molecules due to poor crosslinking. It cannot be excluded that only a 
fraction of molecules, e. g. those present in vesicular structures, were retained in 
the cells while the major part of those present in the cytoplasm and nucleus were 
lost. For this reason, all analyses in our report were based on fluorescence in 
living cells. In one of the initial analyses of the structure-activity relationship of the 
Antp-peptide, Derossi et al., reported that removal of only two amino acids from 
either the N- or C-terminus abolished import (Derossi et al., 1994). For the 
truncated peptide, import competence was rescued by conjugation of the highly 
hydrophobic cargo KLILFLLL. It seems that in this case, the cargo complements 
the cell-permeable moiety.  
In summary, attachment of fluorophores that differed markedly in their 
physicochemical characteristics was tolerated surprisingly well. Import depended 
much more on the cargo than on the nature of the fluorophore. Analysis of import 
by FCM revealed that the concentrations in the buffer did not reflect the 
concentrations of these molecules inside the cells. Both findings stress the need 
for a detailed monitoring of intracellular peptide concentrations in applications such 
as the analysis of structure function relationships and quantitatively controlled 
inhibition of intracellular processes. The fluorescent peptide analogues identified in 
this study provide the tools for that purpose. 
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4.5 Materials and methods 
4.5.1 Peptide synthesis 
Peptides were synthesized in a 15 µmol scale by solid-phase Fmoc-chemistry 
on an automated peptide synthesizer for multiple peptide synthesis (RSP5032, 
Tecan, Hombrechtlikon, Switzerland). Fmoc-amino acids were purchased from 
Novabiochem (Heidelberg, Germany) and Fmoc-protected 8-amino-3,6-
dioxaoctanoic acid (Ado) from Neosystem (Strasburg, France). Standard 
chemicals in peptide chemistry were obtained from Fluka (Deisenhofen, Germany) 
and Merck (Darmstadt, Germany), solvents were p.a. grade. Peptides were 
synthesized as free acids on a 2-chlorotrityl resin (capacity 0.5 mmol/g; Senn 
Chemicals, Dielsdorf, Switzerland) and as peptide amides on Rink amide resin 
(Rapp Polymere, Tübingen).  The amino acid sequence of the Antp peptide was 
RQIKIWFQNRRMKWKK and of the MTS peptide AAVALLPAVLLALLAP. The 
MTS peptide was extended at its N- and/or C-termini with one Ado-building block 
to increase its water solubility.  
The resin bound peptides were labeled at the N-terminus with 5(6)-
carboxyfluorescein as described (Fischer et al., 2003). Labeling with 5(6)-
carboxytetramethylrhodamine was accomplished using 5 eq each 5(6)-
carboxytetramethylrhodamine, HOBt and DIC in DMF twice for 20 h. N-terminal 
labeling of the resin bound Antp-peptide with the free carboxylic acid of the S0387 
fluorophore was carried out in the presence of 2 eq of S0387 (FEW, Wolfen, 
Germany), 5 eq HOBt and 5 eq DIC in DMF  twice for 20 h. Conjugation of 
fluorophores to the ε-amino group of lysine side chains was carried out via 
incorporation of Fmoc-Lys(Dde)-OH (Novabiochem, Läufelfingen, Switzerland) as 
building block in peptide synthesis. After Fmoc-deprotection of the N-terminus of 
the resin bound peptide with piperidine/DMF, the N-terminal amino group was 
acetylated (Ac2O/DIPEA/DMF (1:1:8, v/v/v), 2 x 30 min). Removal of the Dde 
protecting group was performed by treatment with 2% hydrazine monohydrate in 
DMF (v/v) twice for 3 min. The coupling of the fluorophore followed the same 
protocol as the one for N-terminal labeling. 
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The peptides were cleaved off the resin by treatment with TFA/TIS/EDT/H2O 
(92.5:2.5:2.5:2.5, v/v/v/v) twice for 2 h each. Peptides were precipitated by addition 
of diethyl ether (-20°C). Precipitated peptides were washed twice with cold ether. 
Finally the peptides were dissolved in tBuOH/H2O (4:1, v/v) and lyophilized. 
The peptides were analyzed by analytical reverse phase chromatography RP-
HPLC using an H2O (0.1% TFA)/ACN (0.1% TFA) gradient on a Waters 600 
System (Eschborn, Germany) with detection at 214 nm and by MALDI-TOF-MS 
(Hewlett-Packard G2025A). Peptides were purified by preparative RP-HPLC 
(Nucleosil 300 C18 column, 10 µm particle diameter, 250 x 20 mm; Grom, 
Herrenberg, Germany) on a Waters 600 Multisolvent Delivery System using the 
same gradient system as used for analytical HPLC. 
 
4.5.2 Determination of concentrations of fluorescently-labeled 
peptides by UV/VIS-spectroscopy 
Peptides were dissolved in DMSO at a concentration of 20 mg/ml. These stock 
solutions were further diluted 1:10 in H2O. This solution was further diluted 1:100 
in 0.1 M Tris/HCl pH 8.8 and the absorbance at the wavelength of 492 nm 
measured. The concentrations of the stock solutions were calculated assuming 
εcarboxyfluorescein, 492 nm = 75,000 l/(mol⋅cm). Tamra-labeled peptides dissolved in 
DMSO to about 20 mg/ml were diluted 1:10 in H2O followed by a 1:100 dilution in 
methanol. The absorbance of these solutions was measured at 540 nm. The 
concentrations of the solutions were calculated assuming εTamra, 540 nm = 95,000 
l/(mol⋅cm).  
4.5.3 Cell culture 
The adherent SKMel37 cell line was grown in a 5% CO2 humidified atmosphere 
at 37°C in DMEM with GLUTAMAX I, 25 mM HEPES, 4500 mg/l D-glucose, pH 
7.2 (Invitrogen, Karlsruhe, Germany), supplemented with 10% fetal calf serum 
(PAN Biotech, Aidenbach, Germany), 100 U/ml Penicillin, and 0.1 mg/ml 
Streptomycin (Biochrom, Berlin, Germany). Cells were passaged by trypsinization 
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with trypsin/EDTA 0.05/0.02% (w/v) in PBS (Biochrom) every third to fourth day. 
For growth in chambered cover glasses (Nunc, Wiesbaden, Germany), cells were 
seeded at a density of 25,000/cm2 and used for FCM measurements at a 
confluency of approximately 75%. 
4.5.4 Flow cytometry 
SKMel37 cells were seeded at a density of 80,000 per well in 24 well plates 
(Sarstedt, Nümbrecht) in 400 µl serum-containing medium. One day later, the cells 
were washed with serum-free medium and incubated in 200 µl serum-free 
medium. After 2 h, peptides were added in concentrations as indicated in the 
results section. Each condition was tested in duplicate. After 2 h incubation, cells 
were washed with PBS and trypsinized. The cells were suspended in PBS 
containing 0.1% (w/v) BSA and 5 mM glucose. Samples were kept on ice and 
measured immediately.  The fluorescence of 5000 vital cells was acquired. Vital 
cells were gated based on sideward scatter and forward scatter. For the 
determination of non-specific uptake of fluorescein-labeled peptides, the peptide 
Fluo-Ahx-SFHTMSAAKLI-CONH2 was added in the same concentration as were 
the MTS or Antp analogues. This peptide was previously designed as a peptide 
ligand for the HLA-DRB1*1501 MHC class II molecule (Fleckenstein et al., 1999). 
It was selected because of the different physicochemical side-chain characteristics 
and its very different biological relevance. 
4.5.5 FCM 
FCM measurements were carried out on a ConfoCor2 fluorescence correlation 
microscope (Carl Zeiss, Jena), equipped with a SensiCam cooled 12-bit CCD 
camera (PCO Computer Optics, Kelheim, Germany). For image acquisition by 
whole-field epifluorescence microscopy a filter set consisting of an HQ470/40 
excitation filter, a Q495LP beam splitter and an HQ525/50 detection filter (AHF 
Analysentechnik, Tübingen, Germany) was used for imaging of fluorescein. A 
combination of an HQ548/10 excitation filter, a Q565LP beam splitter and an 
HQ610/75 detection filter were employed for imaging of Tamra-labeled samples. 
For FCS measurements of fluorescein-labeled peptides, the 488 nm line of an 
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argon ion laser was reflected into the sample via an HFT488 beam-splitter and 
fluorescence detected with a 500-550 nm band-pass filter. Fluorescence of Tamra-
labeled peptides was excited with a 543 HeNe-laser and detected with an HFT 
488/543 beam-splitter in combination with a BP 560-615 detection filter. For 
positioning along the optical axis, the z-scan option of the ConfoCor2 software was 
employed. Profiles of fluorescence along the optical axis were acquired at 0.4 
kW/cm2 (for both laser lines) at a resolution of 0.5 µm per step. Z-scans were 
saved by screen capture from the computer screen. The position of the detection 
volume in the x- and y-dimensions was determined by bleaching a film of 
fluorescein adsorbed to the surface of a microscopy slide and determining the 
position of the bleached spot in an epifluorescence image. Positioning in x and y 
was based on real-time transmission images acquired by the CCD camera using a 
motorized stage. A series of five subsequent autocorrelation measurements was 
carried out over 30 s each, for every data point. Laser intensities were 40 kW/cm2 
for fluorescein and 16 kW/cm2 for Tamra. The individual autocorrelation functions 
were fitted one-by-one and those unaffected by initial photo bleaching included for 
averaging. 
Reference measurements were carried out for carboxyfluorescein, Tamra, Fluo-
Antp, Fluo-MTS and the corresponding Tamra-labeled peptides at concentrations 
of 25 nM and 75 nM in HBS (135 mM NaCl, 10 mM KCl, 0.4 mM MgCl2, 1 mM 
CaCl2, 10 mM Na-HEPES, pH 7.4), supplemented with 0.1% BSA and 5 mM 
glucose in chambered cover glasses without cells in a volume of 400 µl. 
For the determination of import efficiencies, the cells were incubated with the 
fluorescently-labeled peptide in HBS, 0.1% BSA, 5 mM glucose in a volume of 400 
µl. The respective concentrations were as indicated. After 1 h incubation at 37oC, 
FCM measurements were started at RT. Autocorrelation functions were recorded 
in the nucleus and in the buffer next to each cell. A minimum of eight cells was 
analysed for each condition. Autocorrelation functions were fitted with the built-in 
routines of the ConfoCor2 software. 
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4.5.6 Confocal laser scanning microscopy  
Confocal laser scanning microscopy was performed on an inverted LSM510 
laser scanning microscope (Carl Zeiss, Göttingen, Germany) fitted with a Plan-
Apochromat 63 x 1.4 N. A. lens. Triple detection of fluorescein, Tamra and S0387-
labeled peptides was performed using a filter set consisting of an HFT 
UV/488/543/633 beam splitter in combination with an NFT 545 beam splitter and a 
BP 505-530 band pass filter for fluorescein detection, an NFT 635 VIS beam 
splitter and a BP 560-615 detection filter for Tamra detection, and an LP650 long 
pass filter for S0387-detection. To avoid cross-talk detection, the multi-track 
modality of the LSM was employed for image acquisition. Live cells were 
measured in chambered cover slips as in FCM measurements. 
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5 A stepwise dissection of the intracellular fate of cationic cell-
penetrating peptides 
This chapter was published in Journal of Biological Chemistry in 2004. The 
author of this thesis performed all experiments shown. 
5.1 Summary 
The role of endosomal acidification and retrograde transport for the uptake of 
the highly basic cell-penetrating peptides Penetratin, Tat and oligo-arginine was 
investigated. The effect of a panel of drugs that interfere with discrete steps of 
endocytosis or Golgi-mediated transport on uptake and cellular distribution of 
fluorescein-labeled peptide analogues was probed by confocal microscopy, flow 
cytometry and fluorescence spectroscopy of whole-cell lysates. The analyses were 
carried out in MC57 fibrosarcoma cells and in HeLa cells. While MC57 
fibrosarcoma cells showed some vesicular fluorescence and a pronounced 
cytoplasmic fluorescence, in HeLa cells little cytoplasmic fluorescence was 
observed. In MC57 cells the inhibitors of endosomal acidification chloroquine and 
bafilomycin A1 abolished the release of the peptides into the cytoplasm. Release 
into the cytosol preserved endosomal integrity. In addition, cellular uptake of the 
peptides was inhibited by brefeldin A, a compound interfering with trafficking in the 
trans-Golgi network. In contrast, nordihydroguaiaretic acid, a drug that stimulates 
the rapid retrograde movement of both Golgi stacks and trans-Golgi network to the 
ER, promoted a cytoplasmic localization of Tat-peptides in peptide pulsed HeLa 
cells. The effects of these drugs on trafficking shared characteristics with those 
reported for the trafficking of plant and bacterial toxins, such as cholera toxin, 
which reach the cytoplasm by means of retrograde transport. A sequence 
comparison revealed a common stretch of 8-10 amino acids with high sequence 
homology to the Tat-peptide. The structural and functional data therefore strongly 
suggest a common mechanism of import for cationic cell-penetrating peptides and 
the toxins. 
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5.2 Introduction 
The introduction of membrane-impermeable molecules into mammalian cells 
has become a key strategy for the investigation of intracellular processes 
(Stephens et al., 2001). Peptide-mediated import has been attracting growing 
attention as a delivery technology during the last decade (for reviews see (Fischer 
et al., 2001;Langel, 2002)). Linkage of CPPs to other molecules mediates the non-
invasive import of these cargo molecules into cells ex vivo as well as in whole 
animals (Schutze-Redelmeier et al., 1996;Schwarze et al., 1999). Cargos have 
been peptides (Prochiantz, 1996;Hawiger, 1999), proteins as large as 120 kDa 
(Rojas et al., 1998;Schwarze et al., 1999), oligonucleotides (Astriab-Fisher et al., 
2002), plasmids (Singh et al., 1999), peptide nucleic acids (PNAs) (Pooga et al., 
1998b) and even nanoparticles (Lewin et al., 2000).  
Peptide cargos delivered by conjugation to CPPs included pseudo-substrates 
(Theodore et al., 1995), competitive inhibitors of an enzyme active site (Nishikawa 
et al., 2000), compartment-specific localization sequences (Lin et al., 1995), 
structural mimetics of interaction domains (Horng et al., 2001) and epitopes for 
presentation by MHC class I molecules (Schutze-Redelmeier et al., 1996;Pietersz 
et al., 2001). The advantages of peptide-based functional analyses in cell biology 
are the accessibility of large collections of different compounds by well-established 
automated procedures (Jung et al., 1992) as well as a rational approach to the 
generation of biologically active compounds based on available structural 
information of interaction domains. Structure-function relationships of intracellular 
interaction domains have been analysed by testing a series of different peptides 
fused to cell-penetrating peptides (Liu et al., 1996). The delivery of exogenous 
antigens into the MHC class I processing pathway using CPPs has been 
presented in vitro and in whole animals (Schutze-Redelmeier et al., 1996;Pietersz 
et al., 2001). On dendritic cells CPP-epitope constructs were shown to enable 
prolonged antigen presentation (Wang et al., 2002). CPPs therefore have the 
promise to represent a widely applicable means to enhance immune responses 
against cancer and infectious diseases.  
A total of about 20 different peptide delivery vectors have been described so far, 
the majority of which were identified as structural determinants mediating cellular 
internalization of proteins (Fischer et al., 2001). While some of these peptides are 
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purely cationic, others are amphipathic with a large fraction of basic residues and 
again others are fully hydrophobic. These peptides vary in length from about 9 to 
more than 30 amino acids (Fischer et al., 2001).  
Three highly basic import peptides, the Drosophila Antennapedia homeodomain 
derived Penetratin peptide (Derossi et al., 1994), the HIV-1 Tat derived peptide 
(Vives et al., 1997) and the oligo-arginine peptides (Futaki, 2002) have been used 
widely in many of the applications described above. The Penetratin peptide and 
the HIV-1 Tat peptide have been identified as protein transduction domains 
(PTDs) of their respective proteins, while the oligo-arginine peptides (among them 
the nona-arginine peptide R9) have been developed based on structure-activity 
relationships of the HIV-1 Tat peptide. 
Despite their broad acceptance as molecular carriers, the mechanism of 
internalization of CPPs and CPP/cargo constructs is not well understood. The 
uptake of the Penetratin and the HIV-1 Tat peptide had originally been described 
to be insensitive to low temperature (Derossi et al., 1994;Vives et al., 1997;Futaki 
et al., 2001) and to inhibitors of endocytosis (Vives et al., 1997;Suzuki et al., 
2002). Penetratin was also demonstrated to traverse a pure lipid bilayer (Thoren et 
al., 2000) without forming pores (Thoren et al., 2000;Persson et al., 2003). In 
summary, these results were consistent with the theory of a direct translocation of 
the cationic peptides through the plasma membrane (Derossi et al., 1994;Vives et 
al., 1997;Futaki et al., 2001). 
Recent data demonstrated, however, that earlier interpretations of cell-biological 
experiments, may have suffered from artifactual uptake of CPPs caused by 
fixation of cells. Endocytosis is clearly involved in the internalization of the HIV-1 
Tat peptide (Richard et al., 2003). For Tat fusion proteins it was demonstrated that 
cellular internalization occurs through a temperature-dependent endocytic pathway 
that originates from lipid rafts and follows caveolar endocytosis (Fittipaldi et al., 
2003). Inhibitors of metabolism or endocytosis, such as cytochalasin D were 
demonstrated to impair uptake of Penetratin (Drin et al., 2003). Recently, the 
Penetratin and the Tat peptide were shown to promote endocytosis of high 
molecular weight cargo upon binding to cell surface glycosaminoglycans (Console 
et al., 2003). 
With a picture of an endocytic uptake mechanism emerging, the implications of 
the endosomal pathway for functional cell-biological studies using CPPs need to 
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be readdressed. The biological activity exhibited by CPPs in cell-biological 
applications (Prochiantz, 1996) is fully consistent with intact CPP-constructs 
reaching the cytosol. However, the accumulation of CPPs in the endocytic 
compartment (Richard et al., 2003;Fittipaldi et al., 2003;Drin et al., 2003) raises 
the question to which degree and by which mechanism internalized CPPs reach 
the cytosol. A rational design of more effective CPPs can only be achieved if the 
mechanism of uptake is fully understood.  
In this contribution we address these questions by investigating the effect of 
drugs that interfere with distinct steps of the endosomal pathway and Golgi 
trafficking. In order to study a potential cell-type dependence of the peptide 
trafficking, adherently growing MC57 fibrosarcoma cells and HeLa cells were 
examined. Both cell lines showed marked differences in the intracellular 
distribution of fluorescein-labeled CPPs.  
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5.3 Results 
5.3.1 Cellular uptake of Penetratin, R9 and Tat peptides 
Considering two recent studies demonstrating the involvement of endocytosis in 
the uptake of the R9-peptide, the HIV-1 Tat peptide (Richard et al., 2003), and Tat 
fusion proteins (Fittipaldi et al., 2003), we intended to dissect in detail the cellular 
mechanisms involved in the uptake of cationic CPPs and their release into the 
cytosol. Initially, the effect of wortmannin, bafilomycin A1 and chloroquine as 
inhibitors of endocytosis and endosomal acidification on the uptake of 
fluorescently labeled CPPs was assessed by flow cytometry of living cells. While 
wortmannin affects early endosome fusion by inhibition of the phosphatidylinositol-
3-OH kinase (PI3K) (Simonsen et al., 1998), chloroquine (de Duve et al., 
1974;Kozak et al., 1999) and bafilomycin A1 (Bowman et al., 1988;Clague et al., 
1994) inhibit endosomal acidification. While chloroquine diffuses across 
membranes and binds protons, bafilomycin A1 is a highly potent and selective 
inhibitor of vacuolar H+-ATPases (Bowman et al., 1988). In addition to R9 and the 
Tat peptide, the Penetratin peptide was included in this comparison. 
 
Table 5.1 Primary structures of the cell-penetrating peptides used in this study. All 
peptides were synthesized as peptide amides. Fluo represents an N-terminal fluorescein moiety. 
 
Peptides Sequences 
Fluo-Antp Fluo-RQIKIWFQNRRMKWKK-CONH2 
Fluo-R9 Fluo-RRRRRRRRR-CONH2 
Fluo-Tat Fluo-YGRKKRRQRRR-CONH2 
  
The distortion of uptake experiments by peptides that were only associated with 
the plasma membrane, but had not been internalized by the cells, was avoided by 
treating the cells with trypsin prior to flow cytometry (Richard et al., 2003). While 
Fluo-R9 and Fluo-Antp were taken up efficiently to comparable levels, the 
intracellular fluorescence of Fluo-Tat was less than 10% of the one of cells treated 
with the other two peptides (Figure 5.1).  
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Figure 5.1 Influence of inhibitors of endocytosis on uptake of cell-penetrating peptides. 
MC57 cells were incubated with carboxyfluorescein-labeled cell-penetrating peptides (1 µM) for 2 h 
in serum-free medium in the absence (-) or presence (+) of 100 nM wortmannin (A), 300 nM 
bafilomycin A1 (B), and 100 µM chloroquine (C), washed, trypsinized and analyzed by flow 
cytometry. The inhibitors were added 30 min prior to the peptide. Each condition was tested in 
duplicate; error bars represent the absolute deviations from the mean value. 
 
For Fluo-R9 and Fluo-Antp, all three inhibitors led to a reduction of the cellular 
fluorescence by about 50%. In contrast, for the Fluo-Tat peptide only little effect of 
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wortmannin was observed while for chloroquine and bafilomycin A1 intracellular 
fluorescence increased.  
5.3.2 Impact of bafilomycin A1 on the cellular distribution of 
fluorescently labeled CPPs 
In order to explain the contrasting results for Fluo-Tat and the other two peptides 
obtained by flow cytometry, the effect of bafilomycin A1 on the intracellular 
localization of the peptides was addressed using confocal laser scanning 
microscopy. Live cell confocal microscopy was performed after 2 h incubation with 
peptides at 37°C. Images were acquired in the presence of peptide in the medium 
in order to avoid loss of cellular fluorescence due to wash out (Scheller et al., 
2000). In order to compensate for the lower cellular fluorescence of Fluo-Tat, this 
peptide was applied at a five-fold higher concentration (5 µM). For all three CPPs, 
both a distinct vesicular staining and cytoplasmic localization were detected 
(Figure 5.2 A, B, C, upper panels). Cytoplasmic fluorescence was weakest for the 
Fluo-Tat peptide. For the Fluo-R9 peptide a slight nuclear enrichment of 
fluorescein fluorescence in MC57 cells could be observed (Fig. 5.2 C). 
 
 
Figure 5.2 Lack of cytosolic fluorescence by inhibition of endosomal acidification. MC57 
cells were incubated with serum-free medium containing 1 µM Fluo-Antp (A), 5 µM Fluo-Tat (B), 
and 1 µM Fluo-R9 (C) for 2 h and analyzed by confocal laser scanning microscopy in the presence 
of peptide in the medium. Bafilomycin A1 (300 nM) was added 30 min prior to the peptide. 
Fluorescence images are shown in the left panels, transmission images in the right panels. The 
bright fluorescence outside the cells for the Fluo-Tat peptide is explained by the five-fold higher 
concentration used for this peptide in order to compensate for the less efficient intracellular 
accumulation of this peptide. 
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When bafilomycin A1 was added to the incubation medium, no cytoplasmic 
fluorescence was present for any of the three CPPs. Instead, the vesicular staining 
was enhanced for all three peptides. Using chloroquine as an inhibitor of endosome 
maturation, essentially the same effect was observed. However, this inhibitor led to 
the formation of large vesicular structures (data not shown). 
5.3.3 Exit of Fluo-Tat from the cytosol 
While bafilomycin A1 and chloroquine led to a reduced uptake of Fluo-Antp and 
Fluo-R9, for Fluo-Tat cellular fluorescence increased. This result is in apparent 
disagreement with a common internalization mechanism of Tat and R9 (Suzuki et al., 
2002). Bafilomycin A1 leads to the accumulation of both peptides in vesicular 
structures thereby inhibiting their release into the cytoplasm. For this reason the 
increase in cellular Fluo-Tat fluorescence caused by bafilomycin A1 as observed by 
flow cytometry (Fig. 5.1 B) might be due to the ability of Fluo-Tat or fluorescent 
proteolytic fragments to leave the cells rapidly after entry into the cytosol in the 
absence of bafilomycin A1. In order to test this, MC57 cells were pulsed with the three 
fluorescently-labeled CPPs for 2 h, washed and then incubated with peptide-free 
medium for an additional 3 h (Scheller et al., 2000). The Fluo-Tat peptide was again 
applied at a five-fold higher concentration (5 µM). Cellular fluorescence of MC57 cells 
after pulse and pulse-chase was determined by flow cytometry (Fig. 5.3 A). Both, the 
Fluo-Antp and the Fluo-R9 peptides were not chased out of the cells efficiently. 
However, for Fluo-Tat after a 3 h chase period, only very little fluorescein fluorescence 
remained associated with the MC57 cells. Two different explanations were considered 
as the basis for this experimental outcome. First, in contrast to Penetratin and oligo-
arginine, the Tat peptide itself could possess the ability to exit the cells by crossing the 
plasma membrane. Second, instead of the intact full-length peptide, fluorescent 
fragments generated by proteolytic break-down could leave the cell by diffusion 
through the plasma membrane. In order to answer this question, supernatants of 
MC57 cells after the chase period were desalted, concentrated and analyzed by mass 
spectrometry (Fig. 5.3 B). Peptide fragments bearing an N-terminal carboxyfluorescein 
and one to six amino acids were specifically detected in chase-supernatants of 
peptide-pulsed cells. Intact Tat-peptide could not be detected. This data strongly 
supports that the loss of fluorescence is due to exit of fluorescent peptide fragments 
during the 3 h chase period. 
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Figure 5.3 Pulse/chase experiments. (A) MC57 cells were incubated with Fluo-Antp (1 µM), Fluo-
R9 (1 µM) or Fluo-Tat (5 µM) for 2 h. Internalization was monitored by flow cytometry (P, pulse). For the 
chase value, aliquots of peptide-loaded cells were washed and incubated with peptide-free medium for 
additional 3 h. The remaining cellular fluorescence was determined by flow cytometry (Ch, chase). The 
Fluo-Tat peptide was applied in a five-fold higher concentration in order to compensate for the less 
efficient intracellular accumulation of this peptide. Each condition was tested in duplicate; error bars 
represent the absolute deviations from the mean value. (B) MC57 cells were incubated -/+ 30 µM Fluo-
Tat for 2 h. After 2 h the cells were detached, washed, resuspended in serum-free medium and 
incubated for additional 3 h. The supernatants were desalted, concentrated and subjected to MALDI-
TOF-MS-analysis (B). Fluo-Tat derived signals are highlighted with an asterisk. Calculated [M + H]+: 
Fluo-Y-OH, 540.5 Da; Fluo-YG-OH, 597.6 Da; Fluo-YGR-OH, 753.7 Da; Fluo-YGRK-OH, 881.9 Da; 
Fluo-YGRKK-OH, 1010.1 Da; Fluo-YGRKKR-OH, 1166.3 Da.  
 
A STEPWISE DISSECTION OF THE OF THE INTRACELLULAR FATE OF CATIONIC CPPS  
 
 - 73 -  
5.3.4 Effect on endosomal integrity and intracellular peptide 
stability of CPPs 
Having shown that inhibitors of endosomal acidification inhibited the release of 
cationic CPPs into the cytosol, we next asked whether entry into the cytoplasm 
involves destabilization of endosomal membranes after endosomal acidification. 
Such a mechanism has been described e.g. for peptides containing the N-terminal 
sequence of influenza virus hemagglutinin HA-2 (Plank et al., 1994). MC57 cells 
were incubated with medium containing high molecular weight (10,000 Da) 
AlexaFluor 647-dextran in the absence or presence of Fluo-Antp for 2 h. Dextrans 
are internalized by fluid-phase endocytosis and accumulate in vesicles that appear 
as bright spots (Plank et al., 1994) (Fig. 5.4 B). When MC57 cells were co-
incubated with AlexaFluor 647-dextran and Fluo-Antp the AlexaFluor 647 dextran 
partially co-localized with Fluo-Antp in vesicular structures. However, the 
morphology of the AlexaFluor dextran-spots did not change, even though the Fluo-
Antp peptide clearly localized to the cytoplasm (Fig. 5.4 F and G), indicating that 
Fluo-Antp does not disrupt endosomal membranes. In order to address cellular 
peptide integrity, after 2 h peptide incubation, cell lysates were prepared and 
subjected to MALDI-TOF-MS analysis, essentially as described previously 
(Elmquist and Langel, 2003). Comparison of isolates from peptide-loaded and 
peptide-free cells revealed two peptide-specific signals ([M + H]+ = 2605.3 Da and 
[M + H]+ = 531.3 Da). The former corresponds to the intact Fluo-Antp peptide with 
a calculated [M + H]+ of 2605.1 Da and the latter most likely to Fluo-R-OH with a 
calculated [M + H]+ of 533.5 Da (Fig. 5.4 I).  
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Figure 5.4 Pulse/chase experiments and preservation of endosomal integrity in the 
presence of Fluo-Antp and intracellular stability of Fluo-Antp. MC57 cells were incubated with 
serum-free medium containing 5 µM of AlexaFluor 647-dextran alone (A-D), or a combination of 5 
µM of AlexaFluor 647-dextran and 1 µM Fluo-Antp (E-H) for 2 h, washed and analyzed by multi-
channel confocal laser scanning microscopy. Panels A and E show transmission pictures, panels B 
and F the AlexaFluor 647-dextran fluorescence, panels C and G the fluorescein fluorescence and 
panels D and H the superposition of both fluorescence channels.  
(I) MC57 cells were incubated -/+ 15 µM Fluo-Tat for 2 h. After 2 h the cells were trypsinized, 
washed and lysed. The lysates were desalted, concentrated and subjected to MALDI-TOF-MS-
analysis. Fluo-Antp derived signals are highlighted with an asterisk. Calculated [M + H]+: Fluo-R-
OH, 533.5 Da; Fluo-RQIKIWFQNRRMKWKK-NH2, 2605.1 Da.  
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5.3.5 The subcellular distribution of CPPs is cell-type dependent 
CPPs have been applied for loading of molecules into a variety of different cell 
lines, including tissue culture cells and primary cells growing adherently as well as 
in suspension. A limited number of studies have demonstrated that for a given 
CPP-containing molecule uptake efficiency is cell-type dependent (Mai et al., 
2002;Violini et al., 2002). In these previous studies whole cell read-outs (Mai et al., 
2002) or microscopy of fixed cells (Mai et al., 2002;Violini et al., 2002) were 
employed for comparison of uptake efficiencies. Using confocal microscopy of 
living cells, we determined whether a cell-type dependence could be observed for 
the subcellular distribution of fluorescein-labeled CPPs. HeLa cells were chosen 
as a second cell line, because in the study of Richard et al. (Richard et al., 2003) 
this cell line was also investigated. In contrast to MC57 cells (Fig. 5.5 A, upper 
panels) at a concentration of 1 µM, in HeLa cells the Fluo-Antp peptide was only 
detectable in vesicular structures (Fig. 5.5 A, center panels), as was the case for 
the Fluo-R9 peptide (data not shown). The same difference in localization was 
observed when both cell lines were co-cultivated and co-incubated with the Fluo-
Antp peptide in order to rule out any artifacts from cultivation conditions (Fig. 5.5 
A, lower panels).  
At this point two possibilities were considered as the basis for this observation. 
First, uptake into HeLa cells may be less efficient than uptake into MC57 cells. 
Second, intracellular trafficking may be different in both cell lines. Analysis of 
cellular fluorescence of Fluo-Antp by flow cytometry yielded comparable 
intracellular fluorescence for both cell lines (Fig. 5.5 B). However, vesicular 
accumulation of fluorescein labeled peptides may lead to concentration quenching 
of fluorescein fluorescence (Chen and Knutson, 1988). Moreover, the fluorescence 
of fluorescein is strongly pH dependent, compromising a quantitative comparison 
of the amounts of peptide localized in acidic vesicles with that localized in the 
cytoplasm. For this reason, whole cell lysates of MC57 and HeLa cells loaded with 
peptide were prepared and the amount of fluorescein was determined by 
fluorescence emission spectroscopy (Fig. 5.5 C). In spite of the very similar 
cellular fluorescence observed by flow cytometry, analysis of lysates revealed that 
HeLa cells internalized three times more peptide than MC57 cells (Fig. 5.5 C). For 
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this reason, the differences in the distribution of cellular fluorescence do indeed 
reflect differences in the intracellular trafficking of peptide in these two cell lines. 
However, for treatment with bafilomycin A1, a similar reduction of cellular 
fluorescence was observed for both cell lines, indicating that the differences in 
localization reflect quantitative differences in trafficking rather than a different 
mechanism. 
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Figure 5.5 Cellular distribution and uptake of CPPs in different cell lines. (A) MC57 (upper 
panels) and HeLa (center panels) cells were incubated with serum-free medium containing Fluo-
Antp peptide (1 µM for 2 h) and then analyzed by confocal laser scanning microscopy in the 
presence of peptide in the medium. Fluorescence images are shown in the left panels, 
transmission images in the right panels. In order to exclude incubation conditions as the source of 
the different peptide distributions, both cell lines were co-cultivated and co-incubated with the Fluo-
Antp peptide (lower panels). Arrows indicate MC57 cells, as judged by cell morphology. MC57 and 
HeLa cells were incubated with 4 µM Fluo-Antp for 2 h. Bafilomycin A1 (300 nM) (+) was added 30 
min prior to the peptide, internalization was either determined by flow cytometry (B) or by 
measuring fluorescein concentrations in whole cell lysates (C). The fluorescence present in the cell 
lysates was normalized to the protein content to correct for differences in cell number and cell size. 
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5.3.6 Impact of Golgi-disrupting agents on the uptake and 
distribution of fluorescently labeled CPPs 
Having shown that release of cationic CPPs into the cytosol occurs by a 
mechanism that depends on endosomal acidification and preserves endosomal 
integrity, we next addressed a potential involvement of the Golgi complex in the 
cellular trafficking of cationic CPPs. It was shown recently, that uptake of  a Tat 
fusion protein and Tat-transactivation activity were sensitive to brefeldin A 
(Fittipaldi et al., 2003). We tested whether brefeldin A and nordihydroguaiaretic 
acid (NDGA) (Drecktrah et al., 1998), compounds that interfere both with the 
integrity of the Golgi and the trans-Golgi network (TGN), influence the 
internalization of the cationic CPPs. NDGA is a potent lipoxygenase inhibitor and 
stimulates the rapid retrograde movement of both Golgi stack and TGN 
membranes back to the ER, until both organelles are morphologically absent from 
cells (Drecktrah et al., 1998). Thus NDGA can (i) serve as a Golgi-disrupting drug 
when added prior to the peptide and (ii) provide a means of inducing retrograde 
transport.  
In a first experiment, cells were incubated with brefeldin A or NDGA for 30 min 
prior to the addition of peptides. For both drugs, the cellular fluorescence of Fluo-
R9 and Fluo-Antp was reduced significantly. In contrast, for Fluo-Tat cellular 
fluorescence was reduced by brefeldin A and slightly by NDGA (Fig. 5.6), similar 
to the effects of bafilomycin A and chloroquine on uptake of Fluo-Tat (compare 
Fig. 5.1 B and C).  
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Figure 5.6 Influence of Golgi-disrupting agents on uptake of cell-penetrating peptides. 
MC57 cells were incubated with carboxyfluorescein-labeled cell-penetrating peptides (1 µM) for 2 h 
in serum-free medium in the absence (-) or presence (+) of 20 µM brefeldin A (A) or 25 µM 
nordihydroguaiaretic acid (B), washed, trypsinized and analyzed by flow cytometry. The inhibitors 
were added 30 min before the peptide. Each condition was tested in duplicate; error bars represent 
the absolute deviations from the mean value. 
5.3.7 Induction of retrograde transport of fluorescently-labeled 
CPPs by NDGA 
Since our data suggest that cationic CPPs enter the cytoplasm by means of 
retrograde transport, we tested whether NDGA is able to affect subcellular 
localization of Fluo-Tat in peptide-pulsed cells. In this set of experiments we took 
advantage of NDGA as an inducer of retrograde transport. HeLa cells were pulsed 
with Fluo-Tat for 2 h followed by 3 h incubation with NDGA in the cell culture 
medium (Fig. 5.7). HeLa cells incubated with medium alone during this period 
exhibited only a vesicular fluorescence, whereas in HeLa cells incubated with 
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NDGA-containing medium a cytoplasmic fluorescence was clearly visible (panels 
C and G). In order to exclude that this change in cellular distribution was due to a 
disruption of endosomal compartments by NDGA, cells were co-incubated with 
AlexaFluor 647-dextran. In contrast to the fluorescein-labeled CPP, NDGA did not 
affect the localization of the dextran (panels B and F), indicating that the CPPs 
reach a compartment distinct from endosomal compartments and functionally 
coupled to the cytosol. Similar data were obtained for the Fluo-Antp peptide. 
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Figure 5.7 Induction of retrograde transport by NDGA. HeLa cells were incubated with 5 µM 
Fluo-Tat and 10 µM AlexaFluor 647-dextran. After 2 h cells were washed with serum-free medium 
and then incubated for 3 h in medium with (E-H) or without (A-D) 25 µM NDGA for 3 h. Cellular 
distribution of both the fluorescein fluorescence and the AlexaFluor fluorescence was followed by 
confocal laser scanning microscopy. Panels A and E show transmission pictures, panels B and F 
the AlexaFluor 647-dextran fluorescence, panels C and G the fluorescein fluorescence and panels 
D and H the superposition of both fluorescence channels. 
5.3.8 Co-localization of Fluo-Tat with Golgi-specific fluorescent 
probes 
In order to provide further evidence for the participation of the Golgi-complex in 
the trafficking of cationic CPPs we finally probed for co-localization of Fluo-Tat with 
Golgi membranes. The distortion of the distribution of cationic peptides by fixation 
prohibited an analysis of the co-localization with Golgi-resident proteins by 
immunofluorescence. Instead, cells were incubated with the cell-permeable Golgi 
tracer Bodipy TR ceramide. In MC57 cells (Fig. 5.8, panels A to D) vesicular 
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peptide fluorescence partially co-localized with Golgi-staining, albeit intense 
peptide staining localized to less intensely stained regions of the Golgi complex. In 
HeLa cells (Fig. 5.8, panels E to H) peptide fluorescence present in vesicular 
structures partially co-localized with the cellular regions of Bodipy ceramide 
staining. Similar results were obtained for the Fluo-Antp peptide. 
 
A B C
E F G
D
H
 
 
Figure 5.8 Co-localization of Fluo-Tat and Bodipy ceramide. MC57 (panels A to D) and HeLa 
cells (panels E to H) were incubated with 5 µM Fluo-Tat for 1 h after labeling with Bodipy ceramide. 
Cells were analyzed by confocal laser scanning microscopy in the presence of peptide in the 
medium. Panels D and H show transmission pictures, panels A and E the fluorescein fluorescence 
derived from the Fluo-Tat peptide, panels B and F the fluorescence derived from the fluorescent 
ceramide derivative and panels C and G the superposition of both fluorescence channels. Arrows 
indicate areas where peptide-rich structures co-localize with areas of the Golgi complex. 
 
A STEPWISE DISSECTION OF THE OF THE INTRACELLULAR FATE OF CATIONIC CPPS  
 
 - 81 -  
5.4 Discussion 
Carboxyfluorescein labeled CPPs in combination with inhibitors of endocytosis 
and Golgi-disrupting agents were employed in order to elucidate the intracellular 
fate of cell-penetrating peptides. Artifacts of cellular peptide distribution induced by 
fixation were avoided by conducting all experiments with fluorescein labeled 
peptides in living cells. Fluorescein was selected as a reporter group because of 
minimum impact on the cellular distribution of fluorescently labeled peptides when 
compared to other fluorescent dyes (own unpublished observations). A vesicular 
staining could be observed for Tamra-labeled peptides lacking any CPP-motif. For 
CPPs labeled with the Cy5-like indocyanine dye S0387 a patchy fluorescence at 
the plasma membrane was observed (Fischer et al., 2002). Moreover, large 
collections of fluorescein labeled CPPs can be generated in high yield and purity 
carrying the reporter group at a defined position in the peptide (Fischer et al., 
2002;Fischer et al., 2003). These advantages of fluorescein outweigh the 
limitations imposed by the photophysical characteristics of this dye, i.e. 
concentration quenching (Chen et al., 1988) and pH-dependence of its 
fluorescence characteristics. We addressed these potential drawbacks by 
determining cellular uptake in whole cell lysates. The discrepancies for uptake 
efficiencies derived from flow cytometry and fluorescence spectroscopy underline 
the need for such complementary biochemical analyses. This circumstance needs 
to be considered if quantitative information about molecules entrapped in 
intracellular vesicles is to be obtained.  
MC57 fibrosarcoma cells incubated with Fluo-Tat for 2 h showed a vesicular 
fluorescence, in accordance with the study by Richard et al. (Richard et al., 2003). 
In contrast, both Fluo-R9 and Fluo-Antp also exhibited a homogenous cytoplasmic 
and nuclear fluorescence. This observation is indicative of the escape of these 
latter two CPPs from endocytic compartments and accumulation in the cytoplasm. 
The basis for the failure to detect Tat in the cytosol was clarified by pulse/chase 
experiments and analysis of chase supernatants by mass spectrometry. In 
contrast to Fluo-R9 and Fluo-Antp, after a 3 h chase period in the absence of 
peptide, the cellular fluorescence for Fluo-Tat decreased by more than 90% of the 
value after the peptide pulse. Exit of internalized peptides from the cells into the 
culture medium has already been reported for amphipathic CPPs (Scheller et al., 
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2000). However, the MALDI-MS-analysis of the supernatant of Fluo-Tat pulsed 
MC57 cells provided a different explanation. In the supernatant only 
carboxyfluorescein-labeled fragments of Fluo-Tat carrying one to six amino acids 
could be detected. The poor cellular retention of the Fluo-Tat peptide in MC57 
cells therefore likely reflects a high susceptibility to intracellular proteases and the 
ability of the generated fragments to exit the cells.  
The effective retention of Fluo-R9 and Fluo-Antp inside the cells demonstrates 
that this attribute is sequence- and not dye-specific. Moreover, the sequence-
dependent retention of cellular fluorescence is indicative of intact peptides leaving 
the endocytic compartment. Given the detection of proteolytic Fluo-Tat-fragments 
in the supernatant of Fluo-Tat pulse MC57 cells, the efficient retention of 
fluorescence for the Fluo-R9 and Fluo-Antp peptides after the 3 h chase period 
can as well best be explained by a preservation of structural integrity of peptides, 
reaching the cytosol, in spite of a potential to encounter endolysosomal proteases. 
Using MALDI-MS analysis (Elmquist et al., 2003) we were able to demonstrate the 
intracellular integrity of the Fluo-Antp peptide. Apart from this observation, the 
Fluo-R9 exhibits a nuclear enrichment of fluorescence in MC57 cells in the 
absence of bafilomycin A1 (s. Fig. 5.2 C), which further supports the notion of 
intact peptide entering the cytosol. Highly basic peptide stretches are known to 
serve as conventional nuclear localization sequences (Jans et al., 2000). 
Identification of peptide fragments by MALDI-TOF-MS demonstrates that the 
concentrations of peptide required for a direct analysis of peptide integrity and 
proteolytic degradation are fully compatible with cell biological experiments using 
fluorescence microscopy. Further experiments using inhibitors of cytosolic and 
endosomal proteases in combination with the incorporation of protease-specific 
cleavage motifs, should allow to delineate the basis for the different stabilities of 
Tat and the other two cationic CPPs and enable a rational design of peptides with 
increased stability.  
Since endocytosis and endosomal acidification are required for the lysosomal 
escape of complexes consisting of the cationic polymer polyethylenimine and 
ribozymes (Merdan et al., 2002), we reasoned that cationic CPPs may leave the 
endosomes via a similar mechanism. In order to assess the role of endocytosis for 
the uptake of CPPs, cells were incubated with inhibitors of endocytosis and 
endosomal acidification. In order to exclude inhibitor-dependent artifacts on 
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cellular uptake, experiments were conducted with wortmannin, chloroquine and 
bafilomycin A1 that interfere with endocytosis by different mechanisms. For Fluo-
Antp and Fluo-R9 all three inhibitors led to a decrease of cellular fluorescence. 
The increase of cellular fluorescence for Fluo-Tat in the presence of chloroquine 
and bafilomycin A1 can be explained with the retention of this peptide inside the 
endosomal compartment thereby inhibiting the rapid exit of its fragments from the 
cytosol. Together with the microscopy data obtained, it can be concluded that 
endosomal acidification is required for the delivery of cationic CPPs to the 
cytoplasm. 
Since endocytosis is a well regulated pathway (Gruenberg, 2001), we asked 
whether a cell-type dependence could also be observed for the localization of 
CPPs on the subcellular level. Co-cultivation and co-incubation of MC57 
fibrosarcoma cells and HeLa cells with the Fluo-Antp and the Fluo-R9 peptide 
revealed dramatic differences in subcellular distribution. At 1 µM peptide 
concentration in HeLa cells Fluo-Antp and Fluo-R9 only showed vesicular 
fluorescence. Almost no cytoplasmic fluorescence could be detected. Comparison 
of net uptake of both cell types excluded that the vesicular localization of both 
peptides in HeLa cells resulted from a reduced uptake compared with MC57 cells. 
Bafilomycin A1 reduced the net uptake in both cell lines significantly, consistent 
with a similar uptake mechanism, but differences in the intracellular routing after 
endosomal acidification. The absence of cytoplasmic fluorescence for HeLa cells 
in the presence of equal amounts of extracellular peptides clearly illustrates that a 
comparison of biological activities of CPP constructs in different cell types needs 
to take differences in the subcellular distribution into account. 
Next the mechanism by which CPPs leave the endocytic pathway was 
addressed. Using acidic compartment-specific probes, such as Lysotracker, we 
tested whether the fluorescein-labeled CPPs reach late endosomes or lysosomes. 
However, only little or no co-localization was observed for all three CPPs. In order 
to rule out that the pH-dependent fluorescence properties of fluorescein impaired 
these co-localization studies, we also performed these experiments with 
Penetratin labeled with the indocyanine dye S0387 (Fischer et al., 2002), yielding 
the same results. These data imply that the cationic CPPs leave the endocytic 
compartment at a rather early stage of endosomal maturation.   
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In order to assess whether entry into the cytosol involves endosome disruption, 
cells were co-incubated with CPPs and a fluorescently labeled high-molecular 
weight dextran. However, the presence of the CPP did not affect the distribution of 
the dextran. In addition, the low cytotoxicity of the CPPs (Vives et al., 1997) in 
contrast to agents disrupting endosomes, further supports a mechanism of entry 
that maintains endosomal integrity. 
To this point our observations suggested a mechanism of cellular import that 
occurs via endocytosis and subsequent translocation of the CPPs via an 
acidification-dependent passage through endosomal membranes. Such a 
mechanism would be in line with earlier experiments demonstrating that the 
Penetratin peptide is able to cross a pure lipid bilayer (Thoren et al., 2000). We 
therefore asked whether an acidic extracellular pH enabled a direct non-
endosomal entry of CPPs from the medium into the cytoplasm. Such a pH-
dependent direct passage through the plasma membrane was observed for 
Clostridium botulinum C2 toxin (Barth et al., 2000). This toxin is normally taken up 
by endocytosis and requires oligomerization and endosomal acidification for 
release into the cytosol (Barth et al., 2000). Therefore MC57 cells were briefly 
pulsed with peptide and then incubated with physiological citrate buffer of various 
acidic pH values (pH 5 – 7). However, during the incubation time tolerated by the 
cells, no cytosolic fluorescence was observed (data not shown). 
The failure to obtain evidence for a direct passage of the CPPs from the 
endosomal compartment into the cytoplasm prompted us to address an 
involvement of retrograde transport on cellular trafficking. It was shown that 
brefeldin A affects uptake and cytosolic biological activity of Tat-GFP-fusion 
proteins (Fittipaldi et al., 2003). For this reason, we investigated the effects of 
brefeldin A and NDGA on the net uptake of the fluorescently labeled CPPs in 
MC57 and HeLa cells. When NDGA or brefeldin A were applied to the cells prior to 
the addition of the peptide, the net uptake of Fluo-R9 and Fluo-Antp was reduced 
for both agents, as observed by flow cytometry. However, cellular fluorescence of 
Fluo-Tat treated MC57 cells was slightly enhanced by NDGA (s. Fig. 5.6 B). This 
result implies that for Fluo-Tat, disruption of retrograde trafficking traps this peptide 
in the endosomal compartment thereby preventing its entry into the cytosol and 
rapid cellular exit of its fragments (as shown in Fig. 5.3). This circumstance led to 
an enhanced cellular fluorescence in the case of Fluo-Tat in the presence of 
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NDGA. In the case of Fluo-R9 and Fluo-Antp the absence of TGN and the Golgi 
complex led to reduced uptake. 
In a second series of experiments we utilized the ability of NDGA to induce 
retrograde transport in cells pulsed with Fluo-Tat or Fluo-Antp for 2 h. The 
observed increase of cytoplasmic Tat-fluorescence in peptide-pulsed and 
subsequently NDGA-treated HeLa cells strongly supports an involvement of the 
Golgi apparatus or the trans-Golgi Network (TGN) in the uptake of Tat-peptides (s. 
Figure 7). Essentially the same result was also obtained for Fluo-Antp (data not 
shown). The brefeldin A-sensitive transactivation activity of Tat-GFP fusion 
proteins (Fittipaldi et al., 2003) also supports this hypothesis. The influence of 
furin, a TGN-resident protease on the processing of Tat-MHC class I constructs 
(Lu et al., 2001) provides further evidence for a passage of Tat-peptides through 
the TGN.  
Finally, partial co-localization of Fluo-Tat-derived vesicular structures with the 
Golgi-marker Bodipy ceramide was observed in HeLa cells. Similar co-localization 
data were obtained for Fluo-Antp (data not shown). The inability to detect bulk 
quantities of Fluo-Tat and Fluo-Antp in the Golgi-complex in MC57 cells might be 
due to a rapid passage through this organelle. The plant toxin ricin e.g., which is 
known to traverse the Golgi complex and the ER, has never been visualized by 
microscopy in the ER (Sandvig and van Deurs, 2002). For this reason it was 
initially suggested that ricin A chain translocates from the TGN directly to the 
cytosol (van Deurs et al., 1988). 
For the cationic CPPs, the apparent involvement of the Golgi complex bears 
striking resemblance with features of some bacterial and plant toxins. A number of 
well-characterized toxins reach the cytosol of eukaryotic cells after binding to the 
cell surface, endocytosis by different mechanisms and retrograde transport to the 
Golgi apparatus and the endoplasmic reticulum (for review see (Lord and Roberts, 
1998;Sandvig and van Deurs, 2000)). These toxins, such as ricin and Shiga toxin, 
consist of a membrane binding subunit (B-subunit) and an enzymatically active 
moiety (A-subunit) (Sandvig et al., 2000). Interestingly, a sequence comparison 
with the Tat- and Antp-peptides revealed a highly conserved arginine-rich motif of 
8-10 amino acids in the A subunits of several toxins, which are reported to be 
transported by means of retrograde transport (Tab. 5.2). 
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Table 5.2 Arginine-rich motifs in plant and bacterial toxins. Primary structures of the 
arginine-rich motifs with high sequence homology to the HIV-1 Tat peptide. Sequence homologies 
were identified by visual inspection of the respective proteins. The arginine-rich sequence of the 
HIV-1 Tat protein is included as entry 5. Sequence information was obtained from 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi. 
 
Entry Protein Organism NCBI  
Accession 
number 
Protein function Sequence 
localization 
Amino acid 
sequence 
1 Verotoxin-2 
variant, subunit 
A 
Escherichia 
coli 
AAP37403 Cleavage of 
glycoside bond 
within 28S rRNA 
192-201 RFRQIQREFR 
2 Shiga toxin, 
subunit A 
Shigella 
dysenteriae 
AAF28121 Cleavage of 
glycoside bond 
within 28S rRNA 
192-201 RFRQIQRGFR
3 Cholera 
enterotoxin, A 
chain 
 
Vibrio 
cholerae 
P01555 ADP-
ribosylation of 
Gsα 
159-166 RNRGYRDR 
4 Ricin, A chain  Ricinus 
communis 
2AAIA Cleavage of 
glycoside bond 
within 28S rRNA 
189-207 RTRIRYNRR 
       
5 Tat, 
transactivating 
regulatory 
protein 
 
Human 
immuno-
deficiency 
virus 1 
P04613 Transcriptional  
regulation 
49-57 RKKRRQRRR 
  
 
In addition to other motifs (e.g. the KDEL sequence) within these toxins, these 
arginine-rich motifs may therefore represent a common structural basis for a 
shared route of import along the retrograde pathway of this diverse class of 
proteins. Another fascinating similarity of both cationic CPPs and Golgi-targeted 
toxins is the fact that both Shiga toxin subunit A and Tat-MHC class I epitope-
constructs are processed proteolytically by furin, a TGN-resident protease (Garred 
et al., 1995;Lu et al., 2001). Furthermore a recent study on gentamicin, a member 
of the amino glycoside family of antibiotics, corroborated our findings on the 
retrograde transport of cationic CPPs. This work provided evidence that amino 
glycosides and other cationic amino glycoside structural analogues, such as low 
molecular weight cationic dextrans are transported through the Golgi complex and 
to the ER. These findings indicate that retrograde transport may serve as a 
common rote of transport for a number of different cationic low molecular weight 
compounds (Sandoval and Molitoris, 2003).      
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Figure 5.9 Dissection of intracellular trafficking of cationic CPPs by small molecule drugs. 
(A) Summary of the results of CPP-trafficking along the endosomal and retrograde pathway 
obtained using small molecule inhibitors. (B, C) Effect of NDGA on the localization and trafficking of 
cationic CPPs upon (B) incubation of cells with the compound before addition of peptide and (C) 
addition after a 2 h pulse with peptide that allowed the peptide to enter the Golgi and trans-Golgi 
network. Dark shades indicate an accumulation of peptide in the respective compartment.  
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5.5 Materials and Methods 
5.5.1 Materials 
Standard chemicals for peptide chemistry were obtained from Fluka 
(Deisenhofen, Germany) and Merck (Darmstadt, Germany); solvents were p. a. 
grade. Fmoc-amino acids were purchased from Novabiochem (Heidelberg, 
Germany), Senn Chemicals (Dielsdorf, Switzerland), and Orpegen Pharma 
(Heidelberg, Germany). The isomeric mixture of (5)6-carboxyfluorescein was from 
Fluka, AlexaFluor 647-dextran (anionic; MW 10,000 Da) and Bodipy TR ceramide 
were obtained from Mobitech (Göttingen, Germany). Bafilomycin A1 was from 
Tocris Biotrend (Bristol, UK), chloroquine diphosphate from Fluka, 
nordihydroguaiaretic acid (NDGA) from Alexis Biochemicals (Grünberg, Germany), 
wortmannin from Calbiochem (Bad Soden, Germany) and brefeldin A from Sigma 
(Taufkirchen, Germany). 
5.5.2 Peptide synthesis 
Automated peptide synthesis was performed by solid-phase Fmoc/tBu-chemistry 
using an automated peptide synthesizer for multiple peptide synthesis (RSP5032, 
Tecan, Hombrechtlikon, Switzerland) in 2 ml syringes according to the following 
protocol: Fmoc-amino acids (twelve-fold excess) were coupled by in situ activation 
using DIC/HOBt for 90 min followed by removal of the Fmoc-protecting group by 
treatment with piperidine/DMF (1:4, v/v) twice for 8 min. The resin was washed 
with DMF (6x) after each coupling and deprotection step. The side chain of Tyr 
was tBu-protected, the side chain of Arg was Pbf-protected, the side chains of Gln 
and Asn were Trt-protected and the side chains of Lys and Trp were Boc-
protected. Peptide amides were synthesized on Rink amide resin (Rapp Polymere, 
Tübingen, Germany). 
Peptides were cleaved off the resin by treatment with TFA/TIS/EDT/H2O 
(92.5:2.5:2.5:2.5, v/v/v/v) for 4 h. Crude peptides were precipitated by adding cold 
diethyl ether (-20°C). The precipitated peptides were collected by centrifugation 
and resuspended in cold diethyl ether. This procedure was repeated twice. Finally 
peptides were dissolved in tBuOH/H2O (4:1, v/v) and lyophilized.  
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5.5.3 Labeling of peptides with carboxyfluorescein 
N-terminal labeling of peptides with 5(6)-carboxyfluorescein was essentially 
performed as described (Fischer et al., 2003): Fmoc-deprotected, resin bound 
peptides were reacted with 5 equiv of 5(6)-carboxyfluorescein, DIC, HOBt, each in 
DMF for 16 h in 2 ml syringes on a shaker at RT. Reactions were stopped by 
washing the resins 3 times each with DMF, MeOH, DCM and diethyl ether. 
Subsequently, peptides were treated with piperidine/DMF (1:4, v/v) in order to 
remove ester bound carboxyfluorescein (Fischer et al., 2003). Completeness of 
amine acylation was confirmed using the Kaiser-Test (Sarin et al., 1981). 
5.5.4 HPLC 
Peptides and conjugates were analyzed by analytical RP-HPLC using a water 
(0.1% TFA) (solvent A)/ACN (0.1% TFA) (solvent B) gradient on a Waters 600 
System (Eschborn, Germany) with detection at 214 nm. The samples were 
analyzed on an analytical column (Nucleosil 100, 250 x 2 mm, C18 column, 5 µm 
particle diameter; Grom, Herrenberg, Germany), using a linear gradient from 10% 
B to 100% B within 30 min (flow rate: 0.3 ml/min). Peptides were purified by 
preparative RP-HPLC (Nucleosil 300, 250 x 20 mm, C18 column, 10 µm particle 
diameter; Grom, Herrenberg, Germany) on a Waters 600 Multisolvent Delivery 
System (flow rate: 10 ml/min). Gradients were adjusted according to the elution 
profiles and peak profiles obtained from the analytical HPLC chromatograms.  
5.5.5 MALDI-TOF-MS of synthetic peptides. 
1 µl of DHAP matrix (20 mg of DHAP, 5 mg of ammonium citrate in 1 ml of 
isopropyl alcohol/H2O (4:1, v/v)) was mixed with 1 µl of each sample (dissolved in 
ACN/water (1:1) at a concentration of 1 mg/ml) on a gold target. Measurements 
were performed using a MALDI-TOF system (G2025A, Hewlett-Packard, 
Waldbronn, Germany). For signal generation 20-50 laser shots were added up in 
the single shot mode. 
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5.5.6 Peptide stock solutions 
Carboxyfluorescein-labeled peptides were dissolved in DMSO at concentrations 
of 10 mM. These stock solutions were further diluted 1:20 in ddH2O. Peptide 
concentrations were determined by UV/VIS-spectroscopy of a further 1:100 
dilution in 0.1 M Tris/HCl buffer (pH 8.8) with absorptions measured at 492 nm and 
assuming a molar extinction coefficient of 75,000 L/(mol⋅cm).  
5.5.7 Cell culture 
The adherent MC57 fibrosarcoma cell line (Hosaka et al., 1986) and HeLa cells 
were grown in a 5% CO2 humidified atmosphere at 37°C in RPMI 1640 medium 
with stabilized glutamine and 2.0 g/L NaHCO3 (PAN Biotech, Aidenbach, 
Germany) supplemented with 10% fetal calf serum (PAN Biotech), 100 U/ml 
penicillin, and 100 µg/ml streptomycin (Biochrom, Berlin, Germany). Both cell lines 
were passaged by trypsinization with trypsin/EDTA (0.05/0.02% (w/v)) (Biochrom) 
in PBS every third to fourth day. 
5.5.8 Flow cytometry 
MC57 or HeLa cells were seeded at a density of 50,000 per well in 24 well 
plates (Sarstedt, Nümbrecht, Germany) in serum-containing RPMI 1640. One day 
later, the cells were washed with serum-free RPMI 1640 and incubated in 200 µl 
serum-free RPMI 1640 containing the appropriate inhibitors. After the indicated 
periods of time, peptides were added as described in the results section. Each 
condition was tested in duplicate. After a 2 h incubation, cells were washed with 
PBS, detached by trypsinization for 10 min, suspended in ice cold PBS containing 
0.1% (w/v) BSA, and measured immediately by flow cytometry. The fluorescence 
of 5000 vital cells was acquired. Vital cells were gated based on sideward scatter 
and forward scatter.  
For pulse/chase experiments, MC57 cells were washed three times with PBS 
after 2 h peptide incubation and then incubated with 500 µl serum-free RPMI 1640 
for additional 3 h. Cells were then washed with PBS, detached by trypsinization for 
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10 min, suspended in ice cold PBS containing 0.1% (w/v) BSA, and measured by 
flow cytometry as described above. In order to compare the pulse and the 
pulse/chase values, fluorescence intensities of fluorescent calibration beads 
(Mobitech) were also acquired for each series of measurements. 
5.5.9 Confocal laser scanning microscopy 
Confocal laser scanning microscopy was performed on an inverted LSM510 
laser scanning microscope (Carl Zeiss, Göttingen, Germany) fitted with a Plan-
Apochromat 63x 1.4 N.A. lens. All measurements were performed with living, non-
fixed cells. 
MC57 cells were seeded at a density of 10,000/well in eight-well chambered 
cover glasses (Nunc, Wiesbaden, Germany). Two days later, before addition of 
inhibitors or peptides, cells were washed once with serum-free RPMI 1640. 
Bafilomycin A1 was added at a concentration of 300 nM in 200 µl serum-free 
RPMI 1640 30 min before addition of peptides. After 2 h incubation with peptides, 
images were acquired immediately at RT with excess peptide in the medium. 
For double detection of fluorescein-labeled peptides and AlexaFluor 647-dextran 
the 488 nm line of an Argon Ion laser and the light of a 633 nm Helium/Neon laser 
were directed over an HFT UV/488/633 beam splitter and fluorescence was 
detected using an NFT 545 beam splitter in combination with a BP 505-530 band 
pass filter for fluorescein detection and an LP 650 long pass filter for AlexaFluor 
647-detection. Peptides and AlexaFluor 647-dextran were added as indicated in 
the results section. After 2 h cells were washed three times with serum-free RPMI 
1640 followed immediately by confocal microscopy at RT. For the induction of 
retrograde transport, after 2 h incubation with peptide and dextran, cells were 
washed three times with serum-free RPMI 1640 followed by incubation with 25 µM 
NDGA for 3 h in RPMI. 
For double detection of fluorescein-labeled peptides and Bodipy TR ceramide 
the 488 nm line of an Argon-ion laser and the light of a 543 nm Helium/Neon laser 
were directed over an HFT UV/488/543 beam splitter and fluorescence was 
detected using an NFT 545 beam splitter in combination with a BP 505-530 band 
pass filter for fluorescein detection and an LP 560 long pass filter for Bodipy-
detection.  
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Staining of the Golgi complex in living cells with fluorescent ceramide was 
essentially performed as described by the supplier. Briefly MC57 and HeLa cells 
were seeded at a density of 10,000/well in eight-well chambered cover glasses. 
Two days later, cells were washed once with ice-cold HBSS + 10 mM HEPES (pH 
7.4) (HBSS/HEPES), and then incubated with HBSS/HEPES (containing 5 µM 
sphingolipid and 5 µM BSA, prepared as described by the supplier) for 30 min on 
ice and in the dark. Cells were rinsed three times with ice-cold HBSS/HEPES and 
incubated with the indicated peptide in serum-free medium for 1 h at 37°C in the 
incubator. Confocal microscope images were then acquired immediately at RT 
with excess peptide in the medium. 
5.5.10 MALDI-TOF-MS of peptide-containing cell culture 
supernatant 
A confluent cell layer of MC57 cells in a 25 cm2 tissue culture flask was washed 
once with serum-free RPMI 1640 and incubated with 1 ml serum-free RPMI 1640 
containing 30 µM Fluo-Tat. After 2 h the cells were detached using 5 mM 
EDTA/PBS, transferred into a fresh tube and washed twice with 10 ml PBS. 
EDTA/PBS was used instead of trypsin/EDTA/PBS in order to exclude that peptide 
fragments were generated by residual amounts of trypsin during the chase period. 
Cells were then suspended in 500 µl serum-free RPMI 1640 and incubated for 3 h 
at 37°C in the incubator. The cells were spun down and the cell-free supernatant 
was acidified using 100 µl 0.1% HCl. The yellow sample (the yellow colour 
originated from phenol red) was immediately desalted on a G1001A Sample Prep 
Station (Hewlett Packard) and concentrated to a volume of about 10 µl in a Speed-
Vac concentrator. MS-analysis was performed using a “Future” MALDI-TOF-MS 
(GSG, Mess-und Analysengeräte GmbH, Bruchsal). 1 µl of DHAP matrix was 
mixed with 1 µl of the sample on a gold target. For signal generation 35-50 laser 
shots were added up in the single shot mode (positive ion mode). Instrument 
calibration was performed using two synthetic peptides (calculated [M + H]+: 
1156.7 and 2859.4 Da).  
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5.5.11 Co-incubation of MC57 and HeLa cells 
Intracellular peptide stability was investigated essentially as described 
elsewhere (Elmquist et al., 2003). A confluent cell layer of MC57 cells in a 25 cm2 
tissue culture flask was washed once with serum-free RPMI 1640 and incubated 
with 1 ml serum-free RPMI 1640 containing 15 µM Fluo-Antp. After 2 h the cells 
were washed twice with PBS, detached by trypsinization for 10 min at 37°C, 
transferred into a fresh tube and washed three times with 10 ml PBS (to remove 
trypsin and extracellular trypsinized peptide). Cells were then lysed in 200 µl 0.1% 
HCl for 10 min at RT. The cell lysate was then centrifuged for 10 min at 4°C and 
14,000 rpm. The peptide-containing supernatant was immediately desalted and 
concentrated to a volume of about 10 µl, as described above. MS-analysis of the 
sample was performed using a “Future” MALDI-TOF-MS, as described above. 
5.5.12 Co-incubation of MC57 and HeLa cells 
For co-incubation experiments 5,000 of each MC57 and HeLa cells per well 
were seeded in an eight-well chambered cover glass. Two days later, cells were 
washed once with serum-free RPMI 1640 and 200 µl serum-free RPMI 1640 was 
added. Peptides were added as indicated in the results section. After 2 h peptide 
incubation, pictures were immediately acquired at RT, leaving excess peptide in 
the medium. 
5.5.13 Quantification of cellular internalization of fluorescein-
labeled CPPs by fluorescence emission spectroscopy in whole 
cell lysates 
MC57 and HeLa cells were seeded in 6 well plates (Sarstedt) in serum-
containing RPMI 1640. Two days later, the confluent cell layer was washed with 
serum-free RPMI 1640 and incubated with 500 µl serum-free RPMI 1640 +/- 
bafilomycin A1 for 30 min. Then Fluo-Antp was added and after 2 h incubation, 
cells were washed twice with PBS, detached by trypsinization for 15 min, 
transferred into a fresh tube and washed twice with 10 ml PBS (to remove trypsin 
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and trypsinized peptide). Cells were then lysed in 200 µl NP-40 lysis buffer (0.5% 
(v/v) NP-40, 150 mM NaCl, 5 mM EDTA, 50 mM TRIS, pH 7.0, containing 
protease inhibitor cocktail, Roche Diagnostics, Mannheim, Germany). The lysates 
were then sonicated and centrifuged for 30 min at 4°C and 14.000 rpm. 
Fluorescein concentrations were determined in the supernatant using an LS50B 
spectrofluorometer (Perkin-Elmer, Norwalk, CT, USA), with excitation at 492 nm 
and detection of emission at 520 nm. The protein content of the lysates was 
determined using a commercially available Bradford protein assay kit (Bio-Rad 
Laboratories, München, Germany). Each condition was tested in duplicate. 
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6. A doubly-labeled Penetratin analogue as a ratiometric sensor 
for intracellular proteolytic stability 
 
This chapter will be submitted in 2005. The author of this thesis contributed all 
figures presented.  
6.1 Summary 
The cellular delivery of bioactive molecules by cell-penetrating peptides (CPPs) 
is rapidly gaining significance in biomedical research. Given endocytosis as an 
import mechanism for cationic CPPs it is required to assess in detail the 
consequences of this import mechanism on intracellular integrity of the vector and 
cargo. In this work a Penetratin analogue terminally labeled with two different 
fluorophores was synthesized and used as a sensor to quantitatively dissect the 
contribution of intracellular proteolytic activities on break-down. Using a panel of 
protease inhibitors, the endocytic compartment was identified as the major site of 
degradation. In contrast, inhibition of the proteasome had little effect on 
intracellular peptide integrity. The ability to monitor break-down of CPPs once 
inside the cell will enable a rational optimization of the peptide-based delivery of 
vaccines and therapeutic oligonucleotides. 
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6.2 Introduction 
The lipid bilayer of the plasma protects the cellular content from entry of 
pathogens and molecules that interfere with cellular function and replication. Only 
molecules within a narrow range of molecular size, net charge and polarity are 
able to directly cross the plasma membrane by passive diffusion along a 
concentration gradient (Lipinski et al., 2001). However, the introduction of 
membrane-impermeable molecules into mammalian cells has important 
implications in biomedical research as well as in basic science (Stephens et al., 
2001). Applications include the import of siRNAs interfering with gene expression 
(Chiu et al., 2004) or peptides that disrupt molecular interactions in cellular signal 
transduction (Prochiantz, 1996). 
Peptide-mediated import has been attracting growing attention as a delivery 
technology during the last decade (for reviews see (Fischer et al., 2001;Langel, 
2002)). Cell-penetrating peptides (CPPs) represent a group of functional peptides 
with little cell-type specificity. These peptides mediate the non-invasive import of 
cargo molecules into cells ex vivo as well as in whole animals (Schutze-
Redelmeier et al., 1996;Schwarze et al., 1999). Cargos have been peptides 
(Prochiantz, 1996;Hawiger, 1999), proteins as large as 120 kDa (Rojas et al., 
1998;Schwarze et al., 1999), oligonucleotides (Astriab-Fisher et al., 2002), 
plasmids (Singh et al., 1999), siRNA (Muratovska et al., 2004), peptide nucleic 
acids (PNAs) (Pooga et al., 1998b) and even nanoparticles (Lewin et al., 2000). 
The majority of these cargos exert their biological activity inside the cytoplasm or 
the nucleus of the treated cells. It is therefore generally assumed that CPPs 
mediate the transfer of these cargos into these two compartments 
The amphipathic and basic Penetratin peptide, derived from the third helix of the 
homeodomain of the Drosophila Antennapedia transcription factor, has been used 
widely as a CPP (Derossi et al., 1994). Despite its broad acceptance as a 
molecular carrier, the mechanism of internalization of the Penetratin peptide is still 
not fully understood. Originally, the internalization of the Penetratin peptide into the 
cytoplasm had been described to occur by a direct translocation across the 
plasma membrane independently of endocytosis (Derossi et al., 1994). Consistent 
with this early cellular data, the transfer of Penetratin across a pure lipid bilayer 
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without forming pores (Thoren et al., 2000;Persson et al., 2003) was 
demonstrated.  
However recent data demonstrated that endocytosis is clearly involved in the 
internalization of the Penetratin peptide (Drin et al., 2003;Fischer et al., 2004). 
Functionally, the endocytic uptake was supported by the observation that the 
Penetratin peptide promotes the endocytosis of high molecular weight cargo upon 
binding to cell surface glycosaminoglycans (Console et al., 2003). However, for 
cationic CPPs taken up by endocytosis the mechanism by which these molecules 
are actually released into the cytoplasm still needs to be resolved. Evidence was 
presented that endosomal acidification is involved in this process (Potocky et al., 
2003;Fischer et al., 2004;Vendeville et al., 2004). In addition, independently of the 
actual membrane translocation step, a strong propensity to bind to the plasma 
membrane had been shown to be crucial for cellular uptake (Drin et al., 2001).  
In order to gain insight into the molecular details of membrane permeation, the 
secondary structure of CPPs and especially the one of the Penetratin peptide has 
been a matter of great interest. Circular dichroism measurements showed that 
Penetratin peptides are randomly structured in aqueous buffers (Magzoub et al., 
2001). Binding to model membranes induces distinct secondary structure, the 
nature of which depends strongly on the experimental conditions and model 
system. Both β-sheet and α-helical structures have been reported (Berlose et al., 
1996;Bellet-Amalric et al., 2000;Lindberg and Graeslund, 2001;Persson et al., 
2001;Magzoub et al., 2002;Salamon et al., 2003). Membrane charge and the 
peptide/lipid ratio have impact on the conformation of the peptide (Christiaens et 
al., 2002;Magzoub et al., 2002;Magzoub et al., 2003). 
Given the endocytic uptake of Penetratin and other cationic CPPs two key 
questions arise. First, the role of peptide-membrane interactions for trafficking and 
cytoplasmic release inside the cell has not been clarified. Secondly, the break-
down by endolysosomal proteases has not been investigated. In order to answer 
these questions, specific biosensors that report on the state of the peptide inside 
the cell are required. 
The analysis of cellular trafficking and peptide membrane interactions has 
benefited greatly from the incorporation of fluorophores as reporter moieties. In 
cellular applications, the trafficking and distribution of fluorescently labeled CPPs 
may be followed in living cells (Waizenegger et al., 2002;Richard et al., 2003). Live 
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cell experiments avoid the problems associated with the fixation of CPP-loaded 
cells (Richard et al., 2003). In addition, loading efficiencies may be compared 
quantitatively by flow cytometry (Richard et al., 2003;Fischer et al., 2004). In 
biophysical analyses, the dependence of the spectral characteristics of a 
fluorophore on the environment has been employed for the generation of sensors 
to probe for membrane interactions and transfer across lipid bilayers (Christiaens 
et al., 2002).  
A major difference between biophysical and cellular experiments is the exposure 
to proteolytic activities in the latter case. In order to exploit the potential of 
fluorescence-based biosensors for the analysis of the trafficking and interactions 
of CPPs inside the cell, a biosensor has to report on both, the chemical 
environment and the integrity of the peptide. This combination of read-outs may be 
achieved via incorporation of two different fluorophores. Peptides incorporating 
two different fluorescent dyes have served as sensors for conformational changes 
(Wei et al., 1994;Geoghegan et al., 2000) and proteolytic breakdown (Cummings 
et al., 2002). Förster (Fluorescence) resonance energy transfer (FRET) (Clegg, 
1995) provides a sensitive read-out for molecular events affecting the proximity of 
the reporter groups.  
To our knowledge all investigations using fluorescently labeled CPPs so far 
were limited to the attachment of only one single fluorophore. The majority of 
these studies have been performed with fluorescein-labeled analogues. 
Applications of 7-nitrobenz-2-oxo-1,3-diazol-4-yl (NBD) (Drin et al., 2001), 
rhodamine-based dyes (Penco et al., 2001;Fischer et al., 2002) and indocyanine-
based fluorophores (Fischer et al., 2002) have been reported, however. 
Combinations of dyes suitable for FRET-based sensors can readily be selected 
from this panel of fluorophores.  
In order to address the molecular details of intracellular trafficking and break-
down, we synthesized a Penetratin analogue terminally labeled with fluorescein 
and tetramethylrhodamine. In vitro analyses of the spectral characteristics 
confirmed that this peptide constitutes a sensitive biosensor for membrane 
interactions and proteolytic break-down. By incubation of cells with this peptide in 
the presence of a variety of protease inhibitors we could quantitatively account for 
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the contribution of distinct proteolytic activities. Protocols were developed for 
detecting the fraction of intact peptide in cell lysates as well as in intact cells.  
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6.3. Results 
6.3.1 Straight-forward synthesis of doubly-labeled Penetratin 
The synthesis of the doubly-labeled Penetratin analogue benefited from a 
previously presented Rink amide-based resin for the synthesis of peptide 
collections labeled with carboxyfluorescein (Fluo) at the C-terminus (Fischer et al., 
2003, Chapter 3). This resin is preloaded with a lysine carrying a tritylated 
carboxyfluorescein at its α-amino group. Following automated solid-phase peptide 
synthesis (SPPS) of the Penetratin peptide (termed Antp, sequence 
RQIKIWFQNRRMKWKK (Derossi et al., 1994)), the N-terminus was derivatized 
manually with carboxytetramethylrhodamine (Tamra) using the succinimidylester 
(Figure 6.1. A). The resulting peptide was cleaved off the resin and analyzed. The 
purity of the doubly-labeled Penetratin analogue (Tamra-Antp-Fluo, sequence: 
Tamra-RQIKIWFQNRRMKWKK-εLys(Fluo)-NH2) after reduction of the methionine 
sulfoxide (Beck and Jung, 1994) was 80% (HPLC, 214 nm; Fig. 6.1 B and C), a 
purity comparable with the one of unlabeled Penetratin synthesized according to 
the same protocol on Rink amide resin. Standard RP-HPLC purification was 
sufficient to obtain the peptide in high purity for further applications. The synthesis 
strategy eliminates the need for orthogonal side chain protecting groups for the 
introduction of two different labels (Hoogerhout et al., 1999) and is therefore 
applicable to the straightforward synthesis of collections of different CPPs. 
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Figure 6.1 (A) Scheme for the synthesis of the doubly-labeled Penetratin peptide amide Tamra-
RQIKIWFQNRRMKWKK-εLys(Fluo)-NH2 (Tamra-Antp-Fluo). The Penetratin peptide is assembled 
by automated solid-phase peptide synthesis (a) on the free ε-amino group of the Nα-
carboxyfluorescein-labeled lysyl-Rink amide resin (Fischer et al., 2003), followed by (b) introduction 
of the second fluorophore at the N-terminus of the solid-phase bound peptide, and (c) cleavage of 
the peptide amide off the resin and side-chain deprotection. In order to further increase the purity of 
the raw product, the methionine sulfoxide was subsequently reduced as described previously (Beck 
et al., 1994). (B) MALDI-TOF mass spectrum (theor. [M+H]+ = 3145.7 Da) and (C) HPLC elution 
profile of the crude Tamra-RQIKIWFQNRRMKWKK-εLys(Fluo)-NH2 peptide.  
6.3.2 In vitro proteolytic digestion of Tamra-Antp-Fluo 
Fluo and Tamra were selected as a pair of fluorophores for Förster resonance 
energy transfer (FRET) (i) because of their large spectral overlap, (ii) the availability of 
optimized synthesis procedures, and (iii) the compatibility of these dyes with the 
import of CPPs (Fischer et al., 2002). The emission spectrum of fluorescein overlaps 
extensively with the absorption spectrum of Tamra, making this pair very suitable for 
energy transfer experiments to determine distances within and between labeled 
macromolecules (Murchie et al., 1989;Sjöback et al., 1995). Nevertheless 
fluorescence emission spectra showed that the fluorescence of both dyes in the 
Tamra-Antp-Fluo peptide was almost completely quenched (Fig. 6.2 A, B), a result 
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which is consistent with previous reports (Wei et al., 1994;Packard et al., 1997). This 
loss of fluorescence in both channels was attributed to a mechanism involving 
intramolecular dimer formation of the two fluorophors (Wei et al., 1994). As expected, 
upon digestion with trypsin the fluorescence emission of both fluorophores was 
enhanced significantly (Fig. 6.2 A, B).  
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Figure 6.2 Tamra-Antp-Fluo as proteolytic sensor. Fluorescence emission spectra of Tamra-
Antp-Fluo (100 nM) in HBS with excitation at (A) 492 nm and (B) 541 nm with (upper curves) and 
without (lower curves) digestion with proteinase K (100 µg/ml, 1 h, 37°C). (C) Fluorescence ratios 
were calculated for the data shown in A (digest in HBS, first two columns) and for an identical 
digest in NP40 lysis buffer. Each condition was tested in duplicate; error bars represent the 
absolute deviations from the mean value. 
 
In order to rule out that the differences in fluorescence emission were caused by the 
adhesion of the intact peptide to plastic and glass (Chico et al., 2003), the ratio of the 
fluorescein versus rhodamine emission upon excitation at 492 nm was calculated (Fig. 
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6.2 C). This strategy renders the detection of changes in the fluorescence spectra 
robust towards changes in concentration (Miyawaki et al., 1997). The ratio was almost 
doubled upon proteinase K-digestion in HBS buffer from about 1.7 to 3.0. In 
detergent-containing NP40-lysis buffer the ratiometric difference between intact and 
digested peptide was far more pronounced, the ratio was about 0.3 for the intact 
peptide and 2.8 for the digested peptide.  
6.3.3 Monitoring peptide/membrane interactions with Tamra-
Antp-Fluo 
It was shown previously, that the binding of a 13 amino acid peptide terminally 
labeled with fluorescein and rhodamine to an antibody specific for the peptide, 
diminished the dimer quenching (Wei et al., 1994). Instead, FRET was detected. 
Dimer quenching and FRET therefore provide the basis for a robust read-out for 
molecular interactions that spatially separate the termini of a peptide. We therefore 
investigated whether the induction of secondary structure upon binding of Penetratin 
to lipid bilayers resulted in a similar change in the spectral characteristics. Emission 
spectra were recorded for the Penetratin analogue in the presence of small 
unilamellar phospholipid vesicles (SUVs). A strong increase of Tamra emission and 
the ratio of Tamra over fluorescein emission upon excitation at 492 nm (fluorescein 
excitation) were observed in the presence of SUVs, consistent with the presence of 
FRET (Fig. 6.3 A, B). The disruption of the fluorophore dimer upon binding to SUVs 
was further substantiated by the increase in Tamra emission upon excitation at 541 
nm (Fig. 6.3 C). In order to exclude that the increase in Tamra fluorescence was due 
solely to an increase in quantum yield of this fluorophore upon interaction with the lipid 
bilayer, the mono Tamra-labeled control peptide (Tamra-RQIKIWFQNRRMKWKK-
NH2) was tested as well. Significantly less Tamra emission was observed in the 
presence of SUVs upon excitation at 492 nm (Fig. 6.3 D). For the Tamra-Antp-Fluo 
analogue, FRET is therefore a read-out for the interaction of the peptide with 
phospholipid membranes. In summary, the Tamra-Antp-Fluo peptide is a sensitive 
ratiometric sensor for membrane-induced conformational changes and proteolytic 
break-down. The ratiometric determination of the spectral characteristics renders the 
use of this peptide robust to changes in concentration.  
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Figure 6.3 Tamra-Antp-Fluo as a sensor for peptide/membrane interactions. (A) 
Fluorescence emission spectra of Tamra-Antp-Fluo, with excitation at 492 nm in the absence 
(lower curve) or presence (upper curve) of small unilamellar vesicles (SUV). (B) Fluorescence 
ratios calculated from the data shown in A (Each condition was tested in duplicate; error bars 
represent the absolute deviations from the mean value.) (C) Fluorescence emission spectra of 
Tamra-Antp-Fluo (upper curve) and Tamra-Antp (lower curve) with excitation at 492 nm in the 
presence of SUV. (D) Fluorescence emission spectra of Tamra-Antp-Fluo (upper curve) and 
Tamra-Antp (lower curve) with excitation at 540 nm in the presence of SUV. 
6.3.4 Confocal fluorescence microscopy of Tamra-Antp-Fluo-
incubated cells 
The in vitro spectral characteristics should render Tamra-Antp-Fluo a sensitive 
sensor for probing the state of this peptide inside mammalian cells. As a first step we 
performed live cell confocal fluorescence microscopy of murine MC57 cells incubated 
with Tamra-Antp-Fluo. In these cells, the Penetratin peptide was demonstrated to 
access the cytoplasm in an endocytosis and acidification-dependent manner (Fischer 
et al., 2004). The Tamra-Antp-Fluo peptide was taken up efficiently (Fig. 6.4). A high 
degree of co-localization for the fluorescence of both fluorophores could be observed 
in vesicular structures. However, little Tamra fluorescence was detectable within the 
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cytoplasm or the nucleus. In contrast, pronounced fluorescein fluorescence was 
present in these compartments. Furthermore, some vesicular structures contained 
either fluorescein or Tamra. This differential localization is indicative of proteolytic 
breakdown within the endocytic compartment and preferential release of fluorescein 
labeled fragments into the cytoplasm. We have observed previously, that Tamra-
labeled peptides have a higher propensity for being retained in vesicular structures 
(Fischer et al., 2002).  
 
A DCB
20 µm  
Figure 6.4 Cellular co-localization studies using Tamra-Antp-Fluo. MC57 cells were incubated 
with 1 µM Tamra-Antp-Fluo for 2 h. Living cells were then analyzed by confocal laser scanning 
microscopy in the presence of peptide in the medium. Panel A shows the Tamra fluorescence, panel B 
the fluorescein, panel C the superposition of both fluorescence channels and panel D shows the 
transmission picture. Arrows indicate spots where only one single fluorophore is present. 
6.3.5 Ratiometric fluorescence emission measurements in cell 
lysates 
Next, we intended to identify in more detail the degree of break-down and the 
proteases involved in the intracellular degradation of the peptide. The incubation of 
cells with different inhibitors that affect the activity of cellular proteases should lead to 
different fluorescence properties within subcellular compartments, as it was presented 
for doubly-labeled dextrans (Zen et al., 1992) or transferrins (Zen et al., 1992;van 
Weert et al., 1995). Inside intact cells, the reduction of fluorescein fluorescence by the 
acidic conditions in the endosomes (Sjöback et al., 1995) and concentration 
quenching sets a limit to a quantitative assessment of the proteolytic break-down 
using a microscopic approach (Chen et al., 1988).  
For this reason, we complemented the cellular analyses by spectral analyses in cell 
lysates. MC57 cells were pulsed with the Tamra-Antp-Fluo peptide in the absence and 
presence of inhibitors that affect the activity of proteases inside the cell. After the 
peptide incubation the cell suspensions were first split into two aliquots (Fig. 6.5 A).  
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Figure 6.5 Ratiometric fluorescence emission spectroscopy in cell lysates. (A) Protocol for the 
measurement of fluorescence emission ratios in cell lysates. (B) MC57 cells were incubated with 3 µM 
Tamra-Antp-Fluo for 2 h in serum-free medium in the absence or presence of different inhibitors (100 
µM chloroquine, 300 nM bafilomycin A1, 50 µM furin inhibitor, 50 µM lactacystin). The inhibitors were 
added 30 min prior to the peptide. Cells were then washed, removed from the tissue culture plate using 
EDTA/PBS. Cell lysates were then prepared as described in the experimental section. In brief one half 
was lysed in NP40-lysis buffer containing protease inhibitors. After sonication and centrifugation, 
fluorescence emission spectra were recorded immediately with excitation at 492 nm (upper panel). The 
other half of the peptide pulsed cells was lysed in NP40-lysis buffer. After sonication and centrifugation, 
proteinase K was added. Lysates were then digested for 16 h at 37°C. Fluorescence emission spectra 
were then recorded with excitation at 492 nm (lower panel). (C) Fluorescence ratios were calculated 
from the data shown in B. Each condition was tested in duplicate; error bars represent the absolute 
deviations from the mean value. 
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One half of the cell population was lysed in the presence of protease inhibitors to 
prevent post-lysis proteolysis. Fluorescence emission spectra upon fluorescein 
excitation were recorded immediately (Fig. 6.5 B, upper panel). The second half of the 
cell suspensions were lysed in lysis buffer. These aliquots of the lysates were then 
digested with proteinase K in order to cleave all peptides present in the lysates before 
recording of emission spectra (Fig. 6.5 B, lower panel). The higher the contribution of 
a proteolytic activity to the degradation, the higher the difference in the fluorescence 
ratios should be for both aliquots of one sample.  
A set of four different inhibitors was selected. Bafilomycin A1 (Bowman et al., 
1988;Clague et al., 1994) and chloroquine (de Duve et al., 1974;Kozak et al., 1999) 
represent widely used inhibitors of endosomal acidification (for review see, (Mellman 
et al., 1986)) and therefore also inhibitors of endolysosomal proteolysis. For cationic 
CPPs both drugs abolished the release of theses peptides into the cytoplasm (Fischer 
et al., 2004), indicating that for cationic CPPs endosomal acidification and maturation 
are required for accessing the cytoplasm. The role of endosomal acidification has 
been validated for proteolytically stable (Frackenpohl et al., 2001) cell-penetrating β-
peptides (Potocky et al., 2003) and in an functional assay for the HIV-1-Tat protein 
(Vendeville et al., 2004;Rayne et al., 2004). As a proteolytic inhibitor that blocks a 
major protease activity in the cytoplasm lactacystin was selected, a bacterial 
metabolite that selectively inhibits the 20S proteasome (Fenteany et al., 1995;Dick et 
al., 1996). Finally, a furin synthetic inhibitor was included. The protease furin is 
ubiquitously expressed and localized mainly in the trans-Golgi network, although 
some portion of the furin molecules cycle between this compartment and the cell 
surface. Furin cleaves proteins and peptides within stretches containing cationic 
amino acid residues (Nakayama, 1997) and more importantly furin was recently 
demonstrated to cleave the HIV-1 Tat protein in monocytoid cells (Tikhonov et al., 
2004).  
Digestion with proteinase K led to fluorescence emission ratios very similar to the 
value of 2.8 for all samples observed for digested Tamra-Antp-Fluo in NP-40 lysis 
buffer (Fig. 6.2 C). For cells pulsed with peptide in the absence of inhibitor, the ratio 
was 2.3 indicative of significant degradation of peptides inside the cells. Bafilomycin 
A1 and chloroquine had the strongest effects. The emission ratios decreased in both 
cases to about 0.9. Lactacystin and the furin inhibitor had a little, albeit significant 
effect on the emission ratios (Fig. 6.5 C). These results suggest that the endosomal 
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passage has a major impact on the integrity of the peptide inside the cell. The 
proteasome seems to cleave only a rather small amount of the intracellular peptide.  
6.3.6 Cysteine proteases mediate the intracellular degradation of 
Penetratin 
Endolysosomal proteases require an acidic pH for activity. For this reason, the 
inhibitory effect on endolysosomal proteolysis exerted by both bafilomycin A1 and 
chloroquine is rather indirect, through inhibition of acidification. Therefore at this stage 
it could not be concluded whether the increased integrity of the peptides caused by 
both drugs was due to the inhibition of endolysosomal proteases or due to the 
inhibition of an acidification-dependent entry into the cytoplasm (Potocky et al., 
2003;Fischer et al., 2004). In the latter case, lactacystin-insensitive cytoplasmic 
proteases would contribute significantly to the break-down. In order to resolve this 
issue peptide-pulsed cells were incubated with the broadband cysteine protease 
inhibitors leupeptin (Vidard et al., 1991) and E-64d  (Tamai et al., 1986). Members of 
the aspartic acid and cysteine proteases make up most of the proteases that are 
present in the endolysosomal compartment. Most mammalian lysosomal cysteine 
proteases are known as cathepsins, although not all cathepsins are cysteine 
proteases (Honey and Rudensky, 2003). Both leupeptin and E-64d reduced the 
proteolytic degradation of Tamra-Antp-Fluo significantly, albeit not as drastically as 
bafilomycin A1 (Fig. 6.6 A). 
The investigation of intracellular proteolysis of proteins and peptides is of high 
general relevance for the cellular import of bioactive molecules. In immunology, in 
particular, the endolysosomal pathway is the major route of entry and processing for 
foreign antigens to be presented by antigen-presenting cells. Analysis of the 
processing of peptides and proteins in the endolysosomal compartment is therefore of 
major significance, both, for understanding the basis of antigen-presentation and for 
the development of immunotherapeutics (Honey et al., 2003). Cellular analyses by 
flow cytometry are well established within immunological research. For this reason, we 
next tested whether the ratiometric approach was also applicable to this technique. In 
this case, different concentrations were tested for E-64d and leupeptin. For both 
inhibitors, the ratiometric values within the cell lysates correlated with the 
concentration of the inhibitor (Fig. 6.6 B). The same finding was observed for the 
A DOUBLY-LABELED PENETRATIN ANALOGUE AS RATIOMETRIC SENSOR 
 
 - 109 -  
analysis of cellular fluorescence by flow cytometry (Fig. 6.6 C). The differences in the 
absolute ratiometric values determined with both techniques may be due, first, to the 
different size of the spectral windows, and second, due to concentration- and pH-
dependent quenching effects of the fluorophores inside the cells. Still, both sets of 
values exhibited a strong linear correlation (Fig. 6.6 D).  
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Figure 6.6 Involvement of cysteine proteases in the cellular degradation of Tamra-Antp-Fluo. 
(A) MC57 cells were incubated with Tamra-Antp-Fluo (4 µM) for 2 h in serum-free medium in the 
absence or presence of different inhibitors, as indicated. The inhibitors were added 30 min prior to the 
peptide. Cells were then washed, detached from the tissue culture plate using EDTA/PBS. Cells were 
then washed once more lysed in NP40-lysis buffer containing protease inhibitors. After sonication and 
centrifugation, fluorescence emission spectra were recorded immediately with excitation at 492 nm and 
fluorescence ratios were calculated from the data. (B) The same procedure as under (A) was performed 
applying different concentrations of cysteine protease inhibitors (ratios in cell lysates are shown, each 
condition was tested in duplicate; error bars represent the absolute deviations from the mean value) (C) 
A small fraction of the cells from (B) was subjected to flow cytometry analysis before lysis and ratios of 
FL-1 (fluorescein) versus FL-2 (Tamra) were calculated. Each condition was tested in duplicate; error 
bars represent the absolute deviations from the mean value. (D) For each condition the different ratios 
obtained in B (measurements in cell lysates) and C (flow cytometric data) were plotted. 
A DOUBLY-LABELED PENETRATIN ANALOGUE AS RATIOMETRIC SENSOR 
 
 
 - 110 - 
6.3.7 The endolysomal compartment is the major site of 
degradation of Penetratin 
Since both E-64d and leupeptin are not selective towards endolysosomal cysteine 
proteases it could not be ruled out that the inhibition of cytoplasmic cysteine 
proteases, such as calpains, also accounted for the enhanced peptide stability. This 
could especially be the case as (i) endosomal acidification was shown also to play a 
role for the release of proteolytically stable peptides into the cytoplasm and (ii) the 
proteasome contributed little to the degradation of the peptides. Live cell confocal 
microscopy was performed in the absence or presence of different inhibitors in order 
to resolve this ambiguity.  
A
C
B
20 µm
 
 
Figure 6.7 Impact of cysteine protease inhibitors on subcellular distribution of Tamra-
Antp-Fluo. MC57 cells were incubated with Tamra-Antp-Fluo (4 µM) for 2 h in serum-free medium 
in the absence or presence of different inhibitors (panels A, no inhibitor; panels B, 300 nM 
bafilomycin A1; panels C, 30 µM E-64d). The inhibitors were added 30 min prior to the peptide. Left 
panels show the Tamra fluorescence, the fluorescein channel, the superposition of both 
fluorescence channels. Right panels show the transmission pictures. 
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If the degradation was mediated primarily by endolysosomal cysteine proteases, 
the co-localization of both fluorophores should increase. Incubation of cells with E-
64d increased the degree of co-localization and reduced the cytoplasmic 
fluorescein fluorescence (Fig. 6.7 B). Still the E-64d induced phenotype was 
different from the one induced by bafilomycin A1 (Fig. 6.7 C). Instead of being 
concentrated at a region next to the nucleus for bafilomycin A1, peptide-loaded 
vesicles were strongly present also in the periphery of the cells  
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6.4 Discussion 
The results presented in this paper provide a first semi-quantitative account of 
the intracellular fate of the cell-penetrating peptide Penetratin. The analyses were 
based on an analogue of the Penetratin peptide, terminally labeled with two 
different fluorescent dyes. The synthetic route originated from our previously 
developed Fluo(Trt)-Lys-resin (Fischer et al., 2003), demonstrating that this 
reagent provides a straight-forward and rapid access to highly pure doubly-labeled 
peptides, when compared to other previously published protocols for this dye 
combination (Wei et al., 1994;Hoogerhout et al., 1999;Li et al., 1999;Kruger et al., 
2002). The fluorescence characteristics of Tamra-Antp-Fluo provided a sensitive 
read-out for the interaction with lipid bilayers and proteolytic break-down. 
Detection of the conformational changes induced upon membrane interaction in 
fact greatly benefited from the dimer quenching observed for conformationally 
disordered peptides, labeled with these two fluorophores. The fluorescence 
characteristics were fully compatible with analyses by fluorescence spectroscopy, 
confocal laser scanning microscopy and flow cytometry. 
Our data underline that a large fraction of the peptide entering the cell within 2 h 
incubation had been degraded in the endolysosomal compartment. Our analyses 
therefore confirm that the endocytic uptake has a major impact on peptide 
integrity. The small but significant effect of lactacystin demonstrates, however, that 
intact peptide reaches the cytosol. By a combination of results obtained for the 
effects of bafilomycin A1 and chloroquine on the one hand, and leupeptin and E-
64d on the other hand, the amount of peptide reaching the cytosol in an intact form 
can be estimated to be around 10-20% of the total peptide entering the cell. 
In the original contribution on Penetratin it was found that this peptide is mainly 
found in its intact form inside the cell (Derossi et al., 1994). The assay was based 
on the detection of biotinylated peptides using Western Blot analysis. Another 
more recent contribution has investigated the intracellular stability of the CPP 
pVEC as a CPP using matrix-assisted laser desorption ionization mass 
spectrometry. One might argue that the preparation of cell lysates introduces novel 
artefacts similar to those introduced by fixation (Richard et al., 2003). However, 
one major advantage of the doubly-labeled peptide is that the same molecule can 
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be applied to different fluorescence-based techniques. The results can then be 
cross-validated. We demonstrate that the measurements in the cell lysates 
strongly correlated with live cell techniques i.e. flow cytometry and live cell 
fluorescence microscopy. The results obtained for the doubly-labeled Penetratin 
analogue also demonstrate that one needs to be cautious about the results 
obtained for peptides carrying only one label. Elimination of cytoplasmic 
fluorescein fluorescence upon incubation with leupeptin and E-64d indicates that 
this fluorescence may originate from fluorescein-labeled peptide fragments 
released into the cytoplasm. 
Interestingly, our results suggest that the proteasome contributes little to the 
degradation of the cytosolic population of peptides. The contribution of the 
proteasome is in line with observations obtained from processing studies dealing 
with penetrating-MHC I epitope constructs (Pietersz et al., 2001). This result is 
highly relevant or the development of CPP-based peptide vaccines, since CPPs 
offer the advantage of a rational vaccine design. In a recent study, Tat-epitope 
constructs were joined via furin-sensitive linkers, which led to enhanced 
generation of peptide/MHC complexes (Lu et al., 2004). 
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6.5 Materials and Methods 
6.5.1 Materials 
Standard chemicals for peptide chemistry were obtained from Fluka 
(Deisenhofen, Germany) and Merck (Darmstadt, Germany); solvents were p. a. 
grade. Fmoc-amino acids were purchased from Novabiochem (Heidelberg, 
Germany), Senn Chemicals (Dielsdorf, Switzerland), and Orpegen Pharma 
(Heidelberg, Germany). Fmoc-Lys(Dde)-OH was purchased from Novabiochem 
(Läufelfingen, Schweiz). Rink amide resin was from Rapp Polymere (Tübingen, 
Germany). The isomeric mixtures of 5(6)-carboxyfluorescein (Fluo) and 5(6)-
carboxytetramethylrhodamine (Tamra)-N-succinimidylester were from Fluka 
(Deisenhofen, Germany). Bafilomycin A1 was from Tocris Biotrend (Bristol, UK), 
chloroquine diphosphate from Fluka, the furin inhibitor (Dec-RVKR-CMK) from 
Calbiochem (Bad Soden, Germany), lactacystin from Prof. Corey (Harvard 
University, USA), E-64d from Serva (Heidelberg, Germany) and leupeptin from 
Bachem (Bubendorf, Switzerland). 1-palmitoyl-2-oleoyl-phosphatidylcholine 
(POPC) and 1-palmitoyl-2-2-oleoyl-phosphatidylglycerol (POPG) were purchased 
from Avanti Polar Lipids (Alabaster, Alabama, USA).  
6.5.2 Peptide synthesis and analysis 
Automated peptide synthesis was performed by solid-phase Fmoc/tBu-chemistry 
using an automated peptide synthesizer for multiple peptide synthesis (RSP5032, 
Tecan, Hombrechtlikon, Switzerland) in 2 ml syringes according to the following 
protocol: Fmoc-amino acids (twelve-fold excess) were coupled by in situ activation 
using DIC/HOBt for 90 min followed by removal of the Fmoc-protecting group by 
treatment with piperidine/DMF (1:4, v/v) twice for 8 min. The resin was washed 
with DMF (6x) after each coupling and deprotection step. Side chains of Asn and 
Gln were Trt-protected and the side chains of Lys and Trp were Boc-protected, the 
side chain of Arg was Pbf-protected. Peptides were cleaved off the resin by 
treatment with TFA/TIS/EDT/H2O (92.5:2.5:2.5:2.5, v/v/v/v) for 4 h. Crude peptides 
were precipitated by adding cold diethyl ether (-20°C). The precipitated peptides 
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were collected by centrifugation and resuspended in cold diethyl ether. This 
procedure was repeated twice. Finally, peptides were dissolved in tBuOH/H2O 
(4:1, v/v) and lyophilized.  
Peptides and conjugates were analyzed by analytical RP-HPLC using a water 
(0.1% TFA) (solvent A)/ACN (0.1% TFA) (solvent B) gradient on a Waters 600 
System (Eschborn, Germany) with detection at 214 nm. The samples were 
analyzed on an analytical column (Nucleosil 100, 250 x 2 mm, C18 column, 5 µm 
particle diameter; Grom, Herrenberg, Germany), using a linear gradient from 10% 
B to 100% B within 30 min (flow rate: 0.3 ml/min). Both peptides were purified by 
preparative RP-HPLC (Nucleosil 300, 250 x 20 mm, C18 column, 10 µm particle 
diameter; Grom, Herrenberg, Germany) on a Gilson preparative system (Bad 
Camberg, Germany, equipped with a 321 Pump and a 156 UV/Vis Detector, flow 
rate 10 ml/min). Gradients were adjusted according to the elution profiles and peak 
profiles obtained from the analytical HPLC chromatograms. Peptide purities of 
both peptides used in this study were > 98% (214 nm, HPLC).  
MALDI-TOF-MS. 1 µl of 2,5-dihydroxyacetophenone (DHAP) matrix (20 mg of 
DHAP, 5 mg of ammonium citrate in 1 ml of isopropyl alcohol/H2O (4:1, v/v)) was 
mixed with 1 µl of each sample (dissolved in ACN/water (1:1) at a concentration of 
1 mg/ml) on a gold target. Measurements were performed using a MALDI-TOF 
system (G2025A, Hewlett-Packard, Waldbronn, Germany). For signal generation 
20-50 laser shots were added up in the single shot mode. 
6.5.3 Solid-phase synthesis of Tamra-Antp-Fluo and Tamra-
Antp 
The doubly-labeled peptide Tamra-Antp-Fluo was synthesized using our 
previously developed Fluo(Trt)-Lys-Rink amide resin (Fischer et al., 2003). The 
peptide RQIKIWFQNRRMKWKK-CONH2 was assembled on this resin in a 15 
µmol scale as described above. A small fraction of this peptide was cleaved off 
and analyzed (RQIKIWFQNRRMKWKK-εLys(Fluo)-CONH2, (purity 80% (HPLC, 
214 nm), calc. [M+H]+ = 2733.3 Da, exp. [M+H]+ = 2733.3  Da, determined by 
MALDI-MS)). 5 µmol of the resin bound and side-chain protected peptide was then 
reacted with   5(6)-carboxytetramethylrhodamine-N-succinimidyl ester (10 µmol, 
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5.3 mg) in DMF (200 µl) containing DIPEA (25 µmol, 4.3 µl). After 16 h, the resin 
was thoroughly washed. Cleavage and deprotection of the doubly-labeled peptide 
amide was performed as described above. The peptide was dissolved in 
ACN/water, lyophilized and analyzed by HPLC and MALDI-MS. Methionine 
sulfoxide reduction was performed as described elsewhere (Beck et al., 1994). 
The peptide was then purified as described by preparative HPLC for spectroscopic 
characterization.  
The mono labeled peptide Tamra-Antp (Tamra-RQIKIWFQNRRMKWKK- 
CONH2) was synthesized on Rink amide resin in a 15 µmol scale. N-terminal 
labeling with Tamra and all other steps were performed as described above for 
Tamra-Antp-Fluo. 
Both peptides were dissolved in DMSO at concentrations of 10 mM. These stock 
solutions were further diluted 1:20 in ddH2O. Peptide concentrations were 
determined by UV/VIS-spectroscopy of a further 1:100 dilution in methanol. 
Absorptions of these solutions were measured at 540 nm (ε = 95.000 l/(mol⋅cm)). 
6.5.4 Fluorescence emission spectra 
Fluorescence emission spectra were recorded at RT using an LS50B 
spectrofluorometer (Perkin-Elmer, Norwalk, CT, USA). The spectra were corrected 
for the sensitivity of the detection system. The excitation and emission bandwidths 
were set to 10 nm.  
6.5.5 Preparation of small unilamellar vesicles (SUVs) 
Vesicles were prepared by initially dissolving the phospholipids (1-palmitoyl-2-2-
oleoyl-phosphocholine (=POPC) and 1-palmitoyl-2-2-oleoyl-phosphoglycerol 
(=POPG)) at a concentration of 25 mg/ml in chloroform. Then the appropriate 
volumes of both solutions were mixed to obtain a ratio of 70/30 (w/w, 
POPC/POPG)). The solvent was removed by placing the sample under high 
vacuum. The dried lipids were then dispersed in the appropriate volume of HBS 
buffer (final concentration 1 mM). The solution was vigorously mixed and 
incubated for 1 h at RT. The sample was then mixed again and sonicated untill the 
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solution turned clear. All steps for SUV-containing solutions were performed using 
glass tubes and glass syringes, in order to prevent adsorption of the lipids to 
plastic surfaces. 
6.5.6. Cell culture 
The adherent MC57 fibrosarcoma cell line (Hosaka et al., 1986) was grown in a 
5% CO2 humidified atmosphere at 37°C in RPMI 1640 medium with stabilized 
glutamine and 2.0 g/l NaHCO3 (PAN Biotech, Aidenbach, Germany) supplemented 
with 10% fetal calf serum (PAN Biotech), 100 U/ml penicillin, and 100 µg/ml 
streptomycin (Biochrom, Berlin, Germany). Both cell lines were passaged by 
trypsinization with trypsin/EDTA (0.05/0.02% (w/v)) (Biochrom) in PBS every third 
to fourth day. 
6.5.7 Confocal laser scanning microscopy 
Confocal laser scanning microscopy was performed on an inverted LSM510 
laser scanning microscope (Carl Zeiss, Göttingen, Germany) fitted with a Plan-
Apochromat 63x 1.4 N.A. lens. All measurements were performed with living, non-
fixed cells. MC57 cells were seeded at a density of 10,000/well in eight-well 
chambered cover glasses (Nunc, Wiesbaden, Germany). Two days later, before 
addition of inhibitors or peptides, cells were washed once with serum-free RPMI 
1640. The indicated inhibitor was added in 200 µl serum-free RPMI 1640 30 min 
before addition of peptides. After 2 h incubation with peptides, images were 
acquired immediately at RT with excess peptide in the medium. For double 
detection of fluorescein and Tamra the 488 nm line of an Argon-Ion laser and the 
light of a 543 nm Helium-Neon laser were directed over an HFT 488/543 beam 
splitter and fluorescence was detected using an NFT 545 beam splitter in 
combination with a BP 505-530 band pass filter for fluorescein detection and an 
LP 560 long pass filter for Tamra-detection.  
6.5.8 Fluorescence emission measurements in cell lysates 
MC57 were seeded in 6 well plates (Sarstedt, Nümbrecht, Germany) in serum-
containing RPMI 1640. Two days later, the confluent cell layer was washed with 
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serum-free RPMI 1640 and incubated with 500 µl serum-free RPMI 1640 (+/- the 
indicated inhibitor) for 30 min. Then Tamra-Antp-Fluo was added and after 2 h 
incubation, cells were washed twice with PBS, detached using EDTA (5 mM)/PBS 
(10 min at 37°C), transferred into a fresh tube and washed twice with 1 ml PBS. A 
small fraction of the cells was used for flow cytometric analysis. Cell suspensions 
were then resuspended in 1 ml PBS and split into half. Both suspensions were 
then transferred into a fresh tube and spun down. Following removal of the 
supernatants, one half was lysed in 200 µl NP-40 lysis buffer (0.5% (v/v) NP-40, 
150 mM NaCl, 5 mM EDTA, 50 mM TRIS, pH 7.0, containing protease inhibitor 
cocktail (Roche Diagnostics, Mannheim, Germany). Theses lysates were then 
sonicated and centrifuged for 30 min at 4°C and 14,000 rpm. Fluorescence 
emission spectra of the supernatants were recorded immediately (excitation 492 
nm). These lysates were always stored on ice. The second half of the cells was 
lysed in 180 µl NP-40 lysis buffer. Theses lysates were then also sonicated and 
centrifuged for 30 min at 4°C and 14.000 rpm. 20 µl of proteinase K-solution (10 
mg/ml, Sigma, Taufkirchen) was then added to the supernatants. After 16 h 
fluorescence emission spectra of the supernatants were recorded (excitation 492 
nm). 
6.5.8 Flow cytometry 
Flow cytometry was performed on a FACS-Calibur (Becton Dickinson). The 
fluorescence of 5000 vital cells was acquired. Vital cells were gated based on 
sideward and forward scatter. For calculating the fluorescence emission ratios the 
median fluorescence intensities of 5000 vital cells were taken. Under the 
experimental conditions, about 35% of the fluorescein emission intensity was 
detectable in the FL-2 channel (= Tamra-channel), whereas no fluorescence 
emission from Tamra was detectable in the FL-1 channel (fluorescein-channel). 
The data obtained were not compensated for this cross-talk. 
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